RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: hepatocellular carcinoma
Accession: DOID:684
browse the term
Definition: A liver carcinoma that has_material_basis_in undifferentiated hepatocytes and located_in the liver. (DO)
Synonyms: exact_synonym: Childhood Hepatocellular Carcinoma; HCC; Hepatocellular Cancer; Hepatocellular Carcinoma, Childhood Type, Somatic; LCC; adult liver cancer; adult liver cancers; hepatocellular cancers; hepatocellular carcinomas; hepatoma; hepatomas; liver cell carcinoma; liver cell carcinomas
narrow_synonym: HEPATOBLASTOMA; HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION; hepatitis B virus induced hepatocellular carcinoma; hepatitis C virus induced hepatocellular carcinoma; hepatitis virus-related hepatocellular carcinoma
primary_id: MESH:D006528
alt_id: OMIM:114550
xref: EFO:0000182 ; EFO:0000189 ; EFO:0008503 ; EFO:0008504 ; EFO:0008505 ; ICD-O:M8170/3; ICDO:8170/3; NCI:C129298 ; NCI:C24029 ; NCI:C3099 ; NCI:C38756 ; NCI:C60416 ; ORDO:88673
For additional species annotation, visit the
Alliance of Genome Resources .
G
A2m
alpha-2-macroglobulin
ISO
mRNA,protein:increased expression:liver: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15509519 PMID:15509519
RGD:1358261
NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
G
A530016L24Rik
RIKEN cDNA A530016L24 gene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:112,455,829...112,466,362
Ensembl chr12:112,455,882...112,466,361
G
Aadat
aminoadipate aminotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:60,958,877...60,998,711
Ensembl chr 8:60,958,966...60,998,711
G
Abca1
ATP-binding cassette, sub-family A member 1
severity
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:16941710 PMID:30580964
RGD:1598532 , RGD:24922199
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism: : c.1465C > T(human) DNA:polymorphism: :c.3751G>A(human)
CTD RGD
PMID:17510421 PMID:25625052 PMID:23488625 PMID:24175826
RGD:11041138 , RGD:14700904 , RGD:14700905
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcb4
ATP-binding cassette, sub-family B member 4
ISO IAGP
CTD Direct Evidence: marker/mechanism OMIM:114550
CTD MouseDO
PMID:22022477
NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
G
Abcc3
ATP-binding cassette, sub-family C member 3
ISO
mRNA:increased expression:liver
RGD
PMID:25842354
RGD:11535155
NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
G
Abce1
ATP-binding cassette, sub-family E member 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:21932399
RGD:11041873
NCBI chr 8:80,410,071...80,438,369
Ensembl chr 8:80,410,091...80,438,369
G
Abl1
c-abl oncogene 1, non-receptor tyrosine kinase
IMP
RGD
PMID:32171747
RGD:126907997
NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239
G
Acaca
acetyl-Coenzyme A carboxylase alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477
G
Ace
angiotensin I converting enzyme
susceptibility
ISO
CTD Direct Evidence: therapeutic DNA:insertion/deletion:intron 16:
CTD RGD
PMID:16328049 PMID:25208933
RGD:11343535
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Acer3
alkaline ceramidase 3
disease_progression
ISO
RGD
PMID:30097213
RGD:35673325
NCBI chr 7:97,863,015...97,970,415
Ensembl chr 7:97,855,596...97,970,415
G
Acly
ATP citrate lyase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr11:100,367,178...100,418,826
Ensembl chr11:100,367,179...100,418,826
G
Aco2
aconitase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr15:81,756,664...81,799,338
Ensembl chr15:81,756,510...81,799,334
G
Acox1
acyl-Coenzyme A oxidase 1, palmitoyl
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12771043 PMID:15565109
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
G
Acsl4
acyl-CoA synthetase long-chain family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr X:141,100,989...141,173,792
Ensembl chr X:141,100,989...141,173,531
G
Actb
actin, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:21472284
NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19514085
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
G
Adamts13
ADAM metallopeptidase with thrombospondin type 1 motif 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:26,863,363...26,899,638
Ensembl chr 2:26,863,428...26,899,640
G
Add1
adducin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 5:34,731,008...34,789,652
Ensembl chr 5:34,731,008...34,789,652
G
Adgrg7
adhesion G protein-coupled receptor G7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:56,544,972...56,616,369
Ensembl chr16:56,544,972...56,616,218
G
Adh4
alcohol dehydrogenase 4 (class II), pi polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:138,121,217...138,138,444
Ensembl chr 3:138,121,227...138,136,653
G
Adipoq
adiponectin, C1Q and collagen domain containing
susceptibility
ISO
DNA:SNP:intron:+276T>G (rs1501299) (human)
RGD
PMID:23740135
RGD:14401720
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adra1a
adrenergic receptor, alpha 1a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:66,872,705...67,009,549
Ensembl chr14:66,872,700...67,008,617
G
Adra2b
adrenergic receptor, alpha 2b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:127,205,099...127,209,141
Ensembl chr 2:127,205,128...127,209,141
G
Afp
alpha fetoprotein
severity disease_progression treatment
ISO
protein:increased expression:serum (human) associated with hepatitis B CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9029167 PMID:15276417 PMID:24012840 PMID:28284560 PMID:32961231 PMID:22147961 PMID:28611981 PMID:25968302 PMID:22392353 PMID:25999787 More...
RGD:14401581 , RGD:126790579 , RGD:126790583 , RGD:125097525 , RGD:152177911
NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766
G
Aicda
activation-induced cytidine deaminase
IGI
RGD
PMID:18997814
RGD:127285629
NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139
G
Ak3
adenylate kinase 3
ISO
protein:decreased expression:liver
RGD
PMID:17203974
RGD:13842477
NCBI chr19:28,968,715...29,026,122
Ensembl chr19:28,998,233...29,025,361
G
Akr1a1
aldo-keto reductase family 1, member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32805337
NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877
G
Akr1b1
aldo-keto reductase family 1 member B
ISO
protein:increased expression:liver (human) protein:increased expression:liver (rat)
RGD
PMID:19422879 PMID:21683810
RGD:8548685 , RGD:5509919
NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
G
Akr1b10
aldo-keto reductase family 1, member B10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885
G
Akr1c21
aldo-keto reductase family 1, member C21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
G
Akt1
thymoma viral proto-oncogene 1
treatment
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hepatocellular cancer
CTD ClinVar RGD
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 PMID:18954143 PMID:19418217 PMID:19487299 PMID:19853286 PMID:20233444 PMID:20453058 PMID:21464312 PMID:21512767 PMID:21793738 PMID:22538770 PMID:22610119 PMID:22722201 PMID:22722839 PMID:22980975 PMID:23237847 PMID:23348505 PMID:23700467 PMID:23728071 PMID:23934607 PMID:24190505 PMID:24657128 PMID:25157968 PMID:25741868 PMID:26619011 PMID:28492532 PMID:32045588 PMID:31801250 PMID:25999787 More...
RGD:151893509 , RGD:152177911
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Akt2
thymoma viral proto-oncogene 2
ISO IEP
protein:increased phosphorylation:liver cancer cell (rat) protein:increased phosphorylation:liver (mouse)
RGD
PMID:19309364 PMID:28100771
RGD:2313299 , RGD:127285675
NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251
G
Alb
albumin
susceptibility
ISO
associated with hepatitis C;protein:decreased expression:serum protein:decreased expression:serum (human)
RGD
PMID:23892757 PMID:29040987 PMID:22392353
RGD:11035269 , RGD:14694841 , RGD:125097525
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
susceptibility severity no_association
ISO
associated with alcoholic liver cirrhosis;DNA:missense mutation:cds:p.E487K (human) DNA:missense mutation:cds, exon 12:p.E487K (human) associated with hepatitis C:DNA:SNP:exon 12 (human) protein:decreased expression: liver (human) mRNA, protein:decreased expression:liver (human) DNA:missense mutation:cds: (rs671) (human) associated with hepatitis B;DNA;missense mutation, haplotype:cds: (rs671) (human) DNA:missense mutation:exon 12: (human) associated with alcohol use disorder;DNA:missense mutation:cds: (human)
RGD
PMID:25778454 PMID:1916152 PMID:12940444 PMID:26150517 PMID:28027570 PMID:29765251 PMID:26827895 PMID:10737710 PMID:18439068 More...
RGD:11054822 , RGD:14696699 , RGD:14696778 , RGD:14696779 , RGD:15036809 , RGD:14700899 , RGD:15042857 , RGD:15042859 , RGD:15042862
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Aldh7a1
aldehyde dehydrogenase family 7, member A1
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr18:56,657,794...56,706,112
Ensembl chr18:56,642,759...56,706,023
G
Aldoc
aldolase C, fructose-bisphosphate
ISO
mRNA:increased expression:liver
RGD
PMID:3830170
RGD:2301136
NCBI chr11:78,213,899...78,218,607
Ensembl chr11:78,213,794...78,218,607
G
Alx4
aristaless-like homeobox 4
ameliorates
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:28081728 PMID:31132711 PMID:31132711
RGD:153323329 , RGD:153323330 , RGD:153323330
NCBI chr 2:93,472,779...93,511,686
Ensembl chr 2:93,472,729...93,511,684
G
Angptl6
angiopoietin-like 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:20,785,104...20,791,116
Ensembl chr 9:20,785,104...20,791,023
G
Ank3
ankyrin 3, epithelial
IEP
protein:decreased expression:liver
RGD
PMID:26652480
RGD:153344559
NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268
G
Anln
anillin, actin binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:22,243,305...22,302,132
Ensembl chr 9:22,243,308...22,300,484
G
Antxr1
anthrax toxin receptor 1
treatment
IDA
RGD
PMID:20650339
RGD:9684932
NCBI chr 6:87,110,835...87,312,757
Ensembl chr 6:87,110,835...87,312,803
G
Anxa10
annexin A10
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 8:62,510,076...62,576,227
Ensembl chr 8:62,510,076...62,576,184
G
Anxa2
annexin A2
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:33675609
RGD:152999436
NCBI chr 9:69,360,978...69,399,074
Ensembl chr 9:69,360,902...69,399,077
G
Anxa4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 6:86,713,822...86,770,616
Ensembl chr 6:86,713,822...86,770,566
G
Anxa6
annexin A6
disease_progression
ISO
associated with tumor vascularization; protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr11:54,869,779...54,924,297
Ensembl chr11:54,869,934...54,924,271
G
Apc
APC, WNT signaling pathway regulator
ISO IAGP
OMIM:114550 DNA:hypermethylation ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma CTD Direct Evidence: marker/mechanism
OMIM MouseDO ClinVar CTD RGD
PMID:1316610 PMID:8381579 PMID:8381580 PMID:9536098 PMID:9824584 PMID:11247896 PMID:11466687 PMID:15311282 PMID:15459959 PMID:17293347 PMID:17489848 PMID:17576681 PMID:18199528 PMID:19793053 PMID:20223039 PMID:20685668 PMID:21859464 PMID:21901162 PMID:22135120 PMID:22425061 PMID:22431159 PMID:22447671 PMID:22703879 PMID:23159591 PMID:23460355 PMID:23484150 PMID:24033266 PMID:24448499 PMID:24573554 PMID:24599579 PMID:24728327 PMID:25186627 PMID:25479140 PMID:25590978 PMID:25637381 PMID:25741868 PMID:25925381 PMID:25980754 PMID:26207792 PMID:26447891 PMID:26467025 PMID:26530882 PMID:26580448 PMID:26690363 PMID:26845104 PMID:26900293 PMID:27028212 PMID:27081525 PMID:27150160 PMID:27600092 PMID:28051113 PMID:28127413 PMID:28135048 PMID:28135145 PMID:28195569 PMID:28492532 PMID:29641532 PMID:29684080 PMID:30267214 PMID:30374176 PMID:31428572 PMID:32390703 PMID:34426522 PMID:35189564 PMID:35264596 PMID:28203651 More...
RGD:14402050
NCBI chr18:34,353,350...34,455,243
Ensembl chr18:34,353,977...34,455,605
G
Apcs
amyloid P component, serum
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 1:172,721,528...172,722,516
Ensembl chr 1:172,721,528...172,722,608
G
Apex1
apurinic/apyrimidinic endonuclease 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25109342 PMID:33841550
RGD:152998960
NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
G
Apln
apelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:47,114,023...47,123,730
Ensembl chr X:47,114,023...47,123,730
G
Apoa1
apolipoprotein A-I
disease_progression
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:plasma (human) associated with hepatitis B;
CTD RGD
PMID:21472284 PMID:23935864 PMID:31211449
RGD:25671438 , RGD:153350082
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Apoa2
apolipoprotein A-II
ISO
associated with hepatitis B; mRNA:increased expression:liver
RGD
PMID:31211449
RGD:153350082
NCBI chr 1:171,049,133...171,053,948
Ensembl chr 1:171,052,623...171,053,948
G
Apoa4
apolipoprotein A-IV
disease_progression
ISO
associated with hepatitis B;
RGD
PMID:31211449
RGD:153350082
NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
G
Apoc1
apolipoprotein C-I
disease_progression
ISO
associated with hepatitis B;
RGD
PMID:31211449
RGD:153350082
NCBI chr 7:19,423,405...19,426,584
Ensembl chr 7:19,423,406...19,426,585
G
Apoc2
apolipoprotein C2
ISO
associated with hepatitis B; mRNA:increased expression:liver
RGD
PMID:31211449
RGD:153350082
NCBI chr 7:19,405,504...19,411,866
Ensembl chr 7:19,405,504...19,411,866
G
Apoc3
apolipoprotein C-III
susceptibility disease_progression
ISO
associated with Chronic Hepatitis B;DNA:SNP: :rs2854116(human) associated with hepatitis B;
RGD
PMID:27547913 PMID:31211449
RGD:153344620 , RGD:153350082
NCBI chr 9:46,144,348...46,146,934
Ensembl chr 9:46,144,231...46,146,934
G
Apoc4
apolipoprotein C-IV
disease_progression
ISO
associated with hepatitis B;
RGD
PMID:31211449
RGD:153350082
NCBI chr 7:19,412,009...19,415,385
Ensembl chr 7:19,412,008...19,415,404
G
Apoe
apolipoprotein E
IEP
protein:increased expression:liver, serum (mouse)
RGD
PMID:21644509
RGD:6903288
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Apof
apolipoprotein F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:128,104,568...128,107,119
Ensembl chr10:128,103,866...128,106,022
G
Aprt
adenine phosphoribosyl transferase
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6327016
RGD:5135035
NCBI chr 8:123,301,376...123,303,646
Ensembl chr 8:123,301,374...123,303,648
G
Ar
androgen receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18639551
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Arg1
arginase, liver
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:17210712 PMID:30901224
RGD:4140476 , RGD:152995286
NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
G
Arhgap11a
Rho GTPase activating protein 11A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:113,661,837...113,679,006
Ensembl chr 2:113,661,837...113,679,006
G
Arhgap44
Rho GTPase activating protein 44
exacerbates
ISO
protein:decreased expression:liver (human)
RGD
PMID:31136984
RGD:401901276
NCBI chr11:64,892,865...65,053,779
Ensembl chr11:64,892,865...65,053,787
G
Arhgef39
Rho guanine nucleotide exchange factor 39
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:43,496,139...43,508,747
Ensembl chr 4:43,496,142...43,499,695
G
Arid1a
AT-rich interaction domain 1A
treatment exacerbates
ISO IMP
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (human) mRNA, protein:decreased expression:liver (human) associated with non-alcoholic steatohepatitis human gene in mouse model
CTD RGD
PMID:22561517 PMID:22634756 PMID:22922871 PMID:26589513 PMID:25975202 PMID:29113912 PMID:26569409 PMID:29136504 PMID:29136504 More...
RGD:125097485 , RGD:125097495 , RGD:125097519 , RGD:11344640 , RGD:126790634 , RGD:126790634
NCBI chr 4:133,406,319...133,484,682
Ensembl chr 4:133,406,319...133,484,080
G
Arid1b
AT-rich interaction domain 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22634756
NCBI chr17:5,044,481...5,397,931
Ensembl chr17:5,044,607...5,397,931
G
Arid2
AT-rich interaction domain 2
disease_progression exacerbates
ISO
CTD Direct Evidence: marker/mechanism associated with hepatitis B;protein:decreased expression:liver
CTD RGD
PMID:21822264 PMID:22634756 PMID:32071245 PMID:27351279 PMID:28498550 PMID:25701229 More...
RGD:150340708 , RGD:150340711 , RGD:150340712 , RGD:150429631
NCBI chr15:96,185,403...96,303,344
Ensembl chr15:96,185,399...96,302,873
G
Arid3a
AT-rich interaction domain 3A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35179300
NCBI chr10:79,762,877...79,790,852
Ensembl chr10:79,762,877...79,790,852
G
Arrb2
arrestin, beta 2
treatment
ISO
RGD
PMID:33841550
RGD:152998960
NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654
G
Asf1b
anti-silencing function 1B histone chaperone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:84,682,323...84,696,824
Ensembl chr 8:84,682,136...84,696,826
G
Asl
argininosuccinate lyase
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 5:130,040,099...130,053,222
Ensembl chr 5:130,040,099...130,058,088
G
Asns
asparagine synthetase
ISO
protein:increased activity:serum (rat)
RGD
PMID:10081
RGD:2316006
NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254
G
Aspg
asparaginase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:112,073,117...112,094,007
Ensembl chr12:112,073,113...112,093,993
G
Aspm
abnormal spindle microtubule assembly
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28284560 PMID:18676753
RGD:13439743
NCBI chr 1:139,381,450...139,421,826
Ensembl chr 1:139,382,510...139,421,829
G
Ass1
argininosuccinate synthetase 1
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:12359751 PMID:30901224
RGD:4140479 , RGD:152995286
NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
G
Atg101
autophagy related 101
disease_progression
ISO
RGD
PMID:35592424
RGD:153350091
NCBI chr15:101,182,182...101,188,855
Ensembl chr15:101,182,153...101,188,826
G
Atg7
autophagy related 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29191453
NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575
G
Atm
ataxia telangiectasia mutated
exacerbates
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
CTD RGD
PMID:12866955 PMID:19919837
RGD:126781750
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
G
Atp5pb
ATP synthase peripheral stalk-membrane subunit b
ISO
associated with hepatitis C
RGD
PMID:18932288
RGD:14696822
NCBI chr 3:105,850,014...105,866,579
Ensembl chr 3:105,850,014...105,867,415
G
Atp5pd
ATP synthase peripheral stalk subunit d
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr11:115,306,517...115,310,775
Ensembl chr11:115,306,515...115,310,788
G
Atp7b
ATPase, Cu++ transporting, beta polypeptide
onset
ISO
RGD
PMID:8291609
RGD:15036817
NCBI chr 8:22,482,799...22,550,347
Ensembl chr 8:22,482,801...22,550,321
G
Aurka
aurora kinase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:172,198,116...172,212,825
Ensembl chr 2:172,198,110...172,212,455
G
Aurkb
aurora kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490
G
Axin1
axin 1
disease_progression
ISO IMP
CTD Direct Evidence: marker/mechanism associated with Hepatitis B, Chronic,DNA:SNP, haplotype:exon:(rs1805105) T>C (human) protein:decreased expression:liver (human) ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
OMIM CTD ClinVar RGD
PMID:10700176 PMID:25741868 PMID:25822088 PMID:28492532 PMID:37582359 PMID:10700176 PMID:26968103 PMID:22960659 PMID:31514071 More...
RGD:1300371 , RGD:14402039 , RGD:150530481 , RGD:150530482
NCBI chr17:26,350,294...26,414,784
Ensembl chr17:26,357,662...26,414,785
G
Axin2
axin 2
ISO
protein:increased expression:liver:
RGD
PMID:11809809
RGD:151356508
NCBI chr11:108,808,687...108,841,609
Ensembl chr11:108,811,175...108,841,609
G
Azgp1
alpha-2-glycoprotein 1, zinc
disease_progression
ISO
mRNA:decreased expression:liver
RGD
PMID:22625427 PMID:27993894 PMID:26902423
RGD:153350130 , RGD:153350132 , RGD:153350133
NCBI chr 5:137,979,783...137,988,495
Ensembl chr 5:137,979,782...137,988,495
G
Azin1
antizyme inhibitor 1
disease_progression
ISO
RNA:increased editing:liver
RGD
PMID:23291631
RGD:14700705
NCBI chr15:38,487,674...38,523,506
Ensembl chr15:38,487,671...38,519,510
G
Banf1
BAF nuclear assembly factor 1
treatment
ISO IMP
mRNA, protein:increased expression:liver (rat) mRNA, protein:increased expression:liver (human)
RGD
PMID:29059470 PMID:29059470 PMID:29059470
RGD:155791679 , RGD:155791679 , RGD:155791679
NCBI chr19:5,414,661...5,416,904
Ensembl chr19:5,414,666...5,417,196
G
Bax
BCL2-associated X protein
treatment
ISO
RGD
PMID:33841550
RGD:152998960
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
treatment
IEP ISO
mRNA:increased expression:liver (mouse)
RGD
PMID:28100771 PMID:33841550
RGD:127285675 , RGD:152998960
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2l1
BCL2-like 1
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (mouse)
CTD RGD
PMID:10629087 PMID:11509945 PMID:28100771 PMID:33841550
RGD:127285675 , RGD:152998960
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bco2
beta-carotene oxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:50,444,387...50,466,513
Ensembl chr 9:50,444,387...50,466,481
G
Bcorl1
BCL6 co-repressor-like 1
disease_progression
ISO
RGD
PMID:29679906 PMID:26879601
RGD:150340705 , RGD:11556159
NCBI chr X:47,430,235...47,496,945
Ensembl chr X:47,430,235...47,496,926
G
Bhmt
betaine-homocysteine methyltransferase
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr13:93,753,399...93,774,266
Ensembl chr13:93,753,183...93,774,469
G
Bhmt2
betaine-homocysteine methyltransferase 2
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr13:93,792,605...93,810,810
Ensembl chr13:93,792,228...93,810,810
G
Bid
BH3 interacting domain death agonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15289866
NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814
G
Birc3
baculoviral IAP repeat-containing 3
ameliorates exacerbates treatment
ISO
human cell line in a mouse model associated with hepatitis B;mRNA, protein:increased expression:liver (human)
RGD
PMID:30368883 PMID:22682366 PMID:22820591 PMID:33310033 PMID:30210622
RGD:152998937 , RGD:152998984 , RGD:152998986 , RGD:152998988 , RGD:152999010
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
G
Birc5
baculoviral IAP repeat-containing 5
disease_progression
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:increased expression:liver (human)
CTD RGD
PMID:16086872 PMID:20514400 PMID:31964418
RGD:153344516
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
Birc7
baculoviral IAP repeat-containing 7
exacerbates
ISO
mRNA:increased expression:liver (human)
RGD
PMID:31964418
RGD:153344516
NCBI chr 2:180,570,402...180,575,803
Ensembl chr 2:180,570,816...180,575,803
G
Blzf1
basic leucine zipper nuclear factor 1
disease_progression
ISO
RGD
PMID:26342799
RGD:14398326
NCBI chr 1:164,117,368...164,135,056
Ensembl chr 1:164,117,369...164,135,058
G
Bmi1
Bmi1 polycomb ring finger oncogene
treatment
ISO
RGD
PMID:26919246
RGD:14928318
NCBI chr 2:18,681,953...18,691,440
Ensembl chr 2:18,681,829...18,691,440
G
Bmper
BMP-binding endothelial regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:23,134,372...23,396,511
Ensembl chr 9:23,134,372...23,396,496
G
Braf
Braf transforming gene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27222248
NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397
G
Bsg
basigin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36574092
NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803
G
Btg2
BTG anti-proliferation factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18393292
NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
G
Bub1
BUB1, mitotic checkpoint serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:127,642,117...127,673,790
Ensembl chr 2:127,643,036...127,673,785
G
Bub1b
BUB1B, mitotic checkpoint serine/threonine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:118,428,684...118,472,073
Ensembl chr 2:118,428,692...118,472,072
G
C3
complement component 3
ISO
RGD
PMID:23245919
RGD:11040806
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
C9
complement component 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr15:6,474,827...6,528,306
Ensembl chr15:6,474,808...6,528,232
G
Cab39
calcium binding protein 39
disease_progression
ISO
RGD
PMID:28605041 PMID:28605041
RGD:14398832 , RGD:14398832
NCBI chr 1:85,707,796...85,779,298
Ensembl chr 1:85,721,162...85,779,297
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
DNA:amplification:cds (rat) mRNA:increased expression:liver
RGD
PMID:2914957 PMID:2888462 PMID:7053379
RGD:5132587 , RGD:2303530 , RGD:10755426
NCBI chr 5:31,211,964...31,235,823
Ensembl chr 5:31,212,124...31,235,823
G
Cadm1
cell adhesion molecule 1
ISO
DNA, mRNA, protein:hypermethylation, decreased expression:promoter, liver
RGD
PMID:17428255
RGD:2289095
NCBI chr 9:47,441,468...47,773,578
Ensembl chr 9:47,441,471...47,769,413
G
Cadm2
cell adhesion molecule 2
disease_progression
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:24240726
RGD:15092075
NCBI chr16:66,452,302...67,417,825
Ensembl chr16:66,452,307...67,417,796
G
Calml3
calmodulin-like 3
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:29445139
RGD:151665319
NCBI chr13:3,852,893...3,854,318
Ensembl chr13:3,852,896...3,854,316
G
Calr
calreticulin
exacerbates treatment
ISO
protein:increased expression:liver (human) human cells and recombinant gene in a mouse model
RGD
PMID:27055635 PMID:12096119 PMID:24997628
RGD:150521681 , RGD:150521690 , RGD:150521691
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
ISO
RGD
PMID:23651211
RGD:18337283
NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434
G
Cap2
cyclase associated actin cytoskeleton regulatory protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:46,655,379...46,803,757
Ensembl chr13:46,655,324...46,803,757
G
Capn3
calpain 3
ISO
mRNA:decreased expression:skeletal muscle
RGD
PMID:10806331
RGD:1600777
NCBI chr 2:120,294,074...120,335,400
Ensembl chr 2:120,294,053...120,335,399
G
Car12
carbonic anhydrase 12
disease_progression ameliorates
ISO IMP
mRNA:altered expression:liver
RGD
PMID:35362480 PMID:35362480 PMID:31934040 PMID:29900055
RGD:153352325 , RGD:153352325 , RGD:153352328 , RGD:155226869
NCBI chr 9:66,619,026...66,674,127
Ensembl chr 9:66,620,968...66,674,127
G
Car2
carbonic anhydrase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 3:14,951,329...14,965,830
Ensembl chr 3:14,951,333...14,965,830
G
Car9
carbonic anhydrase 9
ISO
mRNA:altered expression:liver
RGD
PMID:29900055
RGD:155226869
NCBI chr 4:43,507,026...43,513,729
Ensembl chr 4:43,506,966...43,513,729
G
Carm1
coactivator-associated arginine methyltransferase 1
ISO
mRNA,protein:increased expression:liver:
RGD
PMID:23912631
RGD:9586718
NCBI chr 9:21,458,163...21,500,763
Ensembl chr 9:21,458,190...21,503,919
G
Casp3
caspase 3
treatment
ISO
RGD
PMID:29133031 PMID:33841550
RGD:13782296 , RGD:152998960
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
treatment severity
ISO
associated with hepatitis B;DNA:insertion/deletion:promoter: (rs3834129) (human) CTD Direct Evidence: marker/mechanism
OMIM CTD RGD
PMID:29133031 PMID:28643196
RGD:13782296 , RGD:14695027
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Casp9
caspase 9
treatment
ISO
RGD
PMID:29133031
RGD:13782296
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cat
catalase
disease_progression
ISO
associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-262T>C (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:33010264 PMID:21907168
RGD:27095879
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cbfb
core binding factor beta
ISO
mRNA:decreased expression:liver
RGD
PMID:17094378
RGD:126775147
NCBI chr 8:105,897,306...105,944,621
Ensembl chr 8:105,897,306...105,944,621
G
Cbl
Casitas B-lineage lymphoma
disease_progression
ISO
RGD
PMID:26474280
RGD:11536137
NCBI chr 9:44,054,273...44,145,556
Ensembl chr 9:44,054,273...44,145,346
G
Cbr1
carbonyl reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21056497
NCBI chr16:93,404,752...93,407,226
Ensembl chr16:93,402,741...93,407,393
G
Cbx2
chromobox 2
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr11:118,913,845...118,922,101
Ensembl chr11:118,913,788...118,922,096
G
Cbx4
chromobox 4
disease_progression
ISO
protein:increased expression:cytoplasm:
RGD
PMID:24838576 PMID:23943028
RGD:9586738 , RGD:9586739
NCBI chr11:118,968,399...118,977,067
Ensembl chr11:118,968,399...118,977,047
G
Cbx7
chromobox 7
ISO
mRNA:decreased expression:liver
RGD
PMID:22041561
RGD:9587355
NCBI chr15:79,800,005...79,855,344
Ensembl chr15:79,800,008...79,855,320
G
Ccbe1
collagen and calcium binding EGF domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:66,189,926...66,424,909
Ensembl chr18:66,178,373...66,435,812
G
Ccl1
C-C motif chemokine ligand 1
IEP
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr11:82,067,492...82,070,638
Ensembl chr11:82,067,483...82,196,516
G
Ccl12
C-C motif chemokine ligand 12
IEP
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr11:81,992,671...81,994,225
Ensembl chr11:81,992,671...81,994,226
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO IMP
RNA:increased expression:liver
RGD
PMID:27980102 PMID:27980102 PMID:12679798 PMID:22402625
RGD:14995459 , RGD:14995459 , RGD:14995468 , RGD:14995927
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl3
C-C motif chemokine ligand 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16284949
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccl5
C-C motif chemokine ligand 5
treatment susceptibility
IMP ISO
DNA:polymorphisms:promoter:-403G>A,-28C>G (human) associated with alcoholic liver cirrhosis;DNA:SNP:promoter:-403G>A(human)
RGD
PMID:28011329 PMID:22374185 PMID:21610221
RGD:14995306 , RGD:14995333 , RGD:14995338
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccl9
C-C motif chemokine ligand 9
IEP
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr11:83,463,743...83,469,462
Ensembl chr11:83,463,745...83,469,462
G
Ccn1
cellular communication network factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17699798
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
G
Ccna1
cyclin A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12029619
NCBI chr 3:54,952,890...54,965,055
Ensembl chr 3:54,952,890...54,962,922
G
Ccnb1
cyclin B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
G
Ccnb2
cyclin B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:70,314,971...70,328,836
Ensembl chr 9:70,314,974...70,328,829
G
Ccnd1
cyclin D1
susceptibility
ISO IEP
CTD Direct Evidence: marker/mechanism associated with Hepatitis B, Chronic;DNA:SNP:splice-site mutation:870G>A (human) mRNA:increased expression:liver (mouse)
CTD RGD
PMID:12029619 PMID:19919837 PMID:22649188 PMID:25822088 PMID:26189965 PMID:25851350 PMID:28100771 More...
RGD:14401586 , RGD:127285675
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Ccnd2
cyclin D2
severity disease_progression susceptibility
ISO
associated with hepatitis B DNA:hypermethylation:CpG site associated with Chronic Hepatitis C;DNA:SNP: :rs1049606(human)
RGD
PMID:33320844 PMID:33320844 PMID:31059558 PMID:22004425
RGD:151664743 , RGD:151664743 , RGD:151665109 , RGD:151665169
NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
G
Ccne1
cyclin E1
ameliorates
ISO IEP IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12029619 PMID:22634754 PMID:17196522 PMID:28100771 PMID:29551768
RGD:2289277 , RGD:127285675 , RGD:153297807
NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
G
Ccnf
cyclin F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:24,441,518...24,470,333
Ensembl chr17:24,441,172...24,470,458
G
Ccng1
cyclin G1
treatment disease_progression severity
ISO IMP
protein:increased expression:liver (human) human cells in mouse model protein:decreased expression:liver (human)
RGD
PMID:25431954 PMID:24034575 PMID:26345095 PMID:23804702 PMID:23804702 PMID:33543294 PMID:19584283 PMID:22835824 PMID:27982046 More...
RGD:151356922 , RGD:151356932 , RGD:151356933 , RGD:151356967 , RGD:151356967 , RGD:151356970 , RGD:151356981 , RGD:151361198 , RGD:151361200
NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138
G
Ccng2
cyclin G2
IMP
RGD
PMID:27982046
RGD:151361200
NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090
G
Ccr1
C-C motif chemokine receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16284949
NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729
G
Cd163
CD163 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486
G
Cd209b
CD209b antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:3,967,655...3,976,841
Ensembl chr 8:3,967,655...3,976,844
G
Cd274
CD274 antigen
disease_progression
ISO
CTD Direct Evidence: marker/mechanism associated with hepatitis B associated with hepatitis B
CTD RGD
PMID:22396772 PMID:30267213 PMID:21912640
RGD:40818240 , RGD:41410800
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
G
Cd276
CD276 antigen
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16217749
NCBI chr 9:58,431,581...58,463,437
Ensembl chr 9:58,431,581...58,462,720
G
Cd34
CD34 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:194,621,239...194,643,587
Ensembl chr 1:194,621,127...194,643,587
G
Cd40lg
CD40 ligand
IMP
RGD
PMID:19016771
RGD:2313413
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Cd5l
CD5 antigen-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:87,265,188...87,278,381
Ensembl chr 3:87,265,188...87,278,380
G
Cd68
CD68 antigen
severity
ISO
protein:increased expression:liver (human)
RGD
PMID:28656201
RGD:40924686
NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979
G
Cdc20
cell division cycle 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:118,290,098...118,294,540
Ensembl chr 4:118,290,098...118,294,549
G
Cdc25c
cell division cycle 25C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586
G
Cdc27
cell division cycle 27
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
NCBI chr11:104,393,350...104,441,371
Ensembl chr11:104,393,571...104,441,446
G
Cdc45
cell division cycle 45
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:18,599,202...18,632,371
Ensembl chr16:18,599,197...18,630,737
G
Cdc6
cell division cycle 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:98,798,627...98,814,768
Ensembl chr11:98,798,627...98,814,766
G
Cdca2
cell division cycle associated 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:67,910,629...67,953,290
Ensembl chr14:67,913,780...67,953,290
G
Cdca3
cell division cycle associated 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:124,806,533...124,810,664
Ensembl chr 6:124,806,510...124,810,664
G
Cdca5
cell division cycle associated 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr19:6,135,127...6,141,803
Ensembl chr19:6,135,013...6,141,807
G
Cdca8
cell division cycle associated 8
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
CTD RGD
PMID:28284560 PMID:35693827
RGD:153344586
NCBI chr 4:124,812,258...124,830,710
Ensembl chr 4:124,812,258...124,833,104
G
Cdh1
cadherin 1
severity
ISO IMP
DNA:hypermethylation mRNA:increased expression:liver protein:decreased expression:liver
RGD
PMID:17295234 PMID:30697077 PMID:30697077 PMID:24840851 PMID:18837082
RGD:2289638 , RGD:14402045 , RGD:14402045 , RGD:14402046 , RGD:14402047
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
G
Cdh13
cadherin 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18425332 PMID:18553387 PMID:28284560
NCBI chr 8:119,010,150...120,051,668
Ensembl chr 8:119,010,472...120,051,660
G
Cdk1
cyclin dependent kinase 1
ISO
protein:increased expression:liver (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28284560 PMID:19136513
RGD:2316317
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
G
Cdk12
cyclin dependent kinase 12
exacerbates
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:31519701
RGD:151361172
NCBI chr11:98,093,259...98,171,941
Ensembl chr11:98,093,885...98,169,330
G
Cdk13
cyclin dependent kinase 13
onset
ISO
DNA:amplification: :
RGD
PMID:22912832
RGD:155641228
NCBI chr13:17,885,309...17,979,960
Ensembl chr13:17,884,900...17,979,682
G
Cdk14
cyclin dependent kinase 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22922871
NCBI chr 5:4,853,384...5,430,650
Ensembl chr 5:4,853,391...5,470,312
G
Cdk4
cyclin dependent kinase 4
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:26189965 PMID:33841550
RGD:152998960
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
IAGP
OMIM:114550
MouseDO
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20698225
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
G
Cdkn1c
cyclin dependent kinase inhibitor 1C
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:26606000
RGD:11354707
NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787
G
Cdkn2a
cyclin dependent kinase inhibitor 2A
severity
ISO
Protein:increased expression:liver DNA:hypermethylation:promoter DNA:hypermethylation:exon Protein:decreased expression:liver CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
RGD CTD ClinVar
PMID:7780957 PMID:8521414 PMID:9185756 PMID:9324288 PMID:10491434 PMID:14508519 PMID:16234564 PMID:16317707 PMID:16896043 PMID:21462282 PMID:25157968 PMID:25741868 PMID:25780468 PMID:25822088 PMID:26225579 PMID:26467025 PMID:26619011 PMID:28284560 PMID:28492532 PMID:33010264 PMID:35001868 PMID:16317707 PMID:12359353 PMID:11301474 More...
RGD:1600816 , RGD:1600816 , RGD:1600822 , RGD:8552680
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
G
Cdkn2b
cyclin dependent kinase inhibitor 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276
G
Cdkn2c
cyclin dependent kinase inhibitor 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:109,518,073...109,523,953
Ensembl chr 4:109,518,073...109,524,386
G
Cdkn3
cyclin dependent kinase inhibitor 3
severity treatment
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver protein:decreased expression:liver associated with alcoholism; protein:increased expression:liver
CTD RGD
PMID:28284560 PMID:22390936 PMID:27314282 PMID:23292002 PMID:23292002
RGD:15090800 , RGD:15090801 , RGD:15090802 , RGD:15090802
NCBI chr14:46,997,912...47,008,987
Ensembl chr14:46,997,998...47,009,126
G
Cdt1
chromatin licensing and DNA replication factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:123,294,754...123,299,869
Ensembl chr 8:123,294,754...123,300,293
G
Cebpa
CCAAT/enhancer binding protein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16288022 PMID:21785164
NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
G
Cebpb
CCAAT/enhancer binding protein beta
ISO
CTD Direct Evidence: marker/mechanism mRNA: increased expression:liver (human)
CTD RGD
PMID:14563831 PMID:30659195
RGD:40903042
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Cebpd
CCAAT/enhancer binding protein delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
G
Celsr3
cadherin, EGF LAG seven-pass G-type receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:108,703,244...108,730,168
Ensembl chr 9:108,703,519...108,730,168
G
Cenpa
centromere protein A
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
CTD RGD
PMID:28284560 PMID:21956590
RGD:36947377
NCBI chr 5:30,824,214...30,832,181
Ensembl chr 5:30,824,121...30,832,174
G
Cenpe
centromere protein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:134,918,324...134,979,301
Ensembl chr 3:134,918,298...134,979,372
G
Cenpf
centromere protein F
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:189,372,803...189,420,302
Ensembl chr 1:189,372,803...189,420,283
G
Cenpm
centromere protein M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:82,115,694...82,128,974
Ensembl chr15:82,117,980...82,128,949
G
Cenpu
centromere protein U
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:47,005,054...47,033,603
Ensembl chr 8:47,005,063...47,033,042
G
Cenpw
centromere protein W
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:30,072,005...30,076,599
Ensembl chr10:30,070,565...30,076,556
G
Cep131
centrosomal protein 131
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:119,955,247...119,977,684
Ensembl chr11:119,955,256...119,977,653
G
Cep164
centrosomal protein 164
susceptibility
ISO
associated with Chronic Hepatitis C;DNA:SNP: :rs573455 (human)
RGD
PMID:22004425
RGD:151665169
NCBI chr 9:45,678,244...45,739,984
Ensembl chr 9:45,678,244...45,739,989
G
Cep55
centrosomal protein 55
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr19:38,043,423...38,062,873
Ensembl chr19:38,043,459...38,062,871
G
Ces1d
carboxylesterase 1D
disease_progression
ISO
protein:decreased expression:liver (human) mRNA, protein:decreased expression:liver tumor (human) associated with tumor vascularization; protein:decreased expression:liver tumor (human)
RGD
PMID:24259486 PMID:19658107 PMID:30901224
RGD:152995276 , RGD:152995279 , RGD:152995286
NCBI chr 8:93,892,700...93,924,432
Ensembl chr 8:93,892,696...93,924,466
G
Cfp
complement factor properdin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:20,791,693...20,797,794
Ensembl chr X:20,791,693...20,797,794
G
Chaf1b
chromatin assembly factor 1, subunit B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:93,680,801...93,703,003
Ensembl chr16:93,680,789...93,703,003
G
Chd4
chromodomain helicase DNA binding protein 4
exacerbates
ISO
mRNA:increased expression:liver (human) protein:increased expression:liver (human)
RGD
PMID:28486105 PMID:26095183
RGD:153323299 , RGD:11571740
NCBI chr 6:125,073,144...125,107,554
Ensembl chr 6:125,072,944...125,107,554
G
Chd5
chromodomain helicase DNA binding protein 5
ISO
mRNA:decreased expression:liver
RGD
PMID:26517514
RGD:11537550
NCBI chr 4:152,423,103...152,474,651
Ensembl chr 4:152,423,108...152,474,651
G
Ckap2l
cytoskeleton associated protein 2-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:129,110,130...129,139,148
Ensembl chr 2:129,110,130...129,139,132
G
Ckap4
cytoskeleton-associated protein 4
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:increased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr10:84,362,169...84,369,752
Ensembl chr10:84,362,169...84,369,926
G
Cldn1
claudin 1
severity
IEP
protein:increased expression:liver (human) protein:decreased expression:liver (human) associated with liver cirrhosis;protein:increased expression:liver (human)
RGD
PMID:24815833 PMID:17270214 PMID:24696415
RGD:26884345 , RGD:26884348 , RGD:26884352
NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
G
Clec1b
C-type lectin domain family 1, member b
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:129,374,260...129,382,376
Ensembl chr 6:129,374,260...129,386,298
G
Clec4g
C-type lectin domain family 4, member g
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:3,757,066...3,770,695
Ensembl chr 8:3,757,064...3,770,651
G
Clptm1l
CLPTM1-like
susceptibility disease_progression
ISO
DNA:SNPs::rs401681(human) DNA:SNP: :rs401681(human)
RGD
PMID:25339005 PMID:29042796
RGD:150530496 , RGD:150537100
NCBI chr13:73,752,121...73,768,758
Ensembl chr13:73,752,125...73,768,724
G
Cltrn
collectrin, amino acid transport regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:162,873,183...162,901,855
Ensembl chr X:162,871,826...162,901,856
G
Cndp1
carnosine dipeptidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:84,628,509...84,668,359
Ensembl chr18:84,628,634...84,668,220
G
Cnot9
CCR4-NOT transcription complex, subunit 9
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26619011
NCBI chr 1:74,545,192...74,570,001
Ensembl chr 1:74,545,217...74,570,001
G
Cntnap4
contactin associated protein-like 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:113,296,523...113,609,339
Ensembl chr 8:113,296,675...113,609,349
G
Col15a1
collagen, type XV, alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:47,207,744...47,313,165
Ensembl chr 4:47,208,161...47,313,167
G
Col18a1
collagen, type XVIII, alpha 1
severity
ISO
Protein:increased expression
RGD
PMID:15739185
RGD:1600906
NCBI chr10:76,888,013...77,002,351
Ensembl chr10:76,888,012...77,002,382
G
Colec10
collectin sub-family member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:54,274,170...54,329,755
Ensembl chr15:54,274,170...54,329,754
G
Comt
catechol-O-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341023
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
G
Cops5
COP9 signalosome subunit 5
severity
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human)
CTD RGD
PMID:20698225 PMID:26606000
RGD:11354707
NCBI chr 1:10,094,825...10,108,384
Ensembl chr 1:10,094,826...10,108,393
G
Cox7b2
cytochrome c oxidase subunit 7B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:71,600,166...71,705,548
Ensembl chr 5:71,600,167...71,705,548
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19229483
NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
G
Cpeb3
cytoplasmic polyadenylation element binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr19:36,996,742...37,185,018
Ensembl chr19:36,998,691...37,186,000
G
Cps1
carbamoyl-phosphate synthetase 1
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 1:67,151,294...67,270,426
Ensembl chr 1:67,162,185...67,270,418
G
Crebbp
CREB binding protein
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
ClinVar
PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:28970362 PMID:29551561 PMID:33560380 More...
NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861
G
Crhbp
corticotropin releasing hormone binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:95,567,884...95,581,339
Ensembl chr13:95,567,879...95,581,432
G
Crp
C-reactive protein, pentraxin-related
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Csf1r
colony stimulating factor 1 receptor
severity exacerbates
ISO
DNA:hypomethylation:promoter (human) protein:increased expression: liver (human) protein:increased expression:liver (human)
RGD
PMID:32724427 PMID:32760707 PMID:11412385 PMID:14969845
RGD:150524282 , RGD:150524286 , RGD:150524301 , RGD:150524302
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
treatment
IMP
RGD
PMID:12731087
RGD:10450243
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
G
Csk
c-src tyrosine kinase
ISO
protein:decreased expression:liver
RGD
PMID:9918913
RGD:5134372
NCBI chr 9:57,533,929...57,560,758
Ensembl chr 9:57,533,929...57,560,914
G
Csmd1
CUB and Sushi multiple domains 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:15,942,538...17,586,908
Ensembl chr 8:15,942,537...17,585,602
G
Cspg4
chondroitin sulfate proteoglycan 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:56,772,388...56,807,154
Ensembl chr 9:56,772,317...56,807,154
G
Csrnp1
cysteine-serine-rich nuclear protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:119,800,229...119,813,808
Ensembl chr 9:119,800,229...119,813,724
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
susceptibility
ISO
protein:increased expression:CD4+ and CD8+ T cells: DNA:SNPs: :rs231775,rs231725(human)
RGD
PMID:28648905 PMID:23432218
RGD:14398741 , RGD:14398742
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Ctnnb1
catenin beta 1
susceptibility severity exacerbates
ISO
DNA:mutation:exon 3 CTD Direct Evidence: marker/mechanism associated with Hepatitis B, Chronic,DNA:SNP, haplotype: :rs3864004 (human) associated with hepatitis B;DNA:SNPs: :rs3864004,rs11564475(human) protein:increased expression:liver: DNA:Mutations:exon: DNA:missense mutations:exon 3:multiple (human) ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
OMIM CTD ClinVar RGD
PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 PMID:10027390 PMID:10192393 PMID:10391090 PMID:10398436 PMID:10435629 PMID:10655994 PMID:10666372 PMID:11351304 PMID:11930117 PMID:11950921 PMID:12124804 PMID:15133491 PMID:19234609 PMID:20118494 PMID:21147764 PMID:21903672 PMID:23033978 PMID:23265383 PMID:24614104 PMID:24728327 PMID:24788118 PMID:25157968 PMID:25326635 PMID:25326669 PMID:25741868 PMID:25822088 PMID:26350204 PMID:26502894 PMID:26619011 PMID:26822237 PMID:27738331 PMID:27915094 PMID:27959697 PMID:28284560 PMID:28333917 PMID:28492532 PMID:28575650 PMID:29682453 PMID:30640974 PMID:31526516 PMID:10435629 PMID:26968103 PMID:28328801 PMID:19101982 PMID:19101982 PMID:27276713 More...
RGD:734850 , RGD:14402039 , RGD:14402040 , RGD:14402052 , RGD:14402052 , RGD:150429592
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Ctsb
cathepsin B
ISO
RGD
PMID:15641152
RGD:2315605
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
G
Ctsd
cathepsin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
G
Ctsl
cathepsin L
ISO
RGD
PMID:15641152
RGD:2315605
NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704
G
Cux1
cut-like homeobox 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:30561038
RGD:152985541
NCBI chr 5:136,276,989...136,596,429
Ensembl chr 5:136,276,989...136,596,344
G
Cxcl10
C-X-C motif chemokine ligand 10
disease_progression treatment
ISO IDA
RGD
PMID:28592115 PMID:28638480 PMID:27245433
RGD:27095889 , RGD:27095898 , RGD:27095899
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
G
Cxcl11
chemokine (C-X-C motif) ligand 11
IEP
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr 5:92,507,403...92,511,155
Ensembl chr 5:92,507,403...92,513,344
G
Cxcl12
C-X-C motif chemokine ligand 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
G
Cxcl14
C-X-C motif chemokine ligand 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:56,436,456...56,444,624
Ensembl chr13:56,436,456...56,444,364
G
Cxcl15
C-X-C motif chemokine ligand 15
disease_progression susceptibility
ISO
protein:increased expression:liver (human) mRNA:increased expression:liver (human) DNA:SNPs, haplotype:multiple CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:12432545 PMID:35776891 PMID:26078356 PMID:30523154 PMID:24381110
RGD:11526468 , RGD:26884364 , RGD:26884366
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cxcr4
C-X-C motif chemokine receptor 4
treatment severity
ISO
human cells in mouse model protein:increased expression:liver (human)
RGD
PMID:30034941 PMID:33574707
RGD:151665331 , RGD:151665327
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
G
Cyld
CYLD lysine 63 deubiquitinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21109933
NCBI chr 8:89,423,506...89,478,574
Ensembl chr 8:89,423,675...89,478,573
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341023
NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15341023
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp26b1
cytochrome P450, family 26, subfamily b, polypeptide 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 6:84,548,396...84,570,890
Ensembl chr 6:84,548,396...84,570,890
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp2c29
cytochrome P450, family 2, subfamily c, polypeptide 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
G
Cyp2c38
cytochrome P450, family 2, subfamily c, polypeptide 38
susceptibility
ISO
associated with hepatitis C; DNA:polymorphisms: :
RGD
PMID:11021356
RGD:124713413
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism associated with alcohol dependence DNA, mRNA:SNP, Decreased expression:liver: rs2031920 (human)
CTD RGD
PMID:15162526 PMID:20364586 PMID:29765251
RGD:14700882 , RGD:14700899
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp39a1
cytochrome P450, family 39, subfamily a, polypeptide 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:43,978,263...44,062,322
Ensembl chr17:43,978,316...44,062,322
G
Dab2ip
disabled 2 interacting protein
severity
ISO
mRNA:decreased expression:liver (human) protein:decreased expression:liver (human)
RGD
PMID:31176165 PMID:22168621
RGD:151665110 , RGD:151665148
NCBI chr 2:35,448,285...35,621,006
Ensembl chr 2:35,448,278...35,621,006
G
Dbh
dopamine beta hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:27,055,519...27,073,216
Ensembl chr 2:27,055,245...27,073,212
G
Dcn
decorin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:97,315,362...97,354,025
Ensembl chr10:97,315,471...97,354,005
G
Ddr1
discoidin domain receptor family, member 1
severity
IMP ISO
mRNA:increased expression:liver (human)
RGD
PMID:33173221 PMID:33173221
RGD:151347691 , RGD:151347691
NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
G
Ddr2
discoidin domain receptor family, member 2
treatment disease_progression
ISO
RGD
PMID:33969575 PMID:26362312
RGD:150429748 , RGD:11086753
NCBI chr 1:169,799,874...169,938,525
Ensembl chr 1:169,799,876...169,938,331
G
Ddx3x
DEAD box helicase 3, X-linked
exacerbates sexual_dimorphism
IMP ISO
associated with hepatitis B; mRNA,protein:decreased expression:liver (human)
RGD
PMID:30297359 PMID:16301996
RGD:151356499 , RGD:151356660
NCBI chr X:13,147,261...13,160,222
Ensembl chr X:13,147,209...13,160,291
G
Depdc1a
DEP domain containing 1a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:159,201,042...159,235,690
Ensembl chr 3:159,201,070...159,235,592
G
Depdc1b
DEP domain containing 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:108,452,592...108,526,100
Ensembl chr13:108,452,866...108,544,316
G
Depdc5
DEP domain containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21725309
NCBI chr 5:33,020,996...33,151,581
Ensembl chr 5:33,021,045...33,151,580
G
Dhfr
dihydrofolate reductase
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar
PMID:28492532
NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561
G
Dicer1
dicer 1, ribonuclease type III
susceptibility
ISO
associated with hepatitis B; DNA:SNP: :rs1057035 T>C (human)
RGD
PMID:23868705
RGD:149735346
NCBI chr12:104,654,001...104,718,331
Ensembl chr12:104,654,001...104,718,211
G
Dipk2b
divergent protein kinase domain 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:18,280,406...18,327,657
Ensembl chr X:18,281,120...18,327,636
G
Dlgap5
DLG associated protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:47,625,238...47,655,657
Ensembl chr14:47,625,236...47,655,864
G
Dlk1
delta like non-canonical Notch ligand 1
IEP
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr12:109,418,411...109,429,262
Ensembl chr12:109,418,749...109,429,262
G
Dmgdh
dimethylglycine dehydrogenase precursor
disease_progression
ISO
associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr13:93,810,944...93,889,331
Ensembl chr13:93,810,941...93,889,341
G
Dnajc6
DnaJ heat shock protein family (Hsp40) member C6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:101,353,751...101,499,996
Ensembl chr 4:101,353,828...101,499,996
G
Dnase1l3
deoxyribonuclease 1-like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:14,475,014...14,504,586
Ensembl chr14:14,475,200...14,505,240
G
Dnmt1
DNA methyltransferase 1
ISO
mRNA, protein:increased expression:liver
RGD
PMID:11844796
RGD:2289670
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
G
Dnmt3a
DNA methyltransferase 3A
ISO
protein:increased expression:liver: mRNA, protein:increased expression:liver
RGD
PMID:15885882 PMID:11844796
RGD:9588598 , RGD:2289670
NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443
G
Dnmt3b
DNA methyltransferase 3B
ISO
mRNA:increased expression:liver: mRNA, protein:increased expression:liver
RGD
PMID:15885882 PMID:11844796
RGD:9588598 , RGD:2289670
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
G
Dpyd
dihydropyrimidine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18019677
NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573
G
Dsn1
DSN1 homolog, MIS12 kinetochore complex component
disease_progression
ISO
RGD
PMID:30136646
RGD:27372884
NCBI chr 2:156,836,982...156,848,995
Ensembl chr 2:156,837,185...156,849,074
G
Dtl
denticleless E3 ubiquitin protein ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:191,269,468...191,307,656
Ensembl chr 1:191,269,468...191,307,656
G
Dynlrb1
dynein light chain roadblock-type 1
ISO
RGD
PMID:11750132
RGD:13208527
NCBI chr 2:155,078,453...155,092,197
Ensembl chr 2:155,078,453...155,092,197
G
Dynlrb2
dynein light chain roadblock-type 2
ISO
RGD
PMID:11750132
RGD:13208527
NCBI chr 8:117,231,754...117,242,654
Ensembl chr 8:117,231,713...117,242,654
G
E2f1
E2F transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12029619 PMID:15565109 PMID:28284560
NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
G
E2f8
E2F transcription factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:48,516,177...48,531,821
Ensembl chr 7:48,516,177...48,531,344
G
Eaf2
ELL associated factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20564326
NCBI chr16:36,613,246...36,695,275
Ensembl chr16:36,613,246...36,695,365
G
Ecm1
extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:95,641,459...95,646,880
Ensembl chr 3:95,641,459...95,646,881
G
Ect2
ect2 oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:27,151,371...27,207,971
Ensembl chr 3:27,151,371...27,208,027
G
Eef2
eukaryotic translation elongation factor 2
exacerbates
ISO
protein:increased expression, increased phosphorylation:liver (human)
RGD
PMID:28060762
RGD:153298915
NCBI chr10:81,012,465...81,018,343
Ensembl chr10:81,012,465...81,018,332
G
Efemp1
epidermal growth factor-containing fibulin-like extracellular matrix protein 1
disease_progression
ISO
protein:decreased expression:liver:
RGD
PMID:23936443
RGD:10401793
NCBI chr11:28,803,154...28,876,743
Ensembl chr11:28,803,204...28,876,743
G
Eftud2
elongation factor Tu GTP binding domain containing 2
severity ameliorates
ISO
RGD
PMID:34282556 PMID:34282556
RGD:155791664 , RGD:155791664
NCBI chr11:102,729,298...102,771,999
Ensembl chr11:102,729,299...102,771,811
G
Egf
epidermal growth factor
susceptibility
ISO
CTD Direct Evidence: marker/mechanism associated with liver cirrhosis;DNA:SNP:5'UTR: (rs4444903) (human) associated with hepatitis B;DNA:SNP:exon: (rs11569017) (human)
CTD RGD
PMID:9029167 PMID:18167406 PMID:23790025
RGD:14695013 , RGD:14695014
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
G
Egfr
epidermal growth factor receptor
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9029167 PMID:11355950
RGD:126781769
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Egr1
early growth response 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
G
Egr2
early growth response 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:67,370,334...67,383,354
Ensembl chr10:67,371,305...67,378,018
G
Ehd3
EH-domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:74,111,836...74,139,088
Ensembl chr17:74,111,129...74,139,089
G
Eif3h
eukaryotic translation initiation factor 3, subunit H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14578863
NCBI chr15:51,649,956...51,728,901
Ensembl chr15:51,649,954...51,728,919
G
Enah
ENAH actin regulator
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35030977
RGD:155791678
NCBI chr 1:181,723,949...181,848,132
Ensembl chr 1:181,723,949...181,847,555
G
Eng
endoglin
ISO
protein:increased expression:liver (rat)
RGD
PMID:20368095
RGD:7257538
NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681
G
Eno1
enolase 1, alpha non-neuron
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336
G
Ep300
E1A binding protein p300
ISO
protein:increased expression:liver (rat)
RGD
PMID:17083329
RGD:2312274
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
G
Epas1
endothelial PAS domain protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26735578
NCBI chr17:87,061,292...87,140,838
Ensembl chr17:87,061,128...87,140,838
G
Epcam
epithelial cell adhesion molecule
severity
ISO
protein:increased expression:liver
RGD
PMID:24616575
RGD:14695007
NCBI chr17:87,943,407...87,958,555
Ensembl chr17:87,943,407...87,958,557
G
Ephb1
Eph receptor B1
IEP
protein:increased phosphorylation:liver (mouse)
RGD
PMID:28100771
RGD:127285675
NCBI chr 9:101,799,327...102,231,892
Ensembl chr 9:101,799,327...102,231,892
G
Ephx1
epoxide hydrolase 1, microsomal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7892276
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Epo
erythropoietin
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Eps8l3
EPS8-like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:107,781,177...107,800,216
Ensembl chr 3:107,784,545...107,800,216
G
Erbb3
erb-b2 receptor tyrosine kinase 3
disease_progression
ISO
RGD
PMID:11355950
RGD:126781769
NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521
G
Erbb4
erb-b2 receptor tyrosine kinase 4
ISO
DNA:insertion/deletion:3'UTR:rs6147150 (human)
RGD
PMID:22294845
RGD:126781763
NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218
G
Ercc1
excision repair cross-complementing rodent repair deficiency, complementation group 1
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:15922480
RGD:155598683
NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
G
Ercc2
excision repair cross-complementing rodent repair deficiency, complementation group 2
susceptibility disease_progression
ISO
DNA:SNPs:exon 23: p.K751Q (human) DNA:SNPs:exon 23: p.K751Q (human) DNA:SNPs:exon 23: p.K751Q (rs13181) (human) DNA:SNP:cd: 312A>G (human)
RGD
PMID:19919686 PMID:25531380 PMID:28598207 PMID:28927037
RGD:25671459 , RGD:25671460 , RGD:25671461 , RGD:150530503
NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619
G
Ereg
epiregulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35776891
NCBI chr 5:91,222,476...91,241,508
Ensembl chr 5:91,222,481...91,241,505
G
Ern1
endoplasmic reticulum to nucleus signalling 1
ISO
DNA:hypomethylation: CpG islands:
RGD
PMID:20165882
RGD:14694974
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
G
Erp29
endoplasmic reticulum protein 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 5:121,582,816...121,590,537
Ensembl chr 5:121,566,653...121,590,569
G
Esm1
endothelial cell-specific molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:113,346,193...113,354,638
Ensembl chr13:113,346,193...113,354,632
G
Esr1
estrogen receptor 1 (alpha)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Etfa
electron transferring flavoprotein, alpha polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 9:55,361,720...55,419,528
Ensembl chr 9:55,361,792...55,419,527
G
Exo1
exonuclease 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:175,708,334...175,738,962
Ensembl chr 1:175,708,147...175,741,055
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
susceptibility
ISO
mRNA:increased expression:liver (human) DNA:SNPs: :multiple CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28284560 PMID:34545456 PMID:24211739 PMID:26517514 PMID:24040354 PMID:25226601 More...
RGD:10755339 , RGD:11537550 , RGD:126779595 , RGD:126779608
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
G
F2
coagulation factor II
severity
ISO
CTD Direct Evidence: marker/mechanism associated with liver cirrhosis;protein:altered expression, altered processing:liver (human)
CTD RGD
PMID:2821104 PMID:7620113
RGD:14975114
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
Fabp5
fatty acid binding protein 5, epidermal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 3:10,077,645...10,081,670
Ensembl chr 3:10,077,608...10,081,667
G
Fam180a
family with sequence similarity 180, member A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:35,289,678...35,303,076
Ensembl chr 6:35,289,603...35,303,076
G
Fam83d
family with sequence similarity 83, member D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:158,610,011...158,628,557
Ensembl chr 2:158,610,013...158,628,557
G
Fancd2
Fanconi anemia, complementation group D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:113,508,622...113,573,981
Ensembl chr 6:113,508,643...113,573,978
G
Fanci
Fanconi anemia, complementation group I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:79,042,056...79,100,013
Ensembl chr 7:79,041,677...79,100,012
G
Fas
Fas cell surface death receptor
treatment
ISO IMP
protein:increased expression:liver:
RGD
PMID:29634416 PMID:11274632 PMID:30737368
RGD:13792608 , RGD:14700677 , RGD:14700700
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fasl
Fas ligand
ISO
protein:increased expression:liver:
RGD
PMID:11274632
RGD:14700677
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Fasn
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831 PMID:15543204 PMID:21147110
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
G
Fat1
FAT atypical cadherin 1
disease_progression
ISO
mRNA,protein:increased expression:liver (human)
RGD
PMID:24590895
RGD:151347630
NCBI chr 8:45,386,137...45,505,294
Ensembl chr 8:45,388,484...45,505,294
G
Fate1
fetal and adult testis expressed 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15580283
NCBI chr X:71,016,592...71,032,652
Ensembl chr X:71,016,592...71,032,652
G
Fbp1
fructose bisphosphatase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22039417
NCBI chr13:63,012,567...63,036,112
Ensembl chr13:63,012,567...63,036,096
G
Fbxl18
F-box and leucine-rich repeat protein 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:142,852,701...142,882,696
Ensembl chr 5:142,852,701...142,881,176
G
Fbxo11
F-box protein 11
exacerbates ameliorates
ISO
mRNA:increased expression:liver (human)
RGD
PMID:32657545 PMID:29518611
RGD:152025263 , RGD:152025259
NCBI chr17:88,298,287...88,373,473
Ensembl chr17:88,298,287...88,372,719
G
Fcna
ficolin A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:25,514,677...25,525,448
Ensembl chr 2:25,514,678...25,518,042
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr14:63,382,599...63,419,136
Ensembl chr14:63,382,599...63,417,027
G
Fes
feline sarcoma oncogene
exacerbates
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:31038805
RGD:153323297
NCBI chr 7:80,027,506...80,037,702
Ensembl chr 7:80,027,504...80,037,694
G
Fgf15
fibroblast growth factor 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25822088
NCBI chr 7:144,450,269...144,454,690
Ensembl chr 7:144,450,268...144,454,690
G
Fgf3
fibroblast growth factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25822088
NCBI chr 7:144,392,349...144,397,085
Ensembl chr 7:144,391,820...144,398,173
G
Fgf4
fibroblast growth factor 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25822088
NCBI chr 7:144,415,123...144,418,982
Ensembl chr 7:144,401,104...144,418,980
G
Fgfr1
fibroblast growth factor receptor 1
treatment
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma CTD Direct Evidence: marker/mechanism
ClinVar CTD RGD
PMID:25705862 PMID:26619011 PMID:26942290 PMID:33448156 PMID:36029209 PMID:16452204 PMID:21573021 PMID:20155451 More...
RGD:25330358 , RGD:25440476 , RGD:25440478
NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734
G
Fgfr2
fibroblast growth factor receptor 2
severity
ISO
associated with hepatitis B;DNA:SNPs: promoter, intron:rs308379, rs1219648 (human)
RGD
PMID:30952770
RGD:38501096
NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079
G
Fgfr4
fibroblast growth factor receptor 4
treatment
ISO
RGD
PMID:32677805
RGD:150520166
NCBI chr13:55,300,631...55,316,572
Ensembl chr13:55,300,453...55,316,572
G
Fh1
fumarate hydratase 1
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:10896297 PMID:15221078 PMID:16876016 PMID:17182618 PMID:18313410 PMID:19151755 PMID:20301679 PMID:21445611 PMID:25637381 PMID:25741868 PMID:28492532 PMID:28747166 More...
NCBI chr 1:175,428,944...175,453,201
Ensembl chr 1:175,427,940...175,453,201
G
Fhit
fragile histidine triad gene
ISO
RGD
PMID:12112319
RGD:632723
NCBI chr14:11,307,718...12,919,681
Ensembl chr14:11,307,738...12,919,681
G
Flt3
FMS-like tyrosine kinase 3
ameliorates
ISO
human cells in mouse model
RGD
PMID:27511526
RGD:149735514
NCBI chr 5:147,267,551...147,337,299
Ensembl chr 5:147,267,551...147,337,299
G
Flvcr1
feline leukemia virus subgroup C cellular receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:190,738,029...190,758,387
Ensembl chr 1:190,738,044...190,758,355
G
Fos
FBJ osteosarcoma oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9029167 PMID:28284560
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Fosb
FBJ osteosarcoma oncogene B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:19,036,621...19,043,970
Ensembl chr 7:19,036,621...19,043,976
G
Fosl2
fos-like antigen 2
ISO
mRNA:increased expression:liver (human)
RGD
PMID:30086463 PMID:32048611
RGD:153344517 , RGD:153344521
NCBI chr 5:32,292,599...32,315,184
Ensembl chr 5:32,293,145...32,315,186
G
Foxa1
forkhead box A1
susceptibility disease_progression sexual_dimorphism
ISO
DNA:VNTR, SNPs, haplotypes:multiple: protein:decreased expression:liver
RGD
PMID:29208003 PMID:31400761 PMID:25965836
RGD:151665820 , RGD:151665752 , RGD:11054501
NCBI chr12:57,585,750...57,594,815
Ensembl chr12:57,587,414...57,593,702
G
Foxm1
forkhead box M1
IAGP ISO
OMIM:114550 CTD Direct Evidence: marker/mechanism
MouseDO CTD
PMID:15082532 PMID:17173139 PMID:28284560
NCBI chr 6:128,339,957...128,352,849
Ensembl chr 6:128,339,930...128,353,109
G
Foxo1
forkhead box O1
ISO
mRNA:decreased expression:liver
RGD
PMID:28972178
RGD:14401599
NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
G
Foxp1
forkhead box P1
treatment
ISO
RGD
PMID:25156538
RGD:9587823
NCBI chr 6:98,902,303...99,510,587
Ensembl chr 6:98,902,299...99,499,682
G
Foxp3
forkhead box P3
ISO
protein:increased expression:liver
RGD
PMID:21086571
RGD:38548919
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
G
Fst
follistatin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12203361 PMID:19363144
NCBI chr13:114,588,798...114,595,522
Ensembl chr13:114,588,826...114,595,487
G
Fth1
ferritin heavy polypeptide 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:9054589
RGD:632698
NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462
G
Fubp1
far upstream element (FUSE) binding protein 1
exacerbates ameliorates
ISO
mRNA:increased expression:liver (human) human cell line in a mouse model associated with Chronic Hepatitis C;mRNA:increased expression:liver (human)
RGD
PMID:31587040 PMID:19637194 PMID:25995247
RGD:151361188 , RGD:151361194 , RGD:151361196
NCBI chr 3:151,916,059...151,942,467
Ensembl chr 3:151,916,059...151,942,463
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
treatment
ISO
associated with Glycogen Storage Disease IA, human gene in a mouse model
RGD
PMID:28096054
RGD:14695537
NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:25473368 PMID:35693827
RGD:10449118 , RGD:153344586
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gabrd
gamma-aminobutyric acid (GABA) A receptor, subunit delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:155,469,437...155,482,528
Ensembl chr 4:155,469,437...155,482,569
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16767786 PMID:21472284
NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430
G
Gc
vitamin D binding protein
susceptibility
ISO
protein:increased expression:liver associated with Hepatitis B, Chronic;DNA:SNP: :rs7041(human)
RGD
PMID:21683810 PMID:25541958
RGD:5509919 , RGD:14402025
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
G
Gdf15
growth differentiation factor 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20512989
NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106
G
Gdf2
growth differentiation factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23936038 PMID:28284560
NCBI chr14:33,662,996...33,669,155
Ensembl chr14:33,662,996...33,669,155
G
Ggt1
gamma-glutamyltransferase 1
disease_progression
ISO
HBV associated RNA,protein:increased expression, activity:liver:
RGD
PMID:11940314 PMID:27793641 PMID:10572675
RGD:14701040 , RGD:14701041 , RGD:14701048
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Ghr
growth hormone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:3,347,237...3,612,834
Ensembl chr15:3,347,242...3,612,974
G
Gins1
GINS complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:150,751,482...150,773,200
Ensembl chr 2:150,747,320...150,773,200
G
Gjb1
gap junction protein, beta 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17978847
NCBI chr X:100,419,982...100,429,235
Ensembl chr X:100,419,984...100,429,235
G
Gjb2
gap junction protein, beta 2
ISO
DNA, mRNA:promoter hypermethylation, decreased expression:liver
RGD
PMID:17295234
RGD:2289638
NCBI chr14:57,336,059...57,342,159
Ensembl chr14:57,336,057...57,342,159
G
Gli1
GLI-Kruppel family member GLI1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26189965
NCBI chr10:127,165,751...127,177,448
Ensembl chr10:127,165,751...127,177,843
G
Glul
glutamate-ammonia ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469
G
Gm266
predicted gene 266
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:111,451,043...111,452,257
Ensembl chr12:111,451,043...111,452,257
G
Gmnn
geminin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:24,935,828...24,954,222
Ensembl chr13:24,935,828...24,945,906
G
Gmps
guanine monophosphate synthetase
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6861338
RGD:5135537
NCBI chr 3:63,871,054...63,928,975
Ensembl chr 3:63,883,527...63,930,000
G
Gnao1
guanine nucleotide binding protein, alpha O
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:94,537,213...94,696,016
Ensembl chr 8:94,536,594...94,696,016
G
Gnas
GNAS complex locus
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar
PMID:1517386 PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 PMID:7739708 PMID:8766942 PMID:9626141 PMID:10571700 PMID:11093740 PMID:12727968 PMID:12970318 PMID:15126527 PMID:15952988 PMID:16507630 PMID:16543670 PMID:17873334 PMID:20197676 PMID:21835143 PMID:23403822 PMID:23536913 PMID:23843956 PMID:24855271 PMID:25157968 PMID:25719192 PMID:25741868 PMID:26341786 PMID:26574629 PMID:26619011 PMID:27398169 PMID:27506760 PMID:28492532 PMID:29991465 PMID:30702195 More...
NCBI chr 2:174,126,113...174,188,537
Ensembl chr 2:174,126,113...174,188,537
G
Gnaz
guanine nucleotide binding protein, alpha z subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:74,803,009...74,852,739
Ensembl chr10:74,803,009...74,852,739
G
Gnmt
glycine N-methyltransferase
IAGP ISO
OMIM:114550 CTD Direct Evidence: marker/mechanism
MouseDO CTD
PMID:19146867 PMID:31086990
NCBI chr17:47,036,590...47,040,091
Ensembl chr17:47,036,590...47,040,094
G
Golm1
golgi membrane protein 1
severity
ISO
protein:increased expression:serum mRNA, protein:increased expression:liver
RGD
PMID:21140449 PMID:21443671
RGD:401827118 , RGD:401827119
NCBI chr13:59,782,810...59,823,598
Ensembl chr13:59,782,440...59,823,625
G
Gpc1
glypican 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 1:92,759,367...92,787,933
Ensembl chr 1:92,759,367...92,788,501
G
Gpc3
glypican 3
severity treatment disease_progression exacerbates
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver protein:increased expression:serum mRNA:increased expression:Peripheral Blood (human) mRNA,protein:increased expression:peripheral blood mononuclear cell,blood serum, liver (human) protein:increased expression:blood serum (human) protein:increased expression:liver (human)
CTD RGD
PMID:16698587 PMID:27286460 PMID:28284560 PMID:19496787 PMID:25449037 PMID:25449037 PMID:21438004 PMID:23558072 PMID:28801286 PMID:22883669 More...
RGD:243065134 , RGD:14695019 , RGD:14695020 , RGD:14695020 , RGD:243065125 , RGD:243065131 , RGD:243065135 , RGD:243065139
NCBI chr X:51,361,303...51,702,851
Ensembl chr X:51,361,303...51,702,827
G
Gpm6a
glycoprotein m6a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:55,232,469...55,513,913
Ensembl chr 8:55,407,878...55,513,906
G
Gpr158
G protein-coupled receptor 158
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:21,372,378...21,835,355
Ensembl chr 2:21,372,353...21,835,358
G
Gpr182
G protein-coupled receptor 182
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:127,585,471...127,587,667
Ensembl chr10:127,583,145...127,587,601
G
Gpx1
glutathione peroxidase 1
severity susceptibility no_association
ISO
associated with hepatitis C;DNA:missense mutation:CDS:p.P198L (rs1050450) (human) associated with alcoholic liver cirrhosis;DNA:missense mutation:CDS:p.P198L (human)
RGD
PMID:26990426 PMID:16510607 PMID:19929244 PMID:25894370
RGD:11533013 , RGD:151708729 , RGD:152995483 , RGD:152998906
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gpx3
glutathione peroxidase 3
severity disease_progression
ISO
mRNA,protein:decreased expression:liver, blood plasma (human) DNA:hypermethylation
RGD
PMID:25333265 PMID:25445749 PMID:27570561
RGD:151665355 , RGD:151665509 , RGD:401827855
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Grb7
growth factor receptor bound protein 7
exacerbates
ISO
protein:increased expression:liver (human)
RGD
PMID:17634422
RGD:151347655
NCBI chr11:98,337,660...98,346,199
Ensembl chr11:98,337,220...98,346,199
G
Gstm1
glutathione S-transferase, mu 1
susceptibility no_association
ISO
DNA:deletion:cds (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:7892276 PMID:11859714 PMID:20683151 PMID:20672314
RGD:7488953 , RGD:14700951 , RGD:14700979
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstp1
glutathione S-transferase, pi 1
ISO
CTD Direct Evidence: marker/mechanism DNA:increased methylation:promoter
CTD RGD
PMID:9029167 PMID:22536438
RGD:14401712
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Gstt1
glutathione S-transferase, theta 1
susceptibility no_association
ISO
DNA:deletion
RGD
PMID:23053942 PMID:20683151 PMID:20672314
RGD:14401714 , RGD:14700951 , RGD:14700979
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
Gtse1
G two S phase expressed protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:85,743,928...85,760,774
Ensembl chr15:85,743,946...85,760,774
G
Gys2
glycogen synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:142,368,339...142,418,856
Ensembl chr 6:142,368,339...142,418,835
G
H19
H19, imprinted maternally expressed transcript
ISO
mRNA:increased expression:liver
RGD
PMID:17393425
RGD:2306187
NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,131,917
G
H2-Aa
histocompatibility 2, class II antigen A, alpha
susceptibility
ISO
associated with Hepatitis B, Chronic;DNA:SNP: :rs9272105(human) associated with Hepatitis B, Chronic;DNA:SNPs, haplotype: : rs9275572, rs2596542(human)
RGD
PMID:30160782 PMID:24204805
RGD:14398839 , RGD:14401561
NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
treatment
ISO
associated with hepatitis B associated with hepatitis C;DNA:SNPs,haplotypes
RGD
PMID:27288300 PMID:28921602
RGD:14928325 , RGD:14974233
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
H2-Pa
histocompatibility 2, P region alpha locus
ISO
DNA:hypomethylation: CpG islands:
RGD
PMID:20165882
RGD:14694974
NCBI chr17:34,303,587...34,304,826
Ensembl chr17:34,303,575...34,304,797
G
Hamp
hepcidin antimicrobial peptide
ISO IEP IDA
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver (human) DNA:hypermethylation,hypomethylation:promoter
CTD RGD
PMID:28284560 PMID:29235098 PMID:29235098
RGD:15042879 , RGD:15042879
NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
G
Hao2
hydroxyacid oxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:98,781,835...98,802,692
Ensembl chr 3:98,781,837...98,800,555
G
Havcr1
hepatitis A virus cellular receptor 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Havcr2
hepatitis A virus cellular receptor 2
disease_progression
ISO
associated with hepatitis B;DNA:SNP: : ���1516 G>T (human)
RGD
PMID:27034168
RGD:40818257
NCBI chr11:46,345,758...46,372,082
Ensembl chr11:46,345,762...46,372,082
G
Hdac2
histone deacetylase 2
disease_progression
ISO
mRNA:increased expression:liver:
RGD
PMID:24448241
RGD:9590206
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
G
Hdac4
histone deacetylase 4
ISO
mRNA:increased expression:liver:
RGD
PMID:21837748
RGD:9681451
NCBI chr 1:91,856,501...92,123,424
Ensembl chr 1:91,856,501...92,123,421
G
Hfe
homeostatic iron regulator
disease_progression
ISO
associated with Liver Cirrhosis;DNA:missense mutation:cds:p.C282Y (human)
RGD
PMID:20019189 PMID:29642405
RGD:2317357 , RGD:14746967
NCBI chr13:23,886,017...23,894,837
Ensembl chr13:23,886,017...23,894,837
G
Hgf
hepatocyte growth factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9932610 PMID:11896611
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
G
Hgfac
hepatocyte growth factor activator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 5:35,198,853...35,205,805
Ensembl chr 5:35,198,853...35,205,805
G
Hhip
Hedgehog-interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18559595
NCBI chr 8:80,692,480...80,784,637
Ensembl chr 8:80,692,480...80,784,635
G
Hif1a
hypoxia inducible factor 1, alpha subunit
treatment disease_progression
ISO
protein:increased expression:liver (human)
RGD
PMID:19335982 PMID:26078356 PMID:31321740
RGD:9068886 , RGD:11526468 , RGD:155882550
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hilpda
hypoxia inducible lipid droplet associated
disease_progression
ISO
mRNA, protein:increased expression:liver (human) human cells in mouse model mRNA:increased expression:liver (human)
RGD
PMID:31142329 PMID:31142329 PMID:30205391 PMID:35693827
RGD:153344574 , RGD:153344574 , RGD:153344577 , RGD:153344586
NCBI chr 6:29,272,487...29,275,448
Ensembl chr 6:29,272,487...29,275,445
G
Hjurp
Holliday junction recognition protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:88,186,578...88,205,366
Ensembl chr 1:88,190,193...88,205,355
G
Hmgb2
high mobility group box 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20851854
NCBI chr 8:57,964,877...57,969,033
Ensembl chr 8:57,964,941...57,969,033
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9207284 PMID:21147110
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Hmgcs2
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2
disease_progression
ISO
RGD
PMID:28867541
RGD:14975299
NCBI chr 3:98,187,747...98,218,054
Ensembl chr 3:98,187,751...98,218,054
G
Hmmr
hyaluronan mediated motility receptor (RHAMM)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:40,592,215...40,624,290
Ensembl chr11:40,592,222...40,624,249
G
Hnf1a
HNF1 homeobox A
treatment
IMP
human cell line in mouse model
RGD
PMID:29466992
RGD:14700664
NCBI chr 5:115,087,039...115,109,121
Ensembl chr 5:115,087,039...115,109,153
G
Hnf4a
hepatic nuclear factor 4, alpha
ISO
protein:decreased expression:liver:
RGD
PMID:20876809 PMID:20876809
RGD:12904747 , RGD:12904747
NCBI chr 2:163,348,731...163,414,827
Ensembl chr 2:163,348,728...163,414,830
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
protein:increased expression:liver (human)
RGD
PMID:23633480
RGD:9685423
NCBI chr15:103,148,840...103,155,119
Ensembl chr15:103,148,859...103,155,119
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
ISO
protein:increased expression:liver (human) mRNA:increased expression:liver (rat)
RGD
PMID:20604928 PMID:23633480
RGD:9685422 , RGD:9685423
NCBI chr 6:51,437,414...51,448,054
Ensembl chr 6:51,437,912...51,446,874
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
severity
ISO
mRNA:increased expression:liver (human)
RGD
PMID:24638979
RGD:10059322
NCBI chr11:51,490,927...51,497,708
Ensembl chr11:51,490,927...51,497,674
G
Hnrnpd
heterogeneous nuclear ribonucleoprotein D
ISO
protein:increased expression:liver (human) protein:increased expression:liver (rat)
RGD
PMID:20102719 PMID:22318685
RGD:10042969 , RGD:10042977
NCBI chr 5:100,103,794...100,126,926
Ensembl chr 5:100,103,794...100,126,797
G
Hnrnph1
heterogeneous nuclear ribonucleoprotein H1
ISO
protein:increased expression:liver (human)
RGD
PMID:23633480
RGD:9685423
NCBI chr11:50,266,084...50,277,355
Ensembl chr11:50,267,817...50,277,355
G
Hnrnpl
heterogeneous nuclear ribonucleoprotein L
ISO
associated with Hepatitis B
RGD
PMID:24125732
RGD:9999429
NCBI chr 7:28,507,971...28,521,693
Ensembl chr 7:28,507,966...28,521,691
G
Hotair
HOX transcript antisense RNA (non-protein coding)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21327457
NCBI chr15:102,852,497...102,856,381
Ensembl chr15:102,852,494...102,856,165
G
Hoxa10
homeobox A10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:52,208,177...52,217,658
Ensembl chr 6:52,208,177...52,217,834
G
Hoxa13
homeobox A13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:52,235,833...52,237,865
Ensembl chr 6:52,234,674...52,237,788
G
Hoxd9
homeobox D9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:74,528,107...74,530,552
Ensembl chr 2:74,528,071...74,530,552
G
Hp
haptoglobin
ISO
protein:increased expression:saliva protein:decreased expression:liver (human)
RGD
PMID:31041878 PMID:24259486
RGD:27095881 , RGD:152995276
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6327016
RGD:5135035
NCBI chr X:52,076,955...52,110,537
Ensembl chr X:52,077,014...52,110,536
G
Hras
Harvey rat sarcoma virus oncogene
treatment
ISO IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) human cells in a mouse model human plasmid in a mouse model mRNA:increased expression:liver (mouse) ClinVar Annotator: match by term: Hepatocellular cancer ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
CTD ClinVar RGD
PMID:8200073 PMID:9311599 PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20118494 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27517622 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28284560 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 PMID:15806265 PMID:10791191 PMID:23555816 PMID:2219132 More...
RGD:14688054 , RGD:14688055 , RGD:14694809 , RGD:14694810
NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
G
Hspa5
heat shock protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284 PMID:29698666
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Hspa9
heat shock protein 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
G
Hspb1
heat shock protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
G
Htatip2
HIV-1 Tat interactive protein 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16799960
NCBI chr 7:49,408,761...49,423,748
Ensembl chr 7:49,408,863...49,423,723
G
Htra1
HtrA serine peptidase 1
exacerbates disease_progression
ISO
protein:decreased expression:liver (human) mRNA:decreased expression:liver (human)
RGD
PMID:20943460 PMID:26403966
RGD:152985524 , RGD:152985529
NCBI chr 7:130,537,933...130,587,388
Ensembl chr 7:130,537,841...130,587,390
G
Icam1
intercellular adhesion molecule 1
severity
ISO
protein:increased expression:serum
RGD
PMID:26109813
RGD:11056752
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Idh1
isocitrate dehydrogenase 1 (NADP+), soluble
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hepatocellular cancer
CTD ClinVar
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:21472284 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27993330 PMID:30231226 PMID:36201590 More...
NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
disease_progression
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar RGD
PMID:20946881 PMID:21250968 PMID:21596855 PMID:21997850 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22616558 PMID:22898539 PMID:23949315 PMID:24606448 PMID:25157968 PMID:26619011 PMID:24716838 More...
RGD:14985249
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
Ier2
immediate early response 2
ISO
mRNA, protein:decreased expression:liver (human)
RGD
PMID:32009420
RGD:153323326
NCBI chr 8:85,387,960...85,389,481
Ensembl chr 8:85,387,960...85,389,483
G
Ifna1
interferon alpha 1
susceptibility
ISO
CTD Direct Evidence: therapeutic associated with hepatitis B; DNA:SNP:: ( rs1831583) (human)
CTD RGD
PMID:17088986 PMID:17971768 PMID:18665156 PMID:29080269
RGD:21406429
NCBI chr 4:88,768,324...88,768,893
Ensembl chr 4:88,768,324...88,768,893
G
Ifng
interferon gamma
IEP
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igbp1
immunoglobulin (CD79A) binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21339737
NCBI chr X:99,537,897...99,559,731
Ensembl chr X:99,537,897...99,559,731
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf1r
insulin-like growth factor I receptor
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs, haplotype: :
CTD RGD
PMID:17441810 PMID:23958494 PMID:24758241
RGD:14985227
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Igf2
insulin-like growth factor 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism associated with hepatitis B;DNA:SNPs:intron, 3'utr:+2482A>C, +820A>G (human)
CTD RGD
PMID:12532445 PMID:16092956 PMID:17554210 PMID:16750516
RGD:2311523 , RGD:14401723
NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553
G
Igf2bp1
insulin-like growth factor 2 mRNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:95,847,989...95,896,770
Ensembl chr11:95,847,989...95,896,766
G
Igf2bp3
insulin-like growth factor 2 mRNA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:49,062,152...49,200,225
Ensembl chr 6:49,062,157...49,191,891
G
Igf2r
insulin-like growth factor 2 receptor
disease_progression no_association treatment
ISO
DNA:mutation:G1449V (human) CTD Direct Evidence: marker/mechanism protein:increased expression:serum: DNA:loss of heterozygosity:liver DNA:loss of heterozygosity,mutations:liver: associated with hepatitis B virus; mRNA:decreased expression:liver: ClinVar Annotator: match by term: Hepatocellular carcinoma
OMIM CTD ClinVar RGD
PMID:9722161 PMID:15057872 PMID:25741868 PMID:7493029 PMID:29940770 PMID:18322954 PMID:10347113 PMID:30720132 PMID:11981765 PMID:12736721 More...
RGD:1624323 , RGD:14985218 , RGD:14985219 , RGD:14985220 , RGD:14985221 , RGD:14985222 , RGD:14985225
NCBI chr17:12,901,293...12,988,593
Ensembl chr17:12,901,293...12,988,551
G
Igfals
insulin-like growth factor binding protein, acid labile subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:25,096,818...25,100,985
Ensembl chr17:25,084,971...25,100,984
G
Ikbkg
inhibitor of kappaB kinase gamma
treatment
IMP ISO
protein:decreased expression:liver (human)
RGD
PMID:29551768 PMID:22176836 PMID:25173965 PMID:17292824 PMID:24971483 PMID:22922425 More...
RGD:153297807 , RGD:153297813 , RGD:153305943 , RGD:153305945 , RGD:11079569 , RGD:153305947
NCBI chr X:73,436,883...73,498,013
Ensembl chr X:73,436,896...73,497,460
G
Ikzf1
IKAROS family zinc finger 1
ameliorates
ISO
protein:increased expression:liver (human)
RGD
PMID:25301737
RGD:150540326
NCBI chr11:11,634,970...11,722,930
Ensembl chr11:11,634,980...11,722,926
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:23822114 PMID:26890368
RGD:7365006 , RGD:14975171
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il12a
interleukin 12a
susceptibility
ISO
associated with hepatitis C;DNA:SNP:3'UTR: rs568408( G>A)(human) associated with hepatitis B; DNA:SNP, haplotype:3′UTR::rs568408(human)
RGD
PMID:27819525 PMID:20521253 PMID:26631030
RGD:25440490 , RGD:25440491 , RGD:25440501
NCBI chr 3:68,597,977...68,605,881
Ensembl chr 3:68,597,977...68,605,880
G
Il15ra
interleukin 15 receptor, alpha chain
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 2:11,709,992...11,739,129
Ensembl chr 2:11,710,101...11,739,128
G
Il18
interleukin 18
severity disease_progression susceptibility
ISO
associated with hepatitis C;DNA:SNPs, haplotype:promoter:-607C>A, -137G>C(human) DNA:SNP:promoter:-137G>C(rs187238)(human) associated with hepatitis B, chronic;DNA:SNP:promoter:-607C>A(human)
RGD
PMID:29341496 PMID:26893476 PMID:27429592 PMID:27470888
RGD:14695526 , RGD:11538094 , RGD:14695540 , RGD:14696663
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il18r1
interleukin 18 receptor 1
ISO IMP
mRNA:decreased expression:liver
RGD
PMID:26893476 PMID:26893476
RGD:11538094 , RGD:11538094
NCBI chr 1:40,504,712...40,540,014
Ensembl chr 1:40,504,712...40,540,014
G
Il1b
interleukin 1 beta
susceptibility
ISO
DNA:polymorphism:promoter:-31T>C (human)
RGD
PMID:21653279
RGD:7401222
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rap
interleukin 1 receptor accessory protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:26,400,259...26,548,878
Ensembl chr16:26,400,454...26,548,867
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il2
interleukin 2
treatment
ISO
RGD
PMID:10933975 PMID:9449371
RGD:8693323 , RGD:14747035
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il21
interleukin 21
ISO
associated with hepatitis B;DNA:SNPS, haplotype:(rs13143866, rs2221903, rs907715) (human)
RGD
PMID:25892873
RGD:127285359
NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785
G
Il6
interleukin 6
treatment disease_progression
ISO IEP
CTD Direct Evidence: marker/mechanism DNA:SNP: :rs2069852 (human) mRNA,protein:increased expression:liver, blood serum (mouse)
CTD RGD
PMID:17615358 PMID:20818158 PMID:26297436 PMID:27022031 PMID:27368337 PMID:26569409 More...
RGD:14975289 , RGD:11344640
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il6st
interleukin 6 signal transducer
ISO
RGD
PMID:15780071
RGD:1626706
NCBI chr13:112,600,604...112,643,394
Ensembl chr13:112,600,604...112,646,620
G
Ing3
inhibitor of growth family, member 3
treatment
ISO
RGD
PMID:25156538
RGD:9587823
NCBI chr 6:21,948,002...21,976,037
Ensembl chr 6:21,949,570...21,976,037
G
Inmt
indolethylamine N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:55,147,612...55,151,975
Ensembl chr 6:55,147,611...55,152,028
G
Inpp4b
inositol polyphosphate-4-phosphatase, type II
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29415082
NCBI chr 8:82,068,895...82,865,553
Ensembl chr 8:82,069,185...82,854,543
G
Ins1
insulin I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
G
Ins2
insulin II
ISO
associated with Chronic Hepatitis C;mRNA:decreased expression:liver (human)
RGD
PMID:33132693
RGD:150340613
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
G
Insr
insulin receptor
ISO
mRNA, protein:increased expression:liver (human, rat) human cells in a mouse model
RGD
PMID:23633480 PMID:29610518
RGD:9685423 , RGD:14700930
NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617
G
Iqgap1
IQ motif containing GTPase activating protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20977743
NCBI chr 7:80,361,331...80,453,288
Ensembl chr 7:80,361,331...80,475,722
G
Iqgap2
IQ motif containing GTPase activating protein 2
ISO IAGP
CTD Direct Evidence: marker/mechanism OMIM:114550
CTD MouseDO
PMID:20977743
NCBI chr13:95,763,685...96,028,788
Ensembl chr13:95,763,682...96,028,991
G
Iqgap3
IQ motif containing GTPase activating protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:87,989,309...88,028,355
Ensembl chr 3:87,989,278...88,028,355
G
Irf2
interferon regulatory factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561517
NCBI chr 8:47,192,751...47,300,493
Ensembl chr 8:47,192,767...47,300,493
G
Irs1
insulin receptor substrate 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1311924 PMID:23958494
NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
G
Irs2
insulin receptor substrate 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16127164
NCBI chr 8:11,034,681...11,058,929
Ensembl chr 8:11,034,681...11,058,458
G
Isg15
ISG15 ubiquitin-like modifier
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28919514
NCBI chr 4:156,283,881...156,285,275
Ensembl chr 4:156,283,912...156,285,253
G
Itih3
inter-alpha trypsin inhibitor, heavy chain 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr14:30,630,529...30,645,748
Ensembl chr14:30,630,529...30,645,717
G
Itih4
inter alpha-trypsin inhibitor, heavy chain 4
disease_progression
ISO
associated with hepatitis B;protein:decreased expression:serum
RGD
PMID:24836184
RGD:40903002
NCBI chr14:30,608,433...30,623,943
Ensembl chr14:30,608,433...30,624,310
G
Jag1
jagged 1
ISO
protein:increased expression:liver
RGD
PMID:30660174
RGD:14694832
NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564
G
Jak1
Janus kinase 1
ISO
RGD
PMID:23788652
RGD:150524353
NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479
G
Jak2
Janus kinase 2
severity exacerbates ameliorates treatment
IEP ISO IMP
mRNA:decreased expression:liver (human) protein:increased phosphorylation:liver (human) protein:increased phosphorylation:liver (mouse) associated with Diseases of the Aged and non-alcoholic fatty liver disease L-JAK2 KO
RGD
PMID:25420511 PMID:22392353 PMID:22821478 PMID:31393852 PMID:28100771 PMID:29486150 More...
RGD:18182928 , RGD:125097525 , RGD:127285621 , RGD:127285655 , RGD:127285675 , RGD:127285672
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Jdp2
Jun dimerization protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20214788
NCBI chr12:85,645,190...85,686,652
Ensembl chr12:85,645,801...85,686,652
G
Jun
jun proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20214788
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Jund
jun D proto-oncogene
ISO
associated with HBV;protein:increased expression:liver (human)
RGD
PMID:15927205
RGD:153297768
NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265
G
Kat2b
K(lysine) acetyltransferase 2B
severity
ISO
protein:decreased expression:liver (human)
RGD
PMID:23643089
RGD:9590314
NCBI chr17:53,873,802...53,979,749
Ensembl chr17:53,873,889...53,979,748
G
Kbtbd11
kelch repeat and BTB (POZ) domain containing 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:15,059,408...15,083,333
Ensembl chr 8:15,061,025...15,083,333
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
ISO
protein:increased expression:liver (human)
RGD
PMID:17022810
RGD:9693723
NCBI chr 1:191,871,759...192,192,467
Ensembl chr 1:191,873,082...192,192,467
G
Kcnn2
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:45,401,754...45,818,954
Ensembl chr18:45,401,927...45,818,950
G
Kdm1a
lysine (K)-specific demethylase 1A
severity
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:23236241
RGD:9681002
NCBI chr 4:136,277,844...136,330,127
Ensembl chr 4:136,277,851...136,330,034
G
Kdm3a
lysine (K)-specific demethylase 3A
ISO
mRNA:increased expression:liver (human)
RGD
PMID:21607773
RGD:9590222
NCBI chr 6:71,565,954...71,609,963
Ensembl chr 6:71,565,956...71,609,974
G
Kdm5c
lysine demethylase 5C
exacerbates
ISO
protein:increased expression:liver (human)
RGD
PMID:26503415
RGD:11530160
NCBI chr X:151,015,698...151,062,098
Ensembl chr X:151,016,016...151,057,531
G
Kdm6a
lysine (K)-specific demethylase 6A
ameliorates
ISO
human cells in a mouse model
RGD
PMID:32765772
RGD:150429729
NCBI chr X:18,027,101...18,147,061
Ensembl chr X:18,028,814...18,146,175
G
Kdm8
lysine (K)-specific demethylase 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:125,043,788...125,062,823
Ensembl chr 7:125,043,848...125,061,441
G
Kdr
kinase insert domain protein receptor
treatment disease_progression
ISO
DNA:SNPs: :rs1870377, rs2071559, rs2305948 (human) protein:increased expression:liver protein:decreased expression:liver associated with alcoholic liver cirrhosis;DNA:SNP: :1416A>T (human)
RGD
PMID:25182707 PMID:19177438 PMID:25333267 PMID:23660204 PMID:24445728
RGD:126848806 , RGD:126848810 , RGD:126848812 , RGD:126848813 , RGD:126848814
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Kif11
kinesin family member 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr19:37,364,830...37,410,311
Ensembl chr19:37,364,851...37,410,307
G
Kif14
kinesin family member 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:136,394,044...136,483,676
Ensembl chr 1:136,394,081...136,459,249
G
Kif15
kinesin family member 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:122,780,146...122,847,798
Ensembl chr 9:122,780,111...122,847,798
G
Kif18a
kinesin family member 18A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:109,111,165...109,172,094
Ensembl chr 2:109,111,083...109,172,092
G
Kif18b
kinesin family member 18B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:102,796,344...102,815,960
Ensembl chr11:102,796,355...102,815,950
G
Kif1b
kinesin family member 1B
severity susceptibility
ISO
mRNA, protein:decreased expression:liver (human) DNA:snp:intron:c.2537+518A>G (rs17401966) (human)
RGD
PMID:26217094 PMID:27122668
RGD:11052488 , RGD:12738461
NCBI chr 4:149,260,776...149,392,762
Ensembl chr 4:149,260,776...149,392,150
G
Kif20a
kinesin family member 20A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:34,757,677...34,766,330
Ensembl chr18:34,757,666...34,766,330
G
Kif23
kinesin family member 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:61,824,559...61,854,078
Ensembl chr 9:61,823,187...61,854,056
G
Kif2c
kinesin family member 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:117,016,830...117,039,821
Ensembl chr 4:117,016,836...117,039,836
G
Kif4
kinesin family member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:99,669,693...99,770,878
Ensembl chr X:99,669,343...99,770,820
G
Kifc1
kinesin family member C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:34,094,640...34,109,607
Ensembl chr17:34,094,633...34,109,635
G
Klf4
Kruppel-like transcription factor 4 (gut)
disease_progression treatment
ISO
RGD
PMID:22677193 PMID:22677193
RGD:14402023 , RGD:14402023
NCBI chr 4:55,527,137...55,536,984
Ensembl chr 4:55,527,143...55,532,466
G
Klrb1
killer cell lectin-like receptor subfamily B member 1
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 6:128,683,056...128,701,293
Ensembl chr 6:128,682,799...128,700,022
G
Kmt2a
lysine (K)-specific methyltransferase 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22634756
NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594
G
Kmt2b
lysine (K)-specific methyltransferase 2B
ISO
DNA:insertions, translocations:intron:IVS3, multiple (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22634754 PMID:18320596
RGD:9588597
NCBI chr 7:30,268,280...30,288,371
Ensembl chr 7:30,268,283...30,288,151
G
Kmt2c
lysine (K)-specific methyltransferase 2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22634756
NCBI chr 5:25,476,793...25,703,853
Ensembl chr 5:25,476,796...25,703,781
G
Kras
Kirsten rat sarcoma viral oncogene homolog
induced
ISO
CTD Direct Evidence: marker/mechanism aflatoxin B1 induced:DNA:transversion,transition mutations:cds: mRNA,protein:increased expression:liver ClinVar Annotator: match by term: Hepatocellular cancer
CTD ClinVar RGD
PMID:2278970 PMID:3122217 PMID:11286481 PMID:11563603 PMID:12460918 PMID:15696205 PMID:16361624 PMID:16434492 PMID:16618717 PMID:18316791 PMID:18794081 PMID:19075190 PMID:19114683 PMID:19679400 PMID:20921462 PMID:20921465 PMID:21228335 PMID:22407852 PMID:22722830 PMID:23325582 PMID:25157968 PMID:26619011 PMID:30891959 PMID:8446626 PMID:29275358 More...
RGD:11568697 , RGD:14398750
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
G
Krt18
keratin 18
IAGP
OMIM:114550
MouseDO
NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462
G
Lcat
lecithin cholesterol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:106,666,183...106,670,034
Ensembl chr 8:106,666,183...106,670,014
G
Lect2
leukocyte cell-derived chemotaxin 2
ameliorates
IEP ISO
protein:increased expression:blood serum (mouse) protein:increased expression:blood serum (human) human cells in mouse model
RGD
PMID:24892551 PMID:24892551 PMID:21394108
RGD:153323333 , RGD:153323333 , RGD:153323335
NCBI chr13:56,676,772...56,696,373
Ensembl chr13:56,690,277...56,696,315
G
Lep
leptin
susceptibility severity
IAGP IEP
DNA:SNP:enhancer:-2548G>A (rs7799039) (human) protein:increased expression:liver (human)
RGD
PMID:28452232 PMID:18573568
RGD:15039399 , RGD:25330348
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lepr
leptin receptor
susceptibility
ISO
associated with Hepatitis B, Chronic;DNA:SNPs:cds:p.Gln223Arg, Lys109Arg (human)
RGD
PMID:23090836
RGD:21079466
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
G
Letm1
leucine zipper-EF-hand containing transmembrane protein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23392203
NCBI chr 5:33,897,017...33,940,061
Ensembl chr 5:33,897,017...33,940,161
G
Lifr
LIF receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:7,120,091...7,226,970
Ensembl chr15:7,120,095...7,226,970
G
LOC110806267
Tert 5' regulatory region
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:28492532 PMID:28677271
NCBI chr13:73,770,663...73,775,510
G
Loxl3
lysyl oxidase-like 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35841383
NCBI chr 6:83,011,186...83,029,547
Ensembl chr 6:83,011,154...83,029,543
G
Lpar1
lysophosphatidic acid receptor 1
ISO
RGD
PMID:19000703
RGD:2317680
NCBI chr 4:58,435,252...58,554,601
Ensembl chr 4:58,435,255...58,553,898
G
Lrat
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 3:82,799,889...82,811,281
Ensembl chr 3:82,799,886...82,811,280
G
Lrp1b
low density lipoprotein-related protein 1B
exacerbates
ISO
protein:increased expression:liver (human) DNA:mutations:multiple: (human)
RGD
PMID:33324588 PMID:33391418
RGD:150429776 , RGD:150429785
NCBI chr 2:40,485,302...42,543,747
Ensembl chr 2:40,485,258...42,543,636
G
Lrrc1
leucine rich repeat containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:77,338,103...77,453,749
Ensembl chr 9:77,338,105...77,452,152
G
Lrrc56
leucine rich repeat containing 56
ISO
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
NCBI chr 7:140,774,024...140,789,968
Ensembl chr 7:140,774,070...140,789,968
G
Lrrc59
leucine rich repeat containing 59
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr11:94,520,603...94,536,049
Ensembl chr11:94,520,593...94,536,042
G
Lyve1
lymphatic vessel endothelial hyaluronan receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:110,449,814...110,462,160
Ensembl chr 7:110,449,814...110,462,446
G
Lztr1
leucine-zipper-like transcriptional regulator, 1
ISO
DNA:missense mutation:cds, liver (human)
RGD
PMID:28622513
RGD:151893487
NCBI chr16:17,326,124...17,344,197
Ensembl chr16:17,326,552...17,344,197
G
Mad2l1
MAD2 mitotic arrest deficient-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:66,512,205...66,518,091
Ensembl chr 6:66,512,374...66,524,204
G
Magea3
MAGE family member A3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:153,731,176...153,742,027
Ensembl chr X:153,731,539...153,732,501
G
Magea5
MAGE family member A5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:153,836,057...153,846,147
Ensembl chr X:153,836,057...153,846,141
G
Magea6
MAGE family member A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:153,706,891...153,719,070
Ensembl chr X:153,707,008...153,718,983
G
Magec2
MAGE family member C2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:61,326,566...61,335,690
Ensembl chr X:61,327,105...61,335,684
G
Malat1
metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26735578
NCBI chr19:5,845,718...5,852,700
Ensembl chr19:5,845,717...5,852,706
G
Map2k2
mitogen-activated protein kinase kinase 2
exacerbates
ISO
mRNA:increased expression:liver (human) protein:increased expression:liver, cytosol (rat)
RGD
PMID:33553243 PMID:9397988
RGD:150530475 , RGD:150530477
NCBI chr10:80,941,749...80,960,531
Ensembl chr10:80,941,749...80,969,809
G
Map2k4
mitogen-activated protein kinase kinase 4
ISO
protein:decreased expression:liver (human)
RGD
PMID:32850377
RGD:150429765
NCBI chr11:65,579,070...65,679,185
Ensembl chr11:65,579,069...65,679,123
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
exacerbates
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:31310010
RGD:150573714
NCBI chr13:111,882,962...111,954,803
Ensembl chr13:111,882,962...111,945,527
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
ameliorates
IMP
RGD
PMID:26560698
RGD:11342977
NCBI chr18:4,331,325...4,352,978
Ensembl chr18:4,331,327...4,353,015
G
Map4k4
mitogen-activated protein kinase kinase kinase kinase 4
ameliorates severity treatment
ISO
human cell line in a mouse model human recombinant gene and cell line in a mouse model
RGD
PMID:21196414 PMID:27010469 PMID:31922225
RGD:151347673 , RGD:151347674 , RGD:151347839
NCBI chr 1:39,939,806...40,065,470
Ensembl chr 1:39,940,073...40,065,470
G
Mapk1
mitogen-activated protein kinase 1
ISO
protein:increased expression:liver
RGD
PMID:27468214
RGD:401976278
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk14
mitogen-activated protein kinase 14
treatment exacerbates
IMP
RGD
PMID:25216638 PMID:23271722
RGD:151665347 , RGD:151665348
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mapk8
mitogen-activated protein kinase 8
ameliorates
ISO
protein:decreased phosphorylation:liver (human)
RGD
PMID:33875785
RGD:150340688
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mapt
microtubule-associated protein tau
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916
G
Marco
macrophage receptor with collagenous structure
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:120,402,267...120,432,753
Ensembl chr 1:120,402,267...120,432,753
G
Mat1a
methionine adenosyltransferase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12060674
NCBI chr14:40,826,969...40,846,385
Ensembl chr14:40,826,992...40,846,369
G
Mbl2
mannose-binding lectin (protein C) 2
severity susceptibility no_association
ISO
associated with hepatitis C;DNA:SNP: :221C>G(rs709620)(human) associated with hepatitis B-related cirrhosis;DNA:SNP: :rs11003123(G>A)(human) associated with viral hepatitis;DNA:polymorphisms:exon: DNA:SNPs:promoter:rs7096206(human) protein:decreased expression:plasma associated with hepatitis B;DNA:SNP:exon:
RGD
PMID:21733090 PMID:27298104 PMID:18221301 PMID:25787238 PMID:27557564 PMID:26857650 More...
RGD:14696813 , RGD:14696814 , RGD:14696829 , RGD:14696833 , RGD:14696835 , RGD:14696836
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
G
Mbtps1
membrane-bound transcription factor peptidase, site 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr 8:120,234,890...120,285,603
Ensembl chr 8:120,234,895...120,285,474
G
Mbtps2
membrane-bound transcription factor peptidase, site 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr X:156,330,818...156,381,711
Ensembl chr X:156,318,367...156,381,711
G
Mcm10
minichromosome maintenance 10 replication initiation factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:4,995,535...5,017,602
Ensembl chr 2:4,994,525...5,017,602
G
Mcm2
minichromosome maintenance complex component 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:88,860,456...88,875,762
Ensembl chr 6:88,860,456...88,875,762
G
Mcm7
minichromosome maintenance complex component 7
susceptibility
IAGP IEP
associated with hepatitis B;DNA:SNP:promoter: (rs999885) (human) associated with hepatitis B;miRNA:increased expression:liver (human)
RGD
PMID:24416400 PMID:27298561
RGD:15042885 , RGD:15042853
NCBI chr 5:138,162,845...138,170,675
Ensembl chr 5:138,162,845...138,170,684
G
Mcm9
minichromosome maintenance 9 homologous recombination repair factor
IAGP
OMIM:114550
MouseDO
NCBI chr10:53,412,411...53,507,251
Ensembl chr10:53,412,411...53,506,535
G
Mdm2
transformed mouse 3T3 cell double minute 2
susceptibility
ISO
DNA:transversion:promoter:g.-309T>G (human)
RGD
PMID:20019189
RGD:2317357
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Me1
malic enzyme 1, NADP(+)-dependent, cytosolic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
G
Mecp2
methyl CpG binding protein 2
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver
CTD RGD
PMID:26189965 PMID:11844796
RGD:2289670
NCBI chr X:73,070,198...73,129,296
Ensembl chr X:73,070,198...73,129,296
G
Med1
mediator complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20007298
NCBI chr11:98,042,980...98,084,121
Ensembl chr11:98,042,980...98,084,119
G
Melk
maternal embryonic leucine zipper kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:44,300,876...44,364,301
Ensembl chr 4:44,300,876...44,364,675
G
Met
met proto-oncogene
severity
ISO IMP
protein:increased expression:liver (rat) mRNA:increased expression:liver, carcinoma (human) CTD Direct Evidence: marker/mechanism protein:increased expression:liver (human) ClinVar Annotator: match by term: Hepatocellular cancer
CTD ClinVar OMIM RGD
PMID:21774103 PMID:21970370 PMID:22703879 PMID:24728327 PMID:25741868 PMID:28259294 PMID:28492532 PMID:29641532 PMID:32045588 PMID:17311762 PMID:9927037 PMID:17154373 PMID:29303510 PMID:29303510 More...
RGD:2317495 , RGD:1600123 , RGD:2317575 , RGD:152995524 , RGD:152995524
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:122,840,643...122,855,844
Ensembl chr 4:122,840,643...122,854,981
G
Mir106b
microRNA 106b
disease_progression severity
IEP
miRNA:decreased expression:liver (human) miRNA:increased expression:plasma (human) miRNA:increased expression:serum (human) miRNA:increased expression:liver (human)
RGD
PMID:28958640 PMID:25894380 PMID:28611524 PMID:31406464
RGD:15042874 , RGD:15042875 , RGD:15042876 , RGD:15042877
NCBI chr 5:138,163,999...138,164,080
Ensembl chr 5:138,163,999...138,164,080
G
Mir107
microRNA 107
treatment onset
ISO
RNA:decreased expression:liver: RNA:increased expression:liver:
RGD
PMID:30738047 PMID:27773820 PMID:26191213 PMID:28079796
RGD:14975277 , RGD:14975278 , RGD:11066920 , RGD:14975300
NCBI chr19:34,798,087...34,798,173
Ensembl chr19:34,798,087...34,798,173
G
Mir122
microRNA 122
severity
ISO
CTD Direct Evidence: marker/mechanism associated with hepatitis B miRNA:decreased expression:liver protein:decreased expression:liver (human) mRNA:decreased expression:blood (human)
CTD RGD
PMID:16924677 PMID:25269820 PMID:25422324 PMID:19584283 PMID:27528885
RGD:14394424 , RGD:14401603 , RGD:151356981 , RGD:151361113
NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997
G
Mir125a
microRNA 125a
treatment severity
IEP ISO
RNA:increased expression:liver:
RGD
PMID:30257386 PMID:30257386 PMID:29951066
RGD:21403677 , RGD:21403677 , RGD:21403679
NCBI chr17:18,051,074...18,051,141
Ensembl chr17:18,051,074...18,051,141
G
Mir127
microRNA 127
ISO
miRNA:decreased expression:liver (human)
RGD
PMID:24854842
RGD:152995355
NCBI chr12:109,559,280...109,559,349
Ensembl chr12:109,559,280...109,559,349
G
Mir130b
microRNA 130b
severity
ISO
miRNA:increased expression:liver
RGD
PMID:25387077
RGD:14694845
NCBI chr16:16,941,925...16,942,006
Ensembl chr16:16,941,925...16,942,006
G
Mir133a-1
microRNA 133a-1
disease_progression
ISO
mRNA:decreased expression:liver (human) human cells in mouse model
RGD
PMID:30086463 PMID:30086463
RGD:153344517 , RGD:153344517
NCBI chr18:10,782,909...10,782,976
Ensembl chr18:10,782,909...10,782,976
G
Mir133b
microRNA 133b
severity
ISO
mRNA:decreased expression:liver(human)
RGD
PMID:30391496
RGD:155804298
NCBI chr 1:20,752,993...20,753,111
Ensembl chr 1:20,752,993...20,753,111
G
Mir136
microRNA 136
exacerbates
ISO
RNA:decreased expression:liver (human)
RGD
PMID:28849100
RGD:153345547
NCBI chr12:109,561,761...109,561,822
Ensembl chr12:109,561,761...109,561,822
G
Mir139
microRNA 139
ISO
RNA:decreased expression:liver (human)
RGD
PMID:30710422
RGD:153344549
NCBI chr 7:101,124,583...101,124,650
Ensembl chr 7:101,124,583...101,124,650
G
Mir145a
microRNA 145a
severity
IEP
miRNA:decreased expression:liver (human)
RGD
PMID:30572504
RGD:15039395
NCBI chr18:61,780,896...61,780,965
Ensembl chr18:61,780,896...61,780,965
G
Mir146
microRNA 146
sexual_dimorphism susceptibility
ISO
associated with hepatitis B;miRNA:SNP:exon: (rs2910164) (human) miRNA:SNP: (human) associated with hepatitis B;miRNA:SNP: (human)
RGD
PMID:18711148 PMID:24816919 PMID:24615520
RGD:126925148 , RGD:126925158 , RGD:126925187
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
G
Mir150
microRNA 150
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:30205391
RGD:153344577
NCBI chr 7:44,771,181...44,771,245
Ensembl chr 7:44,771,181...44,771,245
G
Mir152
microRNA 152
disease_progression
ISO
miRNA:decreased expression:liver
RGD
PMID:30967300 PMID:26531720
RGD:19165146 , RGD:21066331
NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291
G
Mir154
microRNA 154
ISO
RNA:decreased expression:liver (human)
RGD
PMID:33195697
RGD:152995478
NCBI chr12:109,704,867...109,704,932
Ensembl chr12:109,704,867...109,704,932
G
Mir155
microRNA 155
disease_progression
ISO
miRNA:decreased expression:peripheral blood mononuclear cell miRNA:increased expression:serum associated with hepatitis C;DNA:SNP: :rs767649 (human)
RGD
PMID:27035278 PMID:27035278 PMID:28074870 PMID:30710754 PMID:29528577 PMID:27531892 More...
RGD:21079433 , RGD:21079433 , RGD:21079477 , RGD:21081523 , RGD:24922222 , RGD:25671465
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir18
microRNA 18
severity
IEP
miRNA:increased expression:liver (human) associated with hepatitis B;miRNA:increased expression:liver (human) associated with Hepatitis C, Chronic;miRNA:increased expression:serum (human)
RGD
PMID:19027010 PMID:30519035 PMID:30191950 PMID:24975878 PMID:29455432
RGD:15039398 , RGD:15039400 , RGD:15039389 , RGD:15039401 , RGD:15039404
NCBI chr14:115,281,283...115,281,378
Ensembl chr14:115,281,283...115,281,378
G
Mir181c
microRNA 181c
IEP
miRNA:decreased expression:liver (human)
RGD
PMID:31114379
RGD:15042894
NCBI chr 8:84,905,502...84,905,590
Ensembl chr 8:84,905,502...84,905,590
G
Mir18b
microRNA 18b
severity
IEP
miRNA:increased expression:liver (human)
RGD
PMID:23496901
RGD:15039403
NCBI chr X:51,831,208...51,831,290
Ensembl chr X:51,831,208...51,831,290
G
Mir193a
microRNA 193a
disease_progression exacerbates
ISO
miRNA:decreased expression:liver (human) RNA:increased expression:blood serum (human) DNA:hypomethylation
RGD
PMID:26263159 PMID:30710422 PMID:32960907 PMID:28036298
RGD:11070076 , RGD:153344549 , RGD:153344563 , RGD:153344564
NCBI chr11:79,602,795...79,602,860
Ensembl chr11:79,602,795...79,602,860
G
Mir195a
microRNA 195a
severity
IEP IMP
miRNA:decreased expression:liver (human) miRNA:decreased expression:liver (mouse)
RGD
PMID:25607636 PMID:25607636
RGD:15042896 , RGD:15042896
NCBI chr11:70,125,868...70,125,961
Ensembl chr11:70,125,868...70,125,961
G
Mir196a-2
microRNA 196a-2
susceptibility
ISO
associated with hepatitis B, chronic; DNA:SNP: : (rs12304647) DNA:SNP: : (rs11614913)
RGD
PMID:21692953 PMID:24248733
RGD:14401594 RGD:14401595
NCBI chr15:102,881,785...102,881,869
Ensembl chr15:102,881,785...102,881,869
G
Mir199b
microRNA 199b
disease_progression
ISO
miRNA:decreased expression:liver
RGD
PMID:30536310
RGD:14694833
NCBI chr 2:32,208,472...32,208,581
Ensembl chr 2:32,208,472...32,208,581
G
Mir200b
microRNA 200b
treatment disease_progression
ISO
mRNA:decreased expression:liver DNA:hypermethylation:promoter
RGD
PMID:26919246 PMID:26919246 PMID:28383782 PMID:28383782 PMID:28383782
RGD:14928318 , RGD:14928318 , RGD:14928322 , RGD:14928322 , RGD:14928322
NCBI chr 4:156,140,138...156,140,207
Ensembl chr 4:156,140,138...156,140,207
G
Mir20a
microRNA 20a
ISO
associated with Human Viral Hepatitis
RGD
PMID:30623908
RGD:25823145
NCBI chr14:115,281,589...115,281,695
Ensembl chr14:115,281,589...115,281,695
G
Mir212
microRNA 212
disease_progression ameliorates
ISO
RGD
PMID:25965836 PMID:25965836
RGD:11054501 , RGD:11054501
NCBI chr11:75,064,214...75,064,304
Ensembl chr11:75,064,214...75,064,304
G
Mir21a
microRNA 21a
severity treatment
ISO
miRNA:increased expression:liver
RGD
PMID:20447717 PMID:24963487 PMID:21749846
RGD:14695022 , RGD:40925952 , RGD:41404642
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
G
Mir22
microRNA 22
severity disease_progression
ISO
in male; RNA:increased expression:liver:
RGD
PMID:23766411 PMID:27811373 PMID:21750200
RGD:14700874 , RGD:14700875 , RGD:14700876
NCBI chr11:75,354,542...75,354,636
Ensembl chr11:75,354,542...75,354,636
G
Mir221
microRNA 221
disease_progression treatment
ISO IEP
RGD
PMID:25817558 PMID:29713162 PMID:29713162 PMID:22009537 PMID:28096271 PMID:28096271 PMID:28096271 PMID:31801250 More...
RGD:11086123 , RGD:18337267 , RGD:18337267 , RGD:18337273 , RGD:18337275 , RGD:18337275 , RGD:18337275 , RGD:151893509
NCBI chr X:19,012,533...19,012,627
Ensembl chr X:19,012,533...19,012,627
G
Mir222
microRNA 222
disease_progression severity
ISO
RGD
PMID:24124720 PMID:20103675
RGD:151709003 , RGD:151709004
NCBI chr X:19,013,132...19,013,210
Ensembl chr X:19,013,132...19,013,210
G
Mir223
microRNA 223
disease_progression
IMP ISO
associated with high-fat diet, associated with Chronic HepatitisC; RNA:decreased expression:serum: associated with Chronic Hepatitis B; RNA:decreased expression:serum: RNA:increased expression:serum:
RGD
PMID:30964207 PMID:28982915 PMID:25391771 PMID:24595450 PMID:21229610
RGD:21408549 , RGD:21408578 , RGD:21408580 , RGD:21408583 , RGD:21408591
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Mir224
microRNA 224
severity
IEP
miRNA:increased expression:liver (human) associated with hepatitis B;miRNA:increased expression:liver (human) miRNA:increased expression:plasma (human)
RGD
PMID:23922662 PMID:22459148 PMID:23913306 PMID:24923856 PMID:27462777
RGD:18182921 , RGD:18182922 , RGD:18182923 , RGD:18182924 , RGD:18182926
NCBI chr X:71,304,637...71,304,718
Ensembl chr X:71,304,637...71,304,718
G
Mir23a
microRNA 23a
ISO
miRNA:increased expression:liver
RGD
PMID:22318941
RGD:14694846
NCBI chr 8:84,935,147...84,935,221
Ensembl chr 8:84,935,147...84,935,221
G
Mir23b
microRNA 23b
ISO
DNA:hypermethylation
RGD
PMID:28036298
RGD:153344564
NCBI chr13:63,448,298...63,448,371
Ensembl chr13:63,448,298...63,448,371
G
Mir25
microRNA 25
severity
IEP
miRNA:increased expression:liver (human) associated with hepatitis B;miRNA:increased expression:serum (human) associated with hepatitis B;miRNA:increased expression:liver (human)
RGD
PMID:30191950 PMID:24593846 PMID:21098710 PMID:27298561
RGD:15039389 , RGD:15042897 , RGD:15042899 , RGD:15042853
NCBI chr 5:138,163,583...138,163,666
Ensembl chr 5:138,163,583...138,163,666
G
Mir27a
microRNA 27a
severity treatment
ISO
human cell line in a mouse model human miRNA and cell line in a mouse model
RGD
PMID:29143999 PMID:30083261
RGD:14696659 , RGD:14696660
NCBI chr 8:84,935,301...84,935,387
Ensembl chr 8:84,935,301...84,935,387
G
Mir29a
microRNA 29a
severity
ISO
associated with hepatitis B;miRNA:increased expression:liver (human)
RGD
PMID:23285022 PMID:23285022
RGD:15042850 , RGD:15042850
NCBI chr 6:31,039,595...31,039,682
Ensembl chr 6:31,039,595...31,039,682
G
Mir302d
microRNA 302d
ameliorates
ISO
Human cells in mouse model
RGD
PMID:28352351
RGD:152998975
NCBI chr 3:127,339,273...127,339,338
Ensembl chr 3:127,339,273...127,339,338
G
Mir31
microRNA 31
severity
ISO
RNA:decreased expression:liver (human) miRNA:decreased expression:liver (human) miRNA:decreased expression:liver (rat)
RGD
PMID:28623129 PMID:25797269 PMID:25797269
RGD:152998991 , RGD:11085965 , RGD:11085965
NCBI chr 4:88,828,794...88,828,899
Ensembl chr 4:88,828,794...88,828,899
G
Mir340
microRNA 340
ISO
miRNA:decreased expression:liver
RGD
PMID:27998770
RGD:18936991
NCBI chr11:49,960,529...49,960,626
Ensembl chr11:49,960,529...49,960,626
G
Mir34a
microRNA 34a
treatment
ISO
human cell line in a mouse model miRNA:decreased expression:liver
RGD
PMID:25217526 PMID:29328457
RGD:14694835 , RGD:14694836
NCBI chr 4:150,152,911...150,153,012
Ensembl chr 4:150,152,911...150,153,012
G
Mir411
microRNA 411
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:30086881
RGD:152999437
NCBI chr12:109,676,609...109,676,690
Ensembl chr12:109,676,609...109,676,690
G
Mir432
microRNA 432
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:25797263 PMID:33675609 PMID:30086881
RGD:11087457 , RGD:152999436 , RGD:152999437
NCBI chr12:109,561,390...109,561,464
Ensembl chr12:109,561,390...109,561,464
G
Mir455
microRNA 455
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35286011
NCBI chr 4:63,175,088...63,175,169
Ensembl chr 4:63,175,088...63,175,169
G
Mir494
microRNA 494
disease_progression
ISO
RGD
PMID:25820676
RGD:155900754
NCBI chr12:109,681,752...109,681,836
Ensembl chr12:109,681,752...109,681,836
G
Mir539
microRNA 539
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27717846
NCBI chr12:109,694,563...109,694,636
Ensembl chr12:109,694,563...109,694,636
G
Mir615
microRNA 615
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22819824
NCBI chr15:102,923,342...102,923,433
Ensembl chr15:102,923,342...102,923,433
G
Mir665
microRNA 665
disease_progression
ISO
mRNA:increased expression:liver (human) associated with metastasis; human cells in mouse model
RGD
PMID:30237408 PMID:30237408
RGD:151361293 , RGD:151361293
NCBI chr12:109,552,748...109,552,841
Ensembl chr12:109,552,748...109,552,841
G
Mir93
microRNA 93
severity
IEP
associated with hepatitis B;miRNA:increased expression:liver (human)
RGD
PMID:27298561 PMID:28592130
RGD:15042853 , RGD:15042900
NCBI chr 5:138,163,785...138,163,872
Ensembl chr 5:138,163,785...138,163,872
G
Mir96
microRNA 96
severity
IEP
miRNA:increased expression:liver (human)
RGD
PMID:28892647 PMID:25813403
RGD:15042901 , RGD:15042902
NCBI chr 6:30,169,445...30,169,550
Ensembl chr 6:30,169,445...30,169,550
G
Mirlet7c-1
microRNA let7c-1
ISO
miRNA:decreased expression:liver
RGD
PMID:22289550
RGD:14695021
NCBI chr16:77,396,545...77,396,638
Ensembl chr16:77,396,545...77,396,638
G
Mki67
antigen identified by monoclonal antibody Ki 67
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Mlxipl
MLX interacting protein-like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 5:135,118,744...135,168,622
Ensembl chr 5:135,118,744...135,167,236
G
Mme
membrane metallo endopeptidase
ISO
RGD
PMID:8302012
RGD:13801035
NCBI chr 3:63,202,632...63,291,134
Ensembl chr 3:63,148,958...63,293,451
G
Mmp14
matrix metallopeptidase 14 (membrane-inserted)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr14:54,669,055...54,679,913
Ensembl chr14:54,669,069...54,682,821
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20084675
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp9
matrix metallopeptidase 9
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20084675 PMID:21681821
RGD:8547864
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mogat2
monoacylglycerol O-acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:98,868,291...98,887,818
Ensembl chr 7:98,868,291...98,887,826
G
Mpl
myeloproliferative leukemia virus oncogene
IMP
human cells in mouse model
RGD
PMID:23157389
RGD:126925755
NCBI chr 4:118,299,609...118,314,771
Ensembl chr 4:118,299,612...118,314,710
G
Mpo
myeloperoxidase
susceptibility disease_progression
ISO
CTD Direct Evidence: marker/mechanism associated with liver cirrhosis; DNA:SNP:promoter:-463G>A( rs2333227)(human) associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-463G>A(human)
CTD RGD
PMID:19731237 PMID:19731237 PMID:21907168
RGD:26923907 , RGD:27095879
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Mro
maestro
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:73,992,465...74,014,405
Ensembl chr18:73,992,456...74,014,404
G
Msh3
mutS homolog 3
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar
PMID:28492532
NCBI chr13:92,348,387...92,491,515
Ensembl chr13:92,348,380...92,491,511
G
Msh5
mutS homolog 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:35,247,581...35,267,842
Ensembl chr17:35,247,581...35,265,721
G
mt-Co1
cytochrome c oxidase I, mitochondrial
ISO
RGD
PMID:2548155
RGD:2302301
NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872
G
mt-Nd5
NADH dehydrogenase 5, mitochondrial
ISO
mRNA:increased expression:liver
RGD
PMID:2507335
RGD:2302316
NCBI chr MT:11,742...13,565
Ensembl chr MT:11,742...13,565
G
Mt2
metallothionein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17363595 PMID:28284560
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Mtbp
Mdm2, transformed 3T3 cell double minute p53 binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29765550
NCBI chr15:55,420,800...55,489,819
Ensembl chr15:55,420,804...55,489,819
G
Mtdh
metadherin
treatment
ISO
human cells in a mouse model
RGD
PMID:26351209
RGD:11096879
NCBI chr15:34,082,613...34,143,683
Ensembl chr15:34,082,840...34,145,770
G
Mthfd2
methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase
ISO
mRNA:increased expression:liver
RGD
PMID:3878730
RGD:2302305
NCBI chr 6:83,282,686...83,302,926
Ensembl chr 6:83,282,673...83,302,890
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility disease_progression onset
ISO
DNA:SNP,haplotype: :677C>T, 1298A>C(human) DNA:SNP: :677C>T(human) DNA:SNP: :1298A>C(human) DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:17503006 PMID:23996892 PMID:19035314 PMID:17659576
RGD:14696703 , RGD:14696704 , RGD:14696707 , RGD:14696708
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Mtor
mechanistic target of rapamycin kinase
severity
ISO
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver (human)
CTD RGD
PMID:21147110 PMID:25371154
RGD:152995471
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Mtrr
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
susceptibility
ISO
DNA:SNP: :66A>G(human)
RGD
PMID:19035314
RGD:14696707
NCBI chr13:68,708,897...68,730,273
Ensembl chr13:68,708,899...68,730,268
G
Mvk
mevalonate kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 5:114,582,324...114,598,652
Ensembl chr 5:114,582,330...114,598,652
G
Mybl2
myeloblastosis oncogene-like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:162,896,246...162,926,608
Ensembl chr 2:162,896,607...162,926,608
G
Myc
myelocytomatosis oncogene
treatment severity
IMP ISO IAGP
mRNA:increased expression:liver (rat) mRNA:increased expression:liver (human) CTD Direct Evidence: marker/mechanism OMIM:114550
CTD MouseDO RGD
PMID:9029167 PMID:12029619 PMID:15565109 PMID:29698666 PMID:21644509 PMID:22129741 PMID:22076107 PMID:22434528 More...
RGD:6903288 , RGD:7240567 , RGD:7240695 , RGD:7241004
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Myd88
myeloid differentiation primary response gene 88
exacerbates ameliorates treatment
ISO IMP
mRNA:increased expression:liver (human) protein, mRNA:decreased expression:liver (human) human cell line in a mouse model protein:increased expression:liver (human) mouse cell line in a mouse model human gene and cell in a mouse model
RGD
PMID:29022910 PMID:28370778 PMID:17615358 PMID:33575076 PMID:32144747 PMID:31068809 PMID:26985932 PMID:31074165 PMID:24603331 More...
RGD:150520022 , RGD:150520169 , RGD:150521532 , RGD:150521534 , RGD:150524327 , RGD:150524329 , RGD:150524330 , RGD:150524334 , RGD:150530285
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
G
Nat2
N-acetyltransferase 2 (arylamine N-acetyltransferase)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
G
Nbn
nibrin
ISO
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar
PMID:9590180 PMID:9590181 PMID:9620777 PMID:10398434 PMID:10799436 PMID:10848790 PMID:10852373 PMID:11093281 PMID:11279524 PMID:11953735 PMID:12123493 PMID:12505263 PMID:12833396 PMID:12845677 PMID:14973119 PMID:15185344 PMID:15279809 PMID:16033915 PMID:16544999 PMID:17103455 PMID:18606567 PMID:18940477 PMID:19635536 PMID:19908051 PMID:20444919 PMID:22131123 PMID:22293976 PMID:22373003 PMID:22491912 PMID:22941933 PMID:23317186 PMID:24033266 PMID:24113799 PMID:25485873 PMID:25741868 PMID:25980754 PMID:26083025 PMID:26467025 PMID:26822949 PMID:26845104 PMID:27150568 PMID:27616075 PMID:28492532 PMID:28873162 PMID:29368341 PMID:29419426 PMID:30426508 PMID:31173646 PMID:32295079 PMID:33050356 PMID:33471974 PMID:33471991 PMID:33840814 PMID:34072463 PMID:34072659 PMID:34544220 PMID:35309086 More...
NCBI chr 4:15,955,388...15,992,589
Ensembl chr 4:15,957,925...15,992,589
G
Ncapg
non-SMC condensin I complex, subunit G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:45,827,212...45,858,491
Ensembl chr 5:45,827,261...45,857,888
G
Ncaph
non-SMC condensin I complex, subunit H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:126,945,729...126,975,857
Ensembl chr 2:126,945,729...126,975,874
G
Ncoa2
nuclear receptor coactivator 2
exacerbates
IMP
RGD
PMID:28273073 PMID:22556267
RGD:153002573 , RGD:153002576
NCBI chr 1:13,209,329...13,444,451
Ensembl chr 1:13,209,329...13,444,307
G
Ndc80
NDC80 kinetochore complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:71,803,095...71,833,852
Ensembl chr17:71,803,095...71,833,852
G
Neil3
nei like 3 (E. coli)
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
CTD RGD
PMID:28284560 PMID:35693827
RGD:153344586
NCBI chr 8:54,039,902...54,092,100
Ensembl chr 8:54,039,902...54,092,100
G
Nek2
NIMA (never in mitosis gene a)-related expressed kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:191,553,622...191,565,161
Ensembl chr 1:191,553,556...191,565,162
G
Nf2
neurofibromin 2
disease_progression
ISO
DNA, protein:SNP, increased expression:intron, liver protein:decreased expression:liver
RGD
PMID:29130106 PMID:27289045 PMID:26443326
RGD:150530489 , RGD:150530504 , RGD:11076529
NCBI chr11:4,715,845...4,799,544
Ensembl chr11:4,715,845...4,799,536
G
Nfe2l1
nuclear factor, erythroid derived 2,-like 1
IAGP
OMIM:114550
MouseDO
NCBI chr11:96,708,239...96,720,810
Ensembl chr11:96,708,240...96,720,794
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hepatocellular carcinoma
CTD ClinVar RGD
PMID:22561517 PMID:26619011 PMID:29018201 PMID:31546024
RGD:21201310
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
disease_progression treatment
ISO
associated with Chronic Hepatitis B;DNA:insertion/deletion:3'utr: -94ins/delATTG (rs28720239) (human)
RGD
PMID:19797428 PMID:25999787
RGD:40400751 , RGD:152177911
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
disease_progression susceptibility
ISO
CTD Direct Evidence: therapeutic associated with Chronic Hepatitis B;DNA:SNPs,haplotype:3'utr,promoter: 826C>T,881A>G (rs2233406,rs3138053) (human) associated with hepatitis B;DNA:SNP:promoter:-826C>T (rs2233406) (human)
CTD RGD
PMID:22022477 PMID:19797428 PMID:25223483
RGD:40400751 , RGD:40902986
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nkx3-1
NK3 homeobox 1
treatment
ISO
mRNA:decreased expression:liver human gene in a mouse model
RGD
PMID:28972178 PMID:28972178
RGD:14401599 , RGD:14401599
NCBI chr14:69,428,141...69,432,107
Ensembl chr14:69,428,087...69,432,111
G
Nlrc3
NLR family, CARD domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30081150
NCBI chr16:3,762,871...3,796,881
Ensembl chr16:3,762,871...3,794,496
G
Nlrc5
NLR family, CARD domain containing 5
ISO
protein:increased expression:liver
RGD
PMID:27338800
RGD:15003194
NCBI chr 8:95,160,963...95,253,900
Ensembl chr 8:95,160,984...95,253,900
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr11:93,849,751...93,859,341
Ensembl chr11:93,847,805...93,859,347
G
Nnmt
nicotinamide N-methyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:48,448,905...48,518,958
Ensembl chr 9:48,503,177...48,516,453
G
Nos2
nitric oxide synthase 2, inducible
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Notch3
notch 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:32,339,794...32,385,869
Ensembl chr17:32,339,794...32,385,826
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23811326
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
G
Nr1h2
nuclear receptor subfamily 1, group H, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 7:44,199,040...44,204,928
Ensembl chr 7:44,199,040...44,203,375
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
ISO IAGP IMP
CTD Direct Evidence: marker/mechanism OMIM:114550 mRNA:splice variant(s):liver (human) intestinally expressed human gene in mouse model
CTD MouseDO RGD
PMID:23811326 PMID:25496033 PMID:23811326 PMID:23213087 PMID:24954587
RGD:14696796 , RGD:14928330 , RGD:14928334
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
G
Nras
neuroblastoma ras oncogene
disease_progression severity
ISO
human gene in mouse model mRNA, protein:increased expression:liver (mouse, human) ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar RGD
PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 PMID:8120410 PMID:10821536 PMID:12460918 PMID:12727991 PMID:14508525 PMID:15899789 PMID:16273091 PMID:16291983 PMID:16434492 PMID:17699718 PMID:18390968 PMID:18633438 PMID:18668139 PMID:18948947 PMID:19075190 PMID:19657110 PMID:19880792 PMID:19966803 PMID:20130576 PMID:20149136 PMID:20179705 PMID:20406486 PMID:20619739 PMID:20736745 PMID:21107323 PMID:21305640 PMID:21576590 PMID:21729679 PMID:21829508 PMID:22407852 PMID:22499344 PMID:22718121 PMID:22761467 PMID:22773810 PMID:23076151 PMID:23392294 PMID:23400451 PMID:23414587 PMID:23515407 PMID:23538902 PMID:23569304 PMID:23614898 PMID:24006476 PMID:24033266 PMID:24148783 PMID:24370118 PMID:24671188 PMID:25157968 PMID:25348872 PMID:25695684 PMID:25741868 PMID:26619011 PMID:26821351 PMID:27050078 PMID:28492532 PMID:28780248 PMID:21993994 PMID:30685691 More...
RGD:14696775 , RGD:14696793
NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230
G
Nrg1
neuregulin 1
disease_progression
ISO
associated with hepatitis C;mRNA:altered expression:liver (human mRNA:increased expression:liver (human)
RGD
PMID:17393520 PMID:27514687
RGD:39456104 , RGD:39456110
NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825 Ensembl chr 8:32,304,579...33,374,825
G
Nrp1
neuropilin 1
disease_progression
ISO
protein:decreased expression:liver
RGD
PMID:25333267
RGD:126848812
NCBI chr 8:129,085,553...129,231,957
Ensembl chr 8:129,085,085...129,229,844
G
Nuf2
NUF2, NDC80 kinetochore complex component
treatment disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28284560 PMID:30653265 PMID:31933938
RGD:28867240 , RGD:28912742
NCBI chr 1:169,325,503...169,359,033
Ensembl chr 1:169,325,503...169,359,033
G
Nusap1
nucleolar and spindle associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:119,449,205...119,480,646
Ensembl chr 2:119,448,779...119,481,725
G
Oit3
oncoprotein induced transcript 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:59,258,782...59,277,601
Ensembl chr10:59,258,780...59,277,600
G
Olfml2a
olfactomedin-like 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:38,821,992...38,850,597
Ensembl chr 2:38,821,990...38,853,765
G
Olfml2b
olfactomedin-like 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:170,472,101...170,510,356
Ensembl chr 1:170,472,101...170,510,358
G
Orc1
origin recognition complex, subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:108,436,651...108,472,030
Ensembl chr 4:108,436,620...108,472,030
G
Otc
ornithine transcarbamylase
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr X:10,118,584...10,187,275
Ensembl chr X:10,118,544...10,187,263
G
Pafah1b1
platelet-activating factor acetylhydrolase, isoform 1b, subunit 1
disease_progression
ISO
mRNA,protein:decreased expression:liver:
RGD
PMID:21569763
RGD:12790589
NCBI chr11:74,564,775...74,615,210
Ensembl chr11:74,564,775...74,615,496
G
Pamr1
peptidase domain containing associated with muscle regeneration 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:102,380,325...102,473,386
Ensembl chr 2:102,380,357...102,473,386
G
Park7
Parkinson disease (autosomal recessive, early onset) 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 4:150,981,590...150,994,378
Ensembl chr 4:150,981,590...150,998,894
G
Parp1
poly (ADP-ribose) polymerase family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18695907
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pbk
PDZ binding kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:66,043,337...66,055,271
Ensembl chr14:66,043,286...66,055,271
G
Pck1
phosphoenolpyruvate carboxykinase 1, cytosolic
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144 PMID:28284560
NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066
G
Pclaf
PCNA clamp associated factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:65,797,605...65,810,833
Ensembl chr 9:65,797,519...65,810,548
G
Pcna
proliferating cell nuclear antigen
treatment
ISO
protein:increased expression:liver:
RGD
PMID:23219601 PMID:25999787
RGD:10448993 , RGD:152177911
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Pdcd1
programmed cell death 1
disease_progression
ISO
associated with hepatitis B;DNA:SNP: : +8669 A>G (human)
RGD
PMID:27034168 PMID:21912640
RGD:40818257 , RGD:41410800
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20506153
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pdgfrl
platelet-derived growth factor receptor-like
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:7898930
NCBI chr 8:41,379,270...41,443,819
Ensembl chr 8:41,379,249...41,443,822
G
Pdia3
protein disulfide isomerase associated 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 2:121,244,383...121,269,168
Ensembl chr 2:121,244,256...121,269,168
G
Pdk4
pyruvate dehydrogenase kinase, isoenzyme 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28003426
NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309
G
Pfas
phosphoribosylformylglycinamidine synthase (FGAR amidotransferase)
ISO
protein:increased expression:liver
RGD
PMID:6722784
RGD:5135276
NCBI chr11:68,876,527...68,899,286
Ensembl chr11:68,876,523...68,899,286
G
Pfn2
profilin 2
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 3:57,749,316...57,755,178
Ensembl chr 3:57,749,316...57,755,500
G
Pgd
phosphogluconate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 4:149,234,448...149,251,162
Ensembl chr 4:149,234,448...149,251,228
G
Pgk1
phosphoglycerate kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr X:105,230,706...105,247,305
Ensembl chr X:105,230,706...105,247,305
G
Phb1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599
G
Phf6
PHD finger protein 6
exacerbates
ISO
mRNA:increased expression:liver (human)
RGD
PMID:31329335 PMID:30888215
RGD:155260288 , RGD:155260308
NCBI chr X:52,001,091...52,045,838
Ensembl chr X:52,001,143...52,045,820
G
Phlda1
pleckstrin homology like domain, family A, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:111,342,147...111,344,510
Ensembl chr10:111,342,147...111,344,506
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
severity no_association susceptibility treatment
ISO
DNA:mutations:exons: DNA:mutation:exon: DNA:SNPs: :rs17849071,rs17849079(human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
OMIM CTD ClinVar RGD
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:15930273 PMID:16906227 PMID:16930767 PMID:17376864 PMID:17673550 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20593314 PMID:20619739 PMID:21078999 PMID:21430269 PMID:21558396 PMID:21824802 PMID:22162582 PMID:22162589 PMID:22209294 PMID:22271473 PMID:22357840 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23408298 PMID:23888070 PMID:23946963 PMID:24033266 PMID:24265155 PMID:24559322 PMID:24782230 PMID:25157968 PMID:25599672 PMID:25741868 PMID:25880439 PMID:26266975 PMID:26266985 PMID:26619011 PMID:26627007 PMID:26637981 PMID:26822237 PMID:26851524 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28151489 PMID:28425981 PMID:28492532 PMID:29446767 PMID:29661094 PMID:29758562 PMID:29988677 PMID:30063105 PMID:30376034 PMID:30543347 PMID:31536475 PMID:31775759 PMID:32778138 PMID:34008892 PMID:34496175 PMID:37712948 PMID:16847462 PMID:24673525 PMID:16331247 PMID:26823876 PMID:25999787 More...
RGD:2290476 , RGD:14402404 , RGD:14402405 , RGD:11556371 , RGD:152177911
NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr 9:98,920,455...99,022,264
Ensembl chr 9:98,918,707...99,022,674
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
treatment
ISO
RGD
PMID:31801250 PMID:25999787
RGD:151893509 , RGD:152177911
NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr 8:71,220,820...71,229,356
Ensembl chr 8:71,220,820...71,229,357
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
treatment
ISO
RGD
PMID:25999787
RGD:152177911
NCBI chr 4:116,078,593...116,160,253
Ensembl chr 4:116,078,815...116,160,253 Ensembl chr 4:116,078,815...116,160,253
G
Pinx1
PIN2/TERF1 interacting, telomerase inhibitor 1
disease_progression
ISO
associated with Chronic Hepatitis B; DNA:SNP::rs1469557(human)
RGD
PMID:27221889
RGD:152977752
NCBI chr14:64,097,728...64,157,311
Ensembl chr14:64,097,813...64,157,308
G
Pitpnm3
PITPNM family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:71,938,354...72,026,715
Ensembl chr11:71,938,354...72,026,604
G
Pitx1
paired-like homeodomain transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:55,972,857...55,984,002
Ensembl chr13:55,972,864...55,984,005
G
Pkm
pyruvate kinase, muscle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr 9:59,563,859...59,586,655
Ensembl chr 9:59,563,651...59,586,658
G
Pkmyt1
protein kinase, membrane associated tyrosine/threonine 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:23,945,385...23,955,709
Ensembl chr17:23,945,310...23,955,709
G
Pkp1
plakophilin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 1:135,799,132...135,846,945
Ensembl chr 1:135,799,133...135,846,945
G
Plac8
placenta-specific 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:100,699,455...100,720,119
Ensembl chr 5:100,701,591...100,720,111
G
Plau
plasminogen activator, urokinase
IAGP
OMIM:114550
MouseDO
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Plcg1
phospholipase C, gamma 1
ameliorates
ISO
human cell line in a mouse model
RGD
PMID:30623526
RGD:151356937
NCBI chr 2:160,573,230...160,617,680
Ensembl chr 2:160,573,220...160,617,680
G
Plk1
polo like kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:121,758,658...121,769,107
Ensembl chr 7:121,758,662...121,769,096
G
Plk4
polo like kinase 4
sexual_dimorphism
IMP ISO
DNA:hypermethylation:promoter
RGD
PMID:21324136 PMID:21324136
RGD:27226690 , RGD:27226690
NCBI chr 3:40,754,463...40,771,318
Ensembl chr 3:40,754,454...40,771,318
G
Plod3
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3
treatment
ISO IMP
mRNA, protein:increased expression:liver (human)
RGD
PMID:29059470 PMID:29059470
RGD:155791679 , RGD:155791679
NCBI chr 5:137,015,873...137,025,500
Ensembl chr 5:137,015,873...137,025,502
G
Plvap
plasmalemma vesicle associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:71,950,397...71,964,446
Ensembl chr 8:71,950,409...71,964,396
G
Plxdc1
plexin domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:97,814,063...97,879,393
Ensembl chr11:97,814,064...97,877,270
G
Pml
promyelocytic leukemia
disease_progression exacerbates ameliorates
ISO IMP IEP
protein:increased expression:liver (human) associated with hepatitis C mRNA:increased expression:liver (mouse)
RGD
PMID:11511788 PMID:31144474 PMID:26118777
RGD:41404685 , RGD:41404687 , RGD:41404690
NCBI chr 9:58,125,359...58,157,077
Ensembl chr 9:58,125,359...58,157,069
G
Pms2
PMS1 homolog2, mismatch repair system component
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
NCBI chr 5:143,846,379...143,922,538
Ensembl chr 5:143,846,782...143,870,786 Ensembl chr 5:143,846,782...143,870,786
G
Pnpla3
patatin-like phospholipase domain containing 3
ISO
associated with Hepatitis C, Chronic;DNA:SNP: :rs738409 (p.I148M) (human)
RGD
PMID:21319195
RGD:14981585
NCBI chr15:84,052,017...84,073,720
Ensembl chr15:84,052,038...84,071,437
G
Pnpt1
polyribonucleotide nucleotidyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr11:29,080,236...29,112,010
Ensembl chr11:29,080,744...29,111,828
G
Polg
polymerase (DNA directed), gamma
susceptibility
IAGP
DNA:SNPs:introns: (rs1061316, rs758130) (human)
RGD
PMID:28457473
RGD:15039387
NCBI chr 7:79,095,979...79,117,659
Ensembl chr 7:79,095,979...79,116,110
G
Pon1
paraoxonase 1
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
G
Pot1a
protection of telomeres 1A
disease_progression
ISO
associated with hepatitis B;DNA:SNP: :rs7784168(human)
RGD
PMID:23907815
RGD:152975963
NCBI chr 6:25,743,939...25,809,280
Ensembl chr 6:25,743,736...25,809,245
G
Ppara
peroxisome proliferator activated receptor alpha
susceptibility
IAGP
associated with hepatitis B;DNA:missense mutation:cds:p.L162V (human)
RGD
PMID:19119483
RGD:15042881
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Pparg
peroxisome proliferator activated receptor gamma
severity
ISO
CTD Direct Evidence: therapeutic protein:decreased expression:liver
CTD RGD
PMID:16374840 PMID:27451128
RGD:14694822
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ppat
phosphoribosyl pyrophosphate amidotransferase
ISO
protein:increased activity:hepatoma (rat)
RGD
PMID:6327016
RGD:5135035
NCBI chr 5:77,061,096...77,099,425
Ensembl chr 5:77,061,096...77,099,425
G
Ppp1r1a
protein phosphatase 1, regulatory inhibitor subunit 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15010824
NCBI chr15:103,438,706...103,446,465
Ensembl chr15:103,438,706...103,446,430
G
Ppp1r9a
protein phosphatase 1, regulatory subunit 9A
onset
ISO
protein:increased expression:liver (rat)
RGD
PMID:20935162
RGD:10002734
NCBI chr 6:4,902,702...5,165,661
Ensembl chr 6:4,902,917...5,165,661
G
Ppp1r9b
protein phosphatase 1, regulatory subunit 9B
severity
ISO
mRNA, protein:decreased expression:liver (human)
RGD
PMID:23591196
RGD:10043803
NCBI chr11:94,882,038...94,897,724
Ensembl chr11:94,881,861...94,897,725
G
Ppp4r3c1
protein phosphatase 4 regulatory subunit 3C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:88,973,703...88,976,458
Ensembl chr X:88,973,704...88,976,458
G
Prc1
protein regulator of cytokinesis 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:79,944,224...79,966,007
Ensembl chr 7:79,944,198...79,966,007
G
Prdm1
PR domain containing 1, with ZNF domain
disease_progression
ISO
associated with hepatitis B; associated with hepatitis B;DNA:SNP: :rs1010273(human)
RGD
PMID:31100710 PMID:31376415
RGD:150530465 , RGD:150530466
NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497
G
Prdx1
peroxiredoxin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27517622
NCBI chr 4:116,542,796...116,557,196
Ensembl chr 4:116,542,741...116,558,019
G
Prdx2
peroxiredoxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 8:85,696,251...85,701,440
Ensembl chr 8:85,696,216...85,701,463
G
Prdx6
peroxiredoxin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 1:161,067,682...161,078,780
Ensembl chr 1:161,067,682...161,078,789
G
Prex2
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
exacerbates
ISO
mRNA:increased expression:liver (human) protein:increased expression:liver (human) mRNA:decreased expression:liver (human)
RGD
PMID:25151370 PMID:28205209 PMID:28000796 PMID:31776854
RGD:151665185 , RGD:151665186 , RGD:151665188 , RGD:151665343
NCBI chr 1:11,063,496...11,373,907
Ensembl chr 1:11,063,689...11,373,905
G
Prkn
parkin RBR E3 ubiquitin protein ligase
severity
IEP
protein:decreased expression:liver (human)
RGD
PMID:28862485
RGD:13432206
NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248
G
Prl
prolactin
onset
ISO
protein:increased expression:serum (human)
RGD
PMID:22392353
RGD:125097525
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
G
Prom1
prominin 1
IEP
mRNA:increased expression:liver (mouse)
RGD
PMID:26569409
RGD:11344640
NCBI chr 5:44,150,963...44,260,850
Ensembl chr 5:44,150,962...44,259,374
G
Ptch1
patched 1
severity disease_progression
ISO
RGD
PMID:18538319 PMID:22911366
RGD:150523837 , RGD:150523842
NCBI chr13:63,656,142...63,721,274
Ensembl chr13:63,656,142...63,721,412
G
Pten
phosphatase and tensin homolog
exacerbates treatment severity
ISO IAGP IMP
CTD Direct Evidence: marker/mechanism OMIM:114550 protein:decreased expression:liver (human) associated with hepatitis B;protein:decreased expression:liver (human) associated with hepatitis C, liver cirrhosis;protein:decreased expression:liver (human)
CTD MouseDO RGD
PMID:27022031 PMID:12673720 PMID:30690477 PMID:12115563 PMID:31801250 PMID:29303510 PMID:29303510 More...
RGD:127285591 , RGD:127285603 , RGD:127285610 , RGD:151893509 , RGD:152995524 , RGD:152995524
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
Ptgs2
prostaglandin-endoperoxide synthase 2
susceptibility severity treatment
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:promoter:-1195A>G (rs689466) (human) mRNA,protein:decreased expression:liver protein:increased expression:liver, cytosol
CTD RGD
PMID:11872629 PMID:12024111 PMID:14563831 PMID:16374840 PMID:17510421 PMID:18373278 PMID:24720952 PMID:24759835 PMID:15800977 PMID:25999787 More...
RGD:2300283 , RGD:14695010 , RGD:14695011 , RGD:14695012 , RGD:152177911
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Pth1r
parathyroid hormone 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:110,551,132...110,576,213
Ensembl chr 9:110,551,153...110,576,213
G
Ptk2
PTK2 protein tyrosine kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:14578863 PMID:17203219
RGD:2292584
NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
susceptibility disease_progression
ISO
DNA:SNP: :p.Y2081D(human)
RGD
PMID:26801674 PMID:16489062
RGD:152176666 , RGD:152599190
NCBI chr 5:103,573,058...103,746,227
Ensembl chr 5:103,573,058...103,746,169
G
Ptprb
protein tyrosine phosphatase receptor type B
disease_progression
ISO
mRNA:decreased expression:liver (human)
RGD
PMID:30237408
RGD:151361293
NCBI chr10:116,111,407...116,225,443
Ensembl chr10:116,111,428...116,225,440
G
Pttg1
pituitary tumor-transforming gene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:43,311,097...43,317,417
Ensembl chr11:43,311,077...43,317,078
G
Pvt1
Pvt1 oncogene
ISO
mRNA:increased expression:liver (human)
RGD
PMID:30205391
RGD:153344577
NCBI chr15:61,909,835...62,132,064
Ensembl chr15:61,909,817...62,249,945
G
Pycard
PYD and CARD domain containing
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17471463
NCBI chr 7:127,590,545...127,593,039
Ensembl chr 7:127,588,880...127,593,039
G
Pygl
liver glycogen phosphorylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2885971
NCBI chr12:70,237,589...70,274,457
Ensembl chr12:70,237,585...70,278,262
G
Rac1
Rac family small GTPase 1
exacerbates
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human) protein:increased expression:liver (human)
CTD RGD
PMID:18506888 PMID:33482578 PMID:20522449
RGD:153298967 , RGD:153350129
NCBI chr 5:143,491,236...143,513,786
Ensembl chr 5:143,489,389...143,513,791
G
Racgap1
Rac GTPase-activating protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:99,518,377...99,549,504
Ensembl chr15:99,518,377...99,549,537
G
Rad21
RAD21 cohesin complex component
treatment exacerbates susceptibility
ISO
human cells in a mouse model mRNA:increased expression:liver (human) associated with hepatitis c, liver cirrhosis;mRNA:increased expression:liver (human)
RGD
PMID:30698808 PMID:33251678 PMID:32596342
RGD:150520029 , RGD:150520026 , RGD:150520035
NCBI chr15:51,826,000...51,856,934
Ensembl chr15:51,825,636...51,855,143
G
Rad50
RAD50 double strand break repair protein
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:16385572 PMID:18281469 PMID:19409520 PMID:24894818 PMID:25452441 PMID:25741868 PMID:26467025 PMID:28492532 PMID:29961768 PMID:31159747 PMID:31589614 PMID:32295079 More...
NCBI chr11:53,540,346...53,598,146
Ensembl chr11:53,540,346...53,598,146
G
Rad52
RAD52 homolog, DNA repair protein
susceptibility onset
ISO
associated with hepatitis B;DNA:SNP:3'utr: (rs7963551) (human) mRNA,protein:increased expression:liver (human)
RGD
PMID:24729511 PMID:31719794
RGD:151361199 , RGD:151361207
NCBI chr 6:119,878,781...119,899,789
Ensembl chr 6:119,879,659...119,899,789
G
Rad54l
RAD54 like (S. cerevisiae)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 4:115,951,458...115,980,875
Ensembl chr 4:115,951,461...115,980,887
G
Rara
retinoic acid receptor, alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18026104
NCBI chr11:98,818,626...98,865,768
Ensembl chr11:98,818,644...98,865,768
G
Rb1
RB transcriptional corepressor 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12029619 PMID:14961299 PMID:33841550
RGD:152998960
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
G
Rbm10
RNA binding motif protein 10
disease_progression
ISO
mRNA:decreased expression:liver
RGD
PMID:32572914
RGD:151356975
NCBI chr X:20,483,596...20,517,128
Ensembl chr X:20,483,742...20,517,140
G
Rbmy
RNA binding motif protein, Y chromosome
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22073224
NCBI chr Y:2,830,680...2,841,858
Ensembl chr Y:2,830,680...2,841,854
G
Rcan1
regulator of calcineurin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:92,188,839...92,263,057
Ensembl chr16:92,188,841...92,267,755
G
Recql
RecQ protein-like
disease_progression
ISO
protein:increased expression:liver
RGD
PMID:18422747 PMID:18422747
RGD:2317370 , RGD:2317370
NCBI chr 6:142,296,068...142,332,802
Ensembl chr 6:142,296,068...142,332,813
G
Reg3b
regenerating islet-derived 3 beta
ISO
mRNA:increased expression:liver (human)
RGD
PMID:10550309
RGD:9831380
NCBI chr 6:78,347,868...78,350,449
Ensembl chr 6:78,347,640...78,350,449
G
Ret
ret proto-oncogene
severity
ISO
protein:increased expression:liver (human) ClinVar Annotator: match by term: Hepatocellular carcinoma
RGD ClinVar
PMID:7784092 PMID:7845675 PMID:7911697 PMID:9111992 PMID:9242375 PMID:9263528 PMID:11230481 PMID:12116277 PMID:14715928 PMID:15184865 PMID:15855933 PMID:16736292 PMID:17047083 PMID:17097365 PMID:18062802 PMID:25157968 PMID:25810047 PMID:26046350 PMID:28350084 PMID:28492532 PMID:29656518 More...
RGD:150340602
NCBI chr 6:118,128,709...118,174,705
Ensembl chr 6:118,128,706...118,174,679
G
Rgn
regucalcin
ISO
protein:decreased expression:liver
RGD
PMID:21683810
RGD:5509919
NCBI chr X:20,413,980...20,428,328
Ensembl chr X:20,416,026...20,428,328
G
Rictor
RPTOR independent companion of MTOR, complex 2
severity
ISO IMP
mRNA, protein:increased expression:liver (human)
RGD
PMID:25371154 PMID:29303510
RGD:152995471 , RGD:152995524
NCBI chr15:6,737,827...6,829,882
Ensembl chr15:6,737,860...6,829,882
G
Rit1
Ras-like without CAAX 1
ameliorates
ISO
human cells in mouse model
RGD
PMID:31247273
RGD:152999016
NCBI chr 3:88,624,154...88,638,354
Ensembl chr 3:88,624,145...88,638,356
G
Rnd3
Rho family GTPase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:51,020,451...51,039,123
Ensembl chr 2:51,020,450...51,039,123
G
Rnf157
ring finger protein 157
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:116,227,179...116,303,859
Ensembl chr11:116,227,179...116,303,858
G
Rnf43
ring finger protein 43
exacerbates
ISO
human cells in a mouse model
RGD
PMID:23136185
RGD:151361219
NCBI chr11:87,553,913...87,626,365
Ensembl chr11:87,553,548...87,626,365
G
Rnf6
ring finger protein (C3H2C3 type) 6
disease_progression
ISO
RGD
PMID:30496760
RGD:151665757
NCBI chr 5:146,146,003...146,158,267
Ensembl chr 5:146,146,002...146,158,365
G
Robo1
roundabout guidance receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr16:71,824,406...72,844,379
Ensembl chr16:72,105,194...72,842,983
G
Rps6
ribosomal protein S6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 4:86,772,336...86,775,604
Ensembl chr 4:86,772,897...86,775,649
G
Rps6ka3
ribosomal protein S6 kinase polypeptide 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561517
NCBI chr X:158,038,652...158,151,240
Ensembl chr X:157,993,303...158,151,240
G
Rrm1
ribonucleotide reductase M1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18230555
NCBI chr 7:102,090,902...102,118,978
Ensembl chr 7:102,090,902...102,118,978
G
Rrm2
ribonucleotide reductase M2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18230555 PMID:28284560
NCBI chr12:24,758,253...24,764,145
Ensembl chr12:24,758,240...24,764,145
G
Rspo3
R-spondin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:29,329,102...29,411,863
Ensembl chr10:29,328,412...29,411,863
G
Rtkn
rhotekin
ISO
mRNA:increased expression:liver
RGD
PMID:27922690
RGD:19165144
NCBI chr 6:83,112,485...83,129,560
Ensembl chr 6:83,112,444...83,129,560
G
Rtp3
receptor transporter protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17693185
NCBI chr 9:110,814,003...110,818,781
Ensembl chr 9:110,814,003...110,819,651
G
Runx1
runt related transcription factor 1
ISO
mRNA:decreased expression:liver
RGD
PMID:17094378
RGD:126775147
NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037
G
Runx3
runt related transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism mRNA:decreased expression:liver
CTD RGD
PMID:28458013 PMID:17094378
RGD:126775147
NCBI chr 4:134,847,956...134,905,301
Ensembl chr 4:134,847,963...134,905,301
G
Rxra
retinoid X receptor alpha
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26619011
NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
G
Ryr3
ryanodine receptor 3
disease_progression
ISO
DNA:SNP:3'UTR:rs1044129(human)
RGD
PMID:26309413
RGD:155882454
NCBI chr 2:112,461,699...113,047,755
Ensembl chr 2:112,461,700...113,047,441
G
S100a9
S100 calcium binding protein A9 (calgranulin B)
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr 3:90,599,937...90,603,028
Ensembl chr 3:90,599,939...90,603,028
G
Sardh
sarcosine dehydrogenase
severity
ISO
mRNA:altered expression:liver tumor (human)
RGD
PMID:30901224
RGD:152995286
NCBI chr 2:27,078,405...27,138,344
Ensembl chr 2:27,078,405...27,138,349
G
Sav1
salvador family WW domain containing 1
IAGP
OMIM:114550
MouseDO
NCBI chr12:70,011,786...70,033,864
Ensembl chr12:70,011,786...70,033,776
G
Scap
SREBF chaperone
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831
NCBI chr 9:110,162,356...110,214,017
Ensembl chr 9:110,162,356...110,214,018
G
Scd2
stearoyl-Coenzyme A desaturase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303
G
Serpina4-ps1
serine (or cysteine) peptidase inhibitor, clade A, member 4, pseudogene 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19709125
NCBI chr12:104,044,218...104,053,179
Ensembl chr12:104,046,908...104,052,983
G
Serpinb5
serine (or cysteine) peptidase inhibitor, clade B, member 5
disease_progression
ISO
associated with hepatitis B;
RGD
PMID:26296971
RGD:11520929
NCBI chr 1:106,788,905...106,811,078
Ensembl chr 1:106,788,903...106,811,078
G
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, member 1
ISO
associated with Human Viral Hepatitis, liver cirrhosis;protein:increased expression:serum (human)
RGD
PMID:27748324
RGD:27226704
NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527
G
Set
SET nuclear oncogene
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26822237
NCBI chr 2:29,952,074...29,962,589
Ensembl chr 2:29,947,390...29,962,589
G
Sf3b1
splicing factor 3b, subunit 1
disease_progression treatment
ISO IEP
ClinVar Annotator: match by term: Hepatocellular carcinoma protein:increased expression:liver mRNA, protein:increased expression:liver
ClinVar RGD
PMID:23634996 PMID:26619011 PMID:29954402 PMID:29954402 PMID:33038489 PMID:33038489 More...
RGD:126790493 , RGD:126790493 , RGD:126790494 , RGD:126790494
NCBI chr 1:55,024,328...55,066,660
Ensembl chr 1:55,024,328...55,066,640
G
Sf3b2
splicing factor 3b, subunit 2
ISO
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
PMID:26619011
NCBI chr19:5,323,949...5,345,485
Ensembl chr19:5,323,960...5,345,483
G
Sf3b4
splicing factor 3b, subunit 4
treatment severity
ISO IMP
mRNA, protein:increased expression:liver (rat) mRNA, protein:increased expression:liver (human) human cells in mouse model mRNA, protein:increased expression:liver(human)
RGD
PMID:29059470 PMID:29059470 PMID:29059470 PMID:30391496 PMID:30391496
RGD:155791679 , RGD:155791679 , RGD:155791679 , RGD:155804298 , RGD:155804298
NCBI chr 3:96,079,822...96,084,880
Ensembl chr 3:96,079,648...96,084,880
G
Sfn
stratifin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 4:133,327,867...133,329,163
Ensembl chr 4:133,327,867...133,329,479
G
Sfrp1
secreted frizzled-related protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:23,901,401...23,939,648
Ensembl chr 8:23,901,518...23,939,648
G
Sh3gl1
SH3-domain GRB2-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33838155
NCBI chr17:56,323,750...56,343,659
Ensembl chr17:56,323,750...56,343,635
G
Shc1
src homology 2 domain-containing transforming protein C1
ISO
protein:increased expression, increased phosphorylation:hepatocyte
RGD
PMID:15375560
RGD:1643188
NCBI chr 3:89,325,858...89,337,336
Ensembl chr 3:89,325,750...89,337,334
G
Shh
sonic hedgehog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26189965
NCBI chr 5:28,661,838...28,672,099
Ensembl chr 5:28,661,813...28,672,254
G
Sik2
salt inducible kinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34491613
NCBI chr 9:50,800,944...50,920,432
Ensembl chr 9:50,804,101...50,920,373
G
Six1
sine oculis-related homeobox 1
severity
ISO
protein:increased expression:liver (human)
RGD
PMID:17008870
RGD:11561961
NCBI chr12:73,088,601...73,093,486
Ensembl chr12:73,086,789...73,100,661
G
Ska1
spindle and kinetochore associated complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:74,328,370...74,340,889
Ensembl chr18:74,328,370...74,340,889
G
Ska3
spindle and kinetochore associated complex subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:58,044,016...58,063,748
Ensembl chr14:58,044,018...58,063,642
G
Skp2
S-phase kinase-associated protein 2
ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12717389 PMID:19533683
RGD:2315050
NCBI chr15:9,112,070...9,155,512
Ensembl chr15:9,112,073...9,155,512
G
Slc22a1
solute carrier family 22 (organic cation transporter), member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
G
Slc25a47
solute carrier family 25, member 47
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr12:108,815,740...108,822,741
Ensembl chr12:108,801,972...108,822,741
G
Slc26a6
solute carrier family 26, member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:108,731,239...108,742,117
Ensembl chr 9:108,730,482...108,742,117
G
Slc2a1
solute carrier family 2 (facilitated glucose transporter), member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8364915
NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8364915
NCBI chr 3:28,752,052...28,782,510
Ensembl chr 3:28,752,052...28,785,508
G
Slc38a1
solute carrier family 38, member 1
ameliorates disease_progression
ISO
RGD
PMID:26389641 PMID:26389641
RGD:151361140 , RGD:151361140
NCBI chr15:96,469,299...96,541,396
Ensembl chr15:96,469,299...96,540,794
G
Slc5a5
solute carrier family 5 (sodium iodide symporter), member 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15347726 PMID:15520214
NCBI chr 8:71,335,529...71,345,429
Ensembl chr 8:71,335,533...71,345,401
G
Slc7a5
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5
ameliorates disease_progression
ISO
mRNA:increased expression:liver
RGD
PMID:26389641 PMID:26389641 PMID:23696029 PMID:7532544
RGD:151361140 , RGD:151361140 , RGD:151361280 , RGD:634202
NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
G
Slco1b2
solute carrier organic anion transporter family, member 1b2
disease_progression exacerbates
ISO
protein:decreased expression:liver (human) mRNA,protein:decreased expression:liver (human)
RGD
PMID:21626360 PMID:32534581
RGD:152995417 , RGD:152995423
NCBI chr 6:141,575,178...141,632,372
Ensembl chr 6:141,575,244...141,632,372
G
Slit2
slit guidance ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19100240
NCBI chr 5:48,138,633...48,465,077
Ensembl chr 5:48,140,480...48,465,075
G
Smad2
SMAD family member 2
ISO
RGD
PMID:18971187
RGD:12880056
NCBI chr18:76,369,898...76,444,819
Ensembl chr18:76,374,651...76,444,034
G
Smad4
SMAD family member 4
disease_progression
ISO
protein:decreased expression:liver protein:increased expression:liver:
RGD
PMID:18971187 PMID:23922662 PMID:22799322 PMID:29924446
RGD:12880056 , RGD:18182921 , RGD:21066341 , RGD:21066342
NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851
G
Smad7
SMAD family member 7
ISO
mRNA:increased expression:liver (human)
RGD
PMID:25602745
RGD:14401589
NCBI chr18:75,500,436...75,529,006
Ensembl chr18:75,500,600...75,529,006
G
Smarca4
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
ISO
DNA:SNPs: :rs11879293, rs2072382 (human)
RGD
PMID:24556940
RGD:127285650
NCBI chr 9:21,527,377...21,615,526
Ensembl chr 9:21,527,465...21,615,526
G
Smarcb1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
disease_progression
ISO
mRNA:decreased expression:liver
RGD
PMID:27111394
RGD:127285647
NCBI chr10:75,732,603...75,757,448
Ensembl chr10:75,732,603...75,757,451
G
Smarcc1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
ameliorates
ISO
mRNA, protein:increased expression:liver (human)
RGD
PMID:32514535
RGD:151347860
NCBI chr 9:109,961,129...110,069,773
Ensembl chr 9:109,946,776...110,069,246
G
Smc3
structural maintenance of chromosomes 3
exacerbates
ISO
mRNA:increased editing:cds:p.K96R,p.Q103R(human)
RGD
PMID:29996118
RGD:156430111
NCBI chr19:53,588,827...53,634,262
Ensembl chr19:53,588,829...53,634,264
G
Smg9
SMG9 nonsense mediated mRNA decay factor
severity
ISO
RGD
PMID:34456727
RGD:155882446
NCBI chr 7:24,099,106...24,122,197
Ensembl chr 7:24,099,044...24,122,203
G
Smo
smoothened, frizzled class receptor
disease_progression
ISO
DNA:SNP: :rs3824 (human)
RGD
PMID:25944162
RGD:150340548
NCBI chr 6:29,735,480...29,761,359
Ensembl chr 6:29,735,502...29,761,364
G
Snai1
snail family zinc finger 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35841383
NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734
G
Snrpe
small nuclear ribonucleoprotein E
ISO
human gene in a mouse model
RGD
PMID:21688285
RGD:10768833
NCBI chr 1:133,531,609...133,538,018
Ensembl chr 1:133,531,609...133,538,029
G
Snw1
SNW domain containing 1
severity
ISO
protein:increased expression:liver (human)
RGD
PMID:23696020
RGD:11035253
NCBI chr12:87,496,680...87,519,069
Ensembl chr12:87,495,845...87,519,044
G
Snx27
sorting nexin family member 27
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36029209
NCBI chr 3:94,404,849...94,490,023
Ensembl chr 3:94,404,851...94,490,023
G
Soat1
sterol O-acyltransferase 1
exacerbates
ISO
associated with hepatitis B;protein:increased expression:liver (human)
RGD
PMID:30814741
RGD:126925204
NCBI chr 1:156,255,678...156,301,898
Ensembl chr 1:156,252,095...156,301,901
G
Soat2
sterol O-acyltransferase 2
ISO
RGD
PMID:16274362
RGD:1581190
NCBI chr15:102,058,853...102,071,871
Ensembl chr15:102,058,961...102,071,904
G
Socs1
suppressor of cytokine signaling 1
treatment
ISO
associated with liver cirrhosis;DNA:altered methylation:liver: DNA:hypermethylation:CpG island, 5'untranslated region:
RGD
PMID:14614012 PMID:18843197 PMID:15235874 PMID:22318090
RGD:150573687 , RGD:150573689 , RGD:150573700 , RGD:150573703
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Socs2
suppressor of cytokine signaling 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:95,219,765...95,253,176
Ensembl chr10:95,221,224...95,253,042
G
Socs3
suppressor of cytokine signaling 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16831601
NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
G
Sod1
superoxide dismutase 1, soluble
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
susceptibility disease_progression
ISO
associated with liver cirrhosis; DNA:SNP:cds:p.Ala16Val(rs1799725)(human) protein:increased expression:saliva CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16767786 PMID:18760346 PMID:19731237 PMID:21472284 PMID:33010264 PMID:15869407 PMID:19731237 PMID:27221200 PMID:31041878 More...
RGD:1581242 , RGD:26923907 , RGD:26923955 , RGD:27095881
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sox30
SRY (sex determining region Y)-box 30
disease_progression exacerbates
ISO
RGD
PMID:30312695 PMID:30312695
RGD:151660341 , RGD:151660341
NCBI chr11:45,869,873...45,908,824
Ensembl chr11:45,871,137...45,908,821
G
Spag9
sperm associated antigen 9
ISO
associated with Human Viral Hepatitis
RGD
PMID:29344208
RGD:30296654
NCBI chr11:93,886,794...94,016,919
Ensembl chr11:93,886,917...94,016,911
G
Spc25
SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:69,009,753...69,036,583
Ensembl chr 2:69,024,239...69,036,538
G
Spock1
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 1
ameliorates
ISO
human cells in mouse model
RGD
PMID:30710422
RGD:153344549
NCBI chr13:57,569,008...58,056,194
Ensembl chr13:57,569,008...58,056,146
G
Spop
speckle-type BTB/POZ protein
exacerbates
ISO
mRNA:decreased expression:liver (human) human cells in mouse model
RGD
PMID:26156804 PMID:33209975
RGD:11074965 , RGD:153298924
NCBI chr11:95,304,909...95,384,236
Ensembl chr11:95,304,906...95,384,232
G
Spp1
secreted phosphoprotein 1
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:16047475 PMID:35693827
RGD:1581375 , RGD:153344586
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
G
Sprtn
SprT-like N-terminal domain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25261934
NCBI chr 8:125,624,612...125,632,903
Ensembl chr 8:125,624,625...125,632,900
G
Src
Rous sarcoma oncogene
disease_progression
ISO
RGD
PMID:9581679 PMID:9581679
RGD:150521543 , RGD:150521543
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
G
Srebf1
sterol regulatory element binding transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14563831 PMID:21147110
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
G
Srebf2
sterol regulatory element binding factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr15:82,031,455...82,089,580
Ensembl chr15:82,031,382...82,089,580
G
Srf
serum response factor
ISO
RGD
PMID:9570363
RGD:1581428
NCBI chr17:46,857,764...46,869,194
Ensembl chr17:46,859,255...46,867,101
G
Srpx
sushi-repeat-containing protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:9,904,216...9,983,879
Ensembl chr X:9,904,216...9,983,948
G
Srsf1
serine and arginine-rich splicing factor 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:23633480
RGD:9685423
NCBI chr11:87,937,325...87,944,583
Ensembl chr11:87,938,199...87,944,581
G
Srsf2
serine and arginine-rich splicing factor 2
treatment disease_progression
IMP ISO
RGD
PMID:32372053 PMID:28082404 PMID:29278882
RGD:150429663 , RGD:150429666 , RGD:150429692
NCBI chr11:116,740,723...116,744,511
Ensembl chr11:116,740,727...116,743,920
G
Ssxb5
SSX member B5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:8,669,930...8,676,348
Ensembl chr X:8,669,930...8,675,625
G
St6gal1
beta galactoside alpha 2,6 sialyltransferase 1
IEP
protein:increased activity:liver:
RGD
PMID:9331085
RGD:10043141
NCBI chr16:23,043,478...23,179,100
Ensembl chr16:23,043,490...23,179,100
G
Stab2
stabilin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:86,677,058...86,843,902
Ensembl chr10:86,677,062...86,843,889
G
Stat1
signal transducer and activator of transcription 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22488367
NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
G
Stat3
signal transducer and activator of transcription 3
IEP
protein:increased phosphorylation:liver (mouse)
RGD
PMID:28100771
RGD:127285675
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Stat4
signal transducer and activator of transcription 4
susceptibility
ISO
CTD Direct Evidence: marker/mechanism Hepatitis B, Chronic; DNA:SNP: intron 3: (rs7574865) (human)
CTD RGD
PMID:23242368 PMID:26745093
RGD:11553302
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
G
Stat5a
signal transducer and activator of transcription 5A
ameliorates
IEP
RGD
PMID:28100771
RGD:127285675
NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995
G
Stat5b
signal transducer and activator of transcription 5B
exacerbates ameliorates
ISO
protein:increased expression:liver (human) mRNA:increased expression:liver (human)
RGD
PMID:17047057 PMID:31485610
RGD:153298929 , RGD:153298932
NCBI chr11:100,671,557...100,741,407
Ensembl chr11:100,671,557...100,741,550
G
Stc2
stanniocalcin 2
disease_progression
ISO
mRNA:increased expression:liver (human)
RGD
PMID:35693827
RGD:153344586
NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074
G
Stim1
stromal interaction molecule 1
ISO
mRNA:increased expression:liver (human)
RGD
PMID:23211538
RGD:152995401
NCBI chr 7:101,909,279...102,086,525
Ensembl chr 7:101,917,013...102,086,526
G
Stmn1
stathmin 1
disease_progression
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28284560 PMID:28982915
RGD:21408578
NCBI chr 4:134,195,631...134,201,154
Ensembl chr 4:134,195,631...134,201,154
G
Tacc3
transforming, acidic coiled-coil containing protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 5:33,814,808...33,836,331
Ensembl chr 5:33,815,472...33,836,339
G
Tagln2
transgelin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 1:172,327,813...172,334,942
Ensembl chr 1:172,327,614...172,334,947
G
Taldo1
transaldolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19436114
NCBI chr 7:140,972,073...140,982,889
Ensembl chr 7:140,972,112...140,982,881
G
Tatdn1
TatD DNase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr15:58,762,002...58,805,605
Ensembl chr15:58,762,004...58,805,587
G
Tbx3
T-box 3
severity disease_progression ameliorates
IMP ISO
protein:increased expression:liver (human) human cells in mouse model
RGD
PMID:33577921 PMID:29295731 PMID:30578408 PMID:26922018 PMID:22811581
RGD:151361112 , RGD:151361114 , RGD:151361122 , RGD:151361123 , RGD:151361132
NCBI chr 5:119,808,600...119,822,789
Ensembl chr 5:119,808,734...119,822,789
G
Tcf19
transcription factor 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:35,823,627...35,827,730
Ensembl chr17:35,823,631...35,827,721
G
Tcim
transcriptional and immune response regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 8:24,927,188...24,928,962
Ensembl chr 8:24,927,196...24,929,000
G
Tedc2
tubulin epsilon and delta complex 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:24,434,028...24,439,825
Ensembl chr17:24,434,028...24,439,825
G
Tek
TEK receptor tyrosine kinase
ISO
protein:increased expression
RGD
PMID:16951510
RGD:1601490
NCBI chr 4:94,627,322...94,763,213
Ensembl chr 4:94,627,526...94,763,213
G
Tep1
telomerase associated protein 1
disease_progression susceptibility
ISO
associated with hepatitis B;DNA:SNPs: :rs1713449,rs1760898, rs872072 (human) DNA:SNP:intron:rs1760893(human)
RGD
PMID:23907815 PMID:27305982
RGD:152975963 , RGD:152977750
NCBI chr14:51,061,513...51,108,036
Ensembl chr14:51,061,516...51,108,017
G
Tert
telomerase reverse transcriptase
disease_progression treatment no_association susceptibility
ISO
protein:increased expression, increased localization:nucleus CTD Direct Evidence: marker/mechanism DNA:mutations:promoter: DNA:mutations, polymorphisms:promoter,intron, exon:rs2736100,rs2736098(human) DNA:SNP,mutations:promoter:rs2853669 (-245T >C), (-124C > T),(-146C > T)human DNA:hypermethylation:promoter DNA:SNPs::rs2736098(human) ClinVar Annotator: match by term: Hepatocellular carcinoma associated with hepatitis B;DNA:SNP: :rs13167280 (human)
CTD ClinVar RGD
PMID:16651430 PMID:22634754 PMID:23000435 PMID:25362482 PMID:25741868 PMID:25822088 PMID:28492532 PMID:28677271 PMID:20353272 PMID:25123086 PMID:17175353 PMID:19184104 PMID:28416747 PMID:26575952 PMID:25683523 PMID:25339005 PMID:23907815 More...
RGD:11038673 , RGD:14696767 , RGD:14696768 , RGD:14696769 , RGD:14696770 , RGD:11564803 , RGD:11530743 , RGD:150530496 , RGD:152975963
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
G
Tet1
tet methylcytosine dioxygenase 1
ISO
protein:decreased expression:liver
RGD
PMID:23671639
RGD:9586747
NCBI chr10:62,640,349...62,723,242
Ensembl chr10:62,640,349...62,744,775
G
Tet2
tet methylcytosine dioxygenase 2
severity ameliorates disease_progression
ISO
mRNA, protein:increased expression:liver (human) human cells in mouse model mRNA:decreased expression:liver (human)
RGD
PMID:26366235 PMID:29331390 PMID:29331390 PMID:33097695 PMID:30070373
RGD:150429684 , RGD:150429595 , RGD:150429595 , RGD:150429597 , RGD:150429689
NCBI chr 3:133,169,438...133,250,882
Ensembl chr 3:133,169,440...133,250,900
G
Tfpi2
tissue factor pathway inhibitor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17464989 PMID:28284560
NCBI chr 6:3,962,589...3,988,977
Ensembl chr 6:3,962,595...3,988,919
G
Tfrc
transferrin receptor
ISO
mRNA:increased expression:liver
RGD
PMID:16953838
RGD:2292036
NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612
G
Tgfa
transforming growth factor alpha
ISO
associated with Diabetes Mellitus, Experimental CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9029167 PMID:15565109 PMID:9060843
RGD:2317471
NCBI chr 6:86,172,020...86,252,726
Ensembl chr 6:86,172,205...86,252,701
G
Tgfb1
transforming growth factor, beta 1
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (mouse)
CTD RGD
PMID:9029167 PMID:28100771
RGD:127285675
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfb2
transforming growth factor, beta 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33010264
NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186
G
Tgfbr2
transforming growth factor, beta receptor II
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:14585397
RGD:1601598
NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428
G
Tgm3
transglutaminase 3, E polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:129,829,700...129,890,814
Ensembl chr 2:129,854,269...129,892,319
G
Th
tyrosine hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
G
Them4
thioesterase superfamily member 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23392203
NCBI chr 3:94,217,415...94,239,847
Ensembl chr 3:94,217,396...94,239,847
G
Thy1
thymus cell antigen 1, theta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:43,954,681...43,959,876
Ensembl chr 9:43,954,681...43,959,876
G
Ticrr
TOPBP1-interacting checkpoint and replication regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:79,309,944...79,347,896
Ensembl chr 7:79,309,944...79,347,896
G
Timd4
T cell immunoglobulin and mucin domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:46,701,613...46,735,160
Ensembl chr11:46,701,627...46,735,159
G
Tk1
thymidine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:117,706,345...117,716,913
Ensembl chr11:117,706,352...117,716,918
G
Tlr2
toll-like receptor 2
susceptibility
ISO IMP
associated with Hepatitis C, Chronic;DNA:deletion:promoter:-196 to -174(human)
RGD
PMID:21500195 PMID:27183918 PMID:22859216
RGD:15090813 , RGD:15090815 , RGD:18337266
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
G
Tlr3
toll-like receptor 3
disease_progression
ISO
RGD
PMID:23197495
RGD:21079421
NCBI chr 8:45,848,702...45,864,112
Ensembl chr 8:45,848,702...45,864,117
G
Tlr4
toll-like receptor 4
susceptibility
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver: DNA:SNP: :rs1057317(human) DNA:SNPs, haplotype: :multiples
CTD RGD
PMID:27022031 PMID:28578348 PMID:25179842 PMID:21559380
RGD:14700552 , RGD:14700557 , RGD:14700558
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tlr7
toll-like receptor 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24990399
NCBI chr X:166,086,376...166,113,570
Ensembl chr X:166,087,925...166,113,554
G
Tlr9
toll-like receptor 9
treatment
ISO
protein: increased expression:peripheral blood mononuclear cell (human) human cells in a mouse model CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24990399 PMID:18215354 PMID:24452201
RGD:18337472 , RGD:18337468
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
G
Tmem70
transmembrane protein 70
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27914986
NCBI chr 1:16,735,415...16,748,501
Ensembl chr 1:16,735,431...16,748,499
G
Tnf
tumor necrosis factor
disease_progression
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:liver, blood serum (mouse)
CTD RGD
PMID:27022031 PMID:26890368 PMID:26569409
RGD:14975171 , RGD:11344640
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfaip3
tumor necrosis factor, alpha-induced protein 3
sexual_dimorphism ameliorates
IMP ISO
protein:decreased expression:liver (human) mRNA,protein:increased expression:liver (human) mRNA:decreased expression:liver (human)
RGD
PMID:27253414 PMID:32015333 PMID:26538215 PMID:29190981
RGD:151347600 , RGD:151347604 , RGD:151347618 , RGD:151347622
NCBI chr10:18,876,658...18,891,158
Ensembl chr10:18,876,658...18,891,405
G
Tnfsf10
tumor necrosis factor (ligand) superfamily, member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17326159
NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
G
Tnfsf9
tumor necrosis factor (ligand) superfamily, member 9
IDA
RGD
PMID:17325342
RGD:2317348
NCBI chr17:57,412,113...57,414,757
Ensembl chr17:57,412,325...57,414,757
G
Tnik
TRAF2 and NCK interacting kinase
disease_progression
ISO
protein:increased phosphorylation:liver, nucleus (human)
RGD
PMID:25160513
RGD:151347837
NCBI chr 3:28,317,362...28,724,734
Ensembl chr 3:28,317,363...28,730,007
G
Tonsl
tonsoku-like, DNA repair protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:76,510,437...76,524,129
Ensembl chr15:76,510,202...76,524,158
G
Top2a
topoisomerase (DNA) II alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015
G
Tpx2
TPX2, microtubule-associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:152,689,859...152,737,241
Ensembl chr 2:152,689,884...152,737,241
G
Traf7
TNF receptor-associated factor 7
treatment
ISO
mRNA:increased expression:liver
RGD
PMID:31730901 PMID:31730901
RGD:151356961 , RGD:151356961
NCBI chr17:24,727,824...24,746,912
Ensembl chr17:24,727,536...24,746,912
G
Traip
TRAF-interacting protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:107,828,158...107,849,469
Ensembl chr 9:107,827,335...107,849,469
G
Trim24
tripartite motif-containing 24
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18026104
NCBI chr 6:37,846,816...37,945,380
Ensembl chr 6:37,847,746...37,943,231
G
Trip13
thyroid hormone receptor interactor 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr13:74,060,577...74,085,855
Ensembl chr13:74,059,466...74,085,903
G
Troap
trophinin associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr15:98,972,854...98,981,290
Ensembl chr15:98,972,456...98,981,290
G
Trp53
transformation related protein 53
treatment
IEP ISO EXP
protein:altered localization:cytoplasm, nucleus CTD Direct Evidence: marker/mechanism|therapeutic DNA:missense mutation: :p.R249S (human) mRNA:increased expression:liver (mouse) ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
CTD ClinVar OMIM RGD
PMID:253702 PMID:960674 PMID:1349102 PMID:1349175 PMID:1359493 PMID:1565143 PMID:1565144 PMID:1569604 PMID:1591732 PMID:1631137 PMID:1631151 PMID:1672732 PMID:1673792 PMID:1679237 PMID:1683921 PMID:1686725 PMID:1849234 PMID:1915267 PMID:1918170 PMID:1975675 PMID:1978757 PMID:1999338 PMID:2046748 PMID:2259385 PMID:2531845 PMID:2554494 PMID:2654466 PMID:4122735 PMID:6736287 PMID:7478555 PMID:7565304 PMID:7651740 PMID:7707106 PMID:7718482 PMID:7732013 PMID:7737263 PMID:7750099 PMID:7761089 PMID:7783166 PMID:7791795 PMID:7881428 PMID:7885831 PMID:7887414 PMID:7969167 PMID:8001119 PMID:8023157 PMID:8033108 PMID:8062826 PMID:8080050 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8242752 PMID:8276238 PMID:8308926 PMID:8336941 PMID:8344492 PMID:8364550 PMID:8401536 PMID:8402598 PMID:8423216 PMID:8425176 PMID:8464896 PMID:8479749 PMID:8527048 PMID:8550239 PMID:8631304 PMID:8633021 PMID:8649776 PMID:8718514 PMID:8825920 PMID:8829627 PMID:8829653 PMID:8843196 PMID:8869100 PMID:9029167 PMID:9047394 PMID:9049183 PMID:9049184 PMID:9150393 PMID:9218725 PMID:9242456 PMID:9268986 PMID:9290701 PMID:9364015 PMID:9399658 PMID:9399838 PMID:9405613 PMID:9407971 PMID:9472631 PMID:9482117 PMID:9525742 PMID:9546439 PMID:9569050 PMID:9572492 PMID:9598730 PMID:9607760 PMID:9627118 PMID:9632751 PMID:9662334 PMID:9667734 PMID:9704930 PMID:9825943 PMID:9839505 PMID:9891044 PMID:10064694 PMID:10089074 PMID:10229196 PMID:10366100 PMID:10411893 PMID:10432928 PMID:10519380 PMID:10557074 PMID:10567903 PMID:10589545 PMID:10616528 PMID:10629033 PMID:10713666 PMID:10753186 PMID:10754498 PMID:10761705 PMID:10797439 PMID:10802655 PMID:10864200 PMID:10871862 PMID:10914716 PMID:10922393 PMID:11051239 PMID:11051241 PMID:11101847 PMID:11139324 PMID:11152481 PMID:11180592 PMID:11313981 PMID:11315715 PMID:11370630 PMID:11403041 PMID:11429705 PMID:11479205 PMID:11494139 PMID:11590071 PMID:11593407 PMID:11668501 PMID:11782540 PMID:11793474 PMID:11896595 PMID:11900253 PMID:11920788 PMID:11920959 PMID:12007217 PMID:12034820 PMID:12076704 PMID:12124823 PMID:12406399 PMID:12506399 PMID:12509279 PMID:12567188 PMID:12619118 PMID:12672316 PMID:12695689 PMID:12700230 PMID:12726864 PMID:12779080 PMID:12782597 PMID:12792784 PMID:12826609 PMID:12885464 PMID:12901974 PMID:12909720 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14673037 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15060172 PMID:15077194 PMID:15161705 PMID:15221755 PMID:15308588 PMID:15355915 PMID:15381368 PMID:15390294 PMID:15541116 PMID:15564800 PMID:15580553 PMID:15607980 PMID:15607981 PMID:15611505 PMID:15703170 PMID:15722483 PMID:15781620 PMID:15825182 PMID:15850016 PMID:15925506 PMID:15951970 PMID:15958617 PMID:15977174 PMID:15982667 PMID:16000567 PMID:16199549 PMID:16206219 PMID:16209708 PMID:16247456 PMID:16258005 PMID:16288208 PMID:16322298 PMID:16337994 PMID:16401470 PMID:16474844 PMID:16489069 PMID:16494995 PMID:16508005 PMID:16551709 PMID:16633321 PMID:16651430 PMID:16682957 PMID:16736287 PMID:16741917 PMID:16754663 PMID:16778209 PMID:16818505 PMID:16827139 PMID:16861262 PMID:16964264 PMID:16969106 PMID:17015838 PMID:17170001 PMID:17191126 PMID:17308077 PMID:17311302 PMID:17390010 PMID:17401428 PMID:17417627 PMID:17427234 PMID:17530187 PMID:17535973 PMID:17540308 PMID:17541742 PMID:17567834 PMID:17572079 PMID:17599946 PMID:17606709 PMID:17636407 PMID:17638920 PMID:17724467 PMID:17875924 PMID:17881637 PMID:17974978 PMID:17999388 PMID:18208484 PMID:18307025 PMID:18391940 PMID:18453682 PMID:18477611 PMID:18511570 PMID:18555592 PMID:18628487 PMID:18685109 PMID:18689542 PMID:18818522 PMID:18937320 PMID:19012332 PMID:19101993 PMID:19127115 PMID:19147582 PMID:19171880 PMID:19336573 PMID:19367287 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19454241 PMID:19462533 PMID:19468865 PMID:19521721 PMID:19556618 PMID:19681600 PMID:19711436 PMID:19714490 PMID:19834951 PMID:19850740 PMID:19881536 PMID:19913028 PMID:19919837 PMID:19930417 PMID:20013323 PMID:20028212 PMID:20113312 PMID:20118236 PMID:20127978 PMID:20128691 PMID:20182602 PMID:20234365 PMID:20308654 PMID:20407015 PMID:20436704 PMID:20505364 PMID:20506564 PMID:20516128 PMID:20520810 PMID:20522432 PMID:20538734 PMID:20586629 PMID:20589832 PMID:20593220 PMID:20689556 PMID:20693561 PMID:20805372 PMID:20878954 PMID:20972454 PMID:21056685 PMID:21059199 PMID:21080251 PMID:21113594 PMID:21115975 PMID:21118481 PMID:21159183 PMID:21187651 PMID:21232794 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21445056 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21535297 PMID:21552135 PMID:21561095 PMID:21590121 PMID:21601526 PMID:21619694 PMID:21626334 PMID:21665182 PMID:21672450 PMID:21674059 PMID:21747090 PMID:21761402 PMID:22006311 PMID:22052707 PMID:22090360 PMID:22110706 PMID:22114072 PMID:22186996 PMID:22198284 PMID:22233476 PMID:22265402 PMID:22319594 PMID:22427690 PMID:22484423 PMID:22553421 PMID:22553460 PMID:22672556 PMID:22675488 PMID:22698404 PMID:22703879 PMID:22710932 PMID:22713868 PMID:22729912 PMID:22744426 PMID:22768918 PMID:22811390 PMID:22822097 PMID:22862161 PMID:22869713 PMID:22887876 PMID:22899716 PMID:22915647 PMID:22919068 PMID:22923379 PMID:22955915 PMID:22983585 PMID:22999923 PMID:23028800 PMID:23031740 PMID:23161690 PMID:23172776 PMID:23246812 PMID:23259501 PMID:23263379 PMID:23265383 PMID:23315175 PMID:23334668 PMID:23406775 PMID:23484829 PMID:23538418 PMID:23612969 PMID:23624782 PMID:23625637 PMID:23630318 PMID:23667202 PMID:23713777 PMID:23792586 PMID:23887774 PMID:23894400 PMID:23939625 PMID:23950206 PMID:23967324 PMID:24033266 PMID:24038938 PMID:24065105 PMID:24122735 PMID:24307375 PMID:24381225 PMID:24382691 PMID:24384472 PMID:24395441 PMID:24487413 PMID:24501221 PMID:24573247 PMID:24590827 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24702488 PMID:24728327 PMID:24744791 PMID:24810334 PMID:24835218 PMID:24857548 PMID:24940547 PMID:25059482 PMID:25119136 PMID:25123297 PMID:25131192 PMID:25157968 PMID:25186627 PMID:25256166 PMID:25293557 PMID:25294809 PMID:25326637 PMID:25339994 PMID:25404506 PMID:25433984 PMID:25503501 PMID:25504633 PMID:25516983 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25612911 PMID:25619955 PMID:25634208 PMID:25691460 PMID:25741868 PMID:25757876 PMID:25765855 PMID:25787918 PMID:25822088 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:25980754 PMID:26014290 PMID:26024390 PMID:26066407 PMID:26205489 PMID:26225655 PMID:26230955 PMID:26270727 PMID:26271412 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26497680 PMID:26554828 PMID:26556299 PMID:26580448 PMID:26585234 PMID:26619011 PMID:26628864 PMID:26641009 PMID:26659639 PMID:26681312 PMID:26718964 PMID:26781615 PMID:26786923 PMID:26787237 PMID:26818906 PMID:26822237 PMID:26845104 PMID:26878390 PMID:26911350 PMID:26976419 PMID:27022024 PMID:27077130 PMID:27146902 PMID:27149858 PMID:27153395 PMID:27179933 PMID:27189670 PMID:27276561 PMID:27276934 PMID:27328919 PMID:27374712 PMID:27458004 PMID:27463065 PMID:27489289 PMID:27493922 PMID:27501770 PMID:27516001 PMID:27523101 PMID:27533082 PMID:27557517 PMID:27616075 PMID:27621308 PMID:27622479 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27730344 PMID:27813088 PMID:27873457 PMID:27895058 PMID:27911860 PMID:27959731 PMID:27993330 PMID:28135145 PMID:28152038 PMID:28160093 PMID:28166194 PMID:28176830 PMID:28271309 PMID:28279309 PMID:28349240 PMID:28356770 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28477316 PMID:28492532 PMID:28664506 PMID:28724667 PMID:28772286 PMID:28802053 PMID:28861920 PMID:28873162 PMID:28949402 PMID:28975465 PMID:29025599 PMID:29058119 PMID:29070607 PMID:29076966 PMID:29126202 PMID:29300620 PMID:29324801 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29581140 PMID:29752822 PMID:29753700 PMID:29785153 PMID:29958926 PMID:29979965 PMID:30076369 PMID:30093976 PMID:30107044 PMID:30128536 PMID:30152528 PMID:30216591 PMID:30224644 PMID:30287823 PMID:30299350 PMID:30311369 PMID:30318520 PMID:30322717 PMID:30327374 PMID:30352134 PMID:30374176 PMID:30450585 PMID:30546832 PMID:30583724 PMID:30630526 PMID:30675318 PMID:30709381 PMID:30720243 PMID:30816478 PMID:30840781 PMID:30918304 PMID:31016814 PMID:31050713 PMID:31105275 PMID:31119730 PMID:31121848 PMID:31127191 PMID:31159747 PMID:31168460 PMID:31206626 PMID:31212162 PMID:31296311 PMID:31300551 PMID:31321604 PMID:31494577 PMID:31559875 PMID:31742824 PMID:31748977 PMID:31775759 PMID:31882575 PMID:31983162 PMID:32000721 PMID:32019277 PMID:32126783 PMID:32156018 PMID:32164171 PMID:32179180 PMID:32187361 PMID:32295079 PMID:32318955 PMID:32371905 PMID:32401780 PMID:32475984 PMID:32658383 PMID:32817165 PMID:32885271 PMID:32888145 PMID:32899294 PMID:32906206 PMID:32959997 PMID:32980694 PMID:33087929 PMID:33138793 PMID:33163847 PMID:33208383 PMID:33245408 PMID:33257846 PMID:33300245 PMID:33332384 PMID:33372952 PMID:33407742 PMID:33471991 PMID:33633026 PMID:33635883 PMID:33674644 PMID:33818021 PMID:33840814 PMID:34026625 PMID:34088725 PMID:34240179 PMID:34266904 PMID:34299313 PMID:34308366 PMID:34503094 PMID:34529667 PMID:34675114 PMID:34709361 PMID:34793666 PMID:34805717 PMID:34994652 PMID:35033608 PMID:35043155 PMID:35127508 PMID:35802772 PMID:35820297 PMID:35938033 PMID:35974385 PMID:36008825 PMID:36219266 PMID:36309086 PMID:36329109 PMID:36988593 PMID:7704023 PMID:29749584 PMID:29429512 PMID:28100771 PMID:33841550 More...
RGD:1302543 , RGD:14995503 , RGD:14995934 , RGD:127285675 , RGD:152998960
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Trp73
transformation related protein 73
exacerbates treatment
ISO
protein:decreased phosphorylation:liver (human) mRNA:increased expression:liver (human) human cells in a mouse model
RGD
PMID:27359056 PMID:31429776 PMID:14760085 PMID:19664633 PMID:25371988
RGD:151347579 , RGD:151347592 , RGD:151347593 , RGD:151347594 , RGD:151347596
NCBI chr 4:154,140,706...154,224,332
Ensembl chr 4:154,140,706...154,224,665
G
Tsc1
TSC complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21499249
NCBI chr 2:28,531,005...28,581,183
Ensembl chr 2:28,531,240...28,581,179
G
Tsc2
TSC complex subunit 2
severity
IEP
protein:decreased expression:liver (human)
RGD
PMID:24119083
RGD:21079731
NCBI chr17:24,814,788...24,851,607
Ensembl chr17:24,814,790...24,851,604
G
Tslp
thymic stromal lymphopoietin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr18:32,948,436...32,952,852
Ensembl chr18:32,948,436...32,952,850
G
Tspy-ps
testis specific protein-Y encoded, pseudogene
ISO
mRNA:increased expression:liver
RGD
PMID:16106251
RGD:2315447
NCBI chr Y:1,055,764...1,058,868
Ensembl chr Y:1,055,764...1,058,868 Ensembl chr Y:1,055,764...1,058,868
G
Tst
thiosulfate sulfurtransferase, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21472284
NCBI chr15:78,283,756...78,290,065
Ensembl chr15:78,283,756...78,290,107
G
Ttc36
tetratricopeptide repeat domain 36
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:44,710,697...44,714,248
Ensembl chr 9:44,710,694...44,714,369
G
Ttk
Ttk protein kinase
disease_progression
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver (human)
CTD RGD
PMID:28284560 PMID:35693827
RGD:153344586
NCBI chr 9:83,716,704...83,754,442
Ensembl chr 9:83,716,742...83,754,442
G
Ttr
transthyretin
disease_progression
ISO
protein:decreased expression:blood serum (human) protein:increased expression:blood serum (human) protein:increased expression:blood serum (rat)
RGD
PMID:29534342 PMID:16240287 PMID:28876464 PMID:28876464
RGD:151356736 , RGD:151665161 , RGD:151664602 , RGD:151664602
NCBI chr18:20,797,266...20,807,383
Ensembl chr18:20,798,337...20,807,378
G
Txnip
thioredoxin interacting protein
IAGP
OMIM:114550
MouseDO
NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
G
Tyms
thymidylate synthase
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:deletion:3'UTR:1494del6(human)
CTD RGD
PMID:18019677 PMID:18230555 PMID:17659576
RGD:14696708
NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
G
Uaca
uveal autoantigen with coiled-coil domains and ankyrin repeats
IAGP
OMIM:114550
MouseDO
NCBI chr 9:60,700,488...60,787,713
Ensembl chr 9:60,701,824...60,787,652
G
Ubd
ubiquitin D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19363144
NCBI chr17:37,504,783...37,506,992
Ensembl chr17:37,504,783...37,506,986
G
Ube2c
ubiquitin-conjugating enzyme E2C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:164,611,849...164,614,822
Ensembl chr 2:164,611,818...164,620,742
G
Ube2e2
ubiquitin-conjugating enzyme E2E 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27914986
NCBI chr14:3,575,429...3,896,133
Ensembl chr14:3,575,429...3,896,121
G
Ube2t
ubiquitin-conjugating enzyme E2T
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 1:134,890,303...134,901,918
Ensembl chr 1:134,890,303...134,901,900
G
Ubr5
ubiquitin protein ligase E3 component n-recognin 5
treatment
IMP
RGD
PMID:32087767
RGD:151665344
NCBI chr15:37,966,421...38,084,103
Ensembl chr15:37,967,572...38,079,098
G
Uchl1
ubiquitin carboxy-terminal hydrolase L1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18666234
NCBI chr 5:66,833,464...66,844,577
Ensembl chr 5:66,833,434...66,844,577
G
Uhrf1
ubiquitin-like, containing PHD and RING finger domains, 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr17:56,610,405...56,630,486
Ensembl chr17:56,610,321...56,630,486
G
Umps
uridine monophosphate synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18230555
NCBI chr16:33,775,152...33,787,408
Ensembl chr16:33,775,152...33,787,408
G
Uroc1
urocanase domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 6:90,310,221...90,341,533
Ensembl chr 6:90,310,266...90,341,533
G
Usp2
ubiquitin specific peptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21147110
NCBI chr 9:43,978,318...44,006,924
Ensembl chr 9:43,978,318...44,006,924
G
Usp4
ubiquitin specific peptidase 4 (proto-oncogene)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35841383
NCBI chr 9:108,223,763...108,269,744
Ensembl chr 9:108,225,052...108,269,744
G
Vasn
vasorin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25826090
NCBI chr16:4,457,809...4,469,030
Ensembl chr16:4,457,805...4,468,666
G
Vav1
vav 1 oncogene
ISO
mRNA:decreased expression:liver
RGD
PMID:2064726
RGD:2306008
NCBI chr17:57,586,080...57,636,236
Ensembl chr17:57,586,100...57,635,031
G
Vcam1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22922871
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
susceptibility
ISO
DNA:hypermethylation:promoter associated with Hepatitis B, Chronic;DNA:SNP: :rs2228570(human) associated with alcoholic liver cirrhosis;DNA:haplotype:: ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar RGD
PMID:24033266 PMID:25741868 PMID:28492532 PMID:29432829 PMID:25541958 PMID:20572305 More...
RGD:14401747 , RGD:14402025 , RGD:14402026
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
Vegfa
vascular endothelial growth factor A
treatment disease_progression susceptibility
ISO IMP
protein:increased expression:liver DNA:polymorphism:promoter:-2578C>A (rs699947)(human) protein:increased expression:serum: associated with liver cirrhosis; protein:increased expression:platelet, liver: DNA:SNP: :2578C>A (human)
RGD
PMID:27338800 PMID:28147320 PMID:28147320 PMID:18544126 PMID:26930285 PMID:16835748 PMID:18392108 PMID:24445728 PMID:25999787 More...
RGD:15003194 , RGD:15003196 , RGD:15003196 , RGD:15003200 , RGD:11527070 , RGD:15014783 , RGD:15036790 , RGD:126848814 , RGD:152177911
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vegfc
vascular endothelial growth factor C
ISO
associated with liver cirrhosis; protein:increased expression:liver:
RGD
PMID:18544126
RGD:15003200
NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131
G
Vhl
von Hippel-Lindau tumor suppressor
disease_progression
ISO
RGD
PMID:31321740
RGD:155882550
NCBI chr 6:113,600,955...113,608,595
Ensembl chr 6:113,600,920...113,608,594
G
Vipr1
vasoactive intestinal peptide receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:121,471,782...121,502,020
Ensembl chr 9:121,471,782...121,502,020
G
Vsig4
V-set and immunoglobulin domain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr X:95,290,807...95,337,044
Ensembl chr X:95,290,809...95,337,044
G
Wdr62
WD repeat domain 62
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:29,939,563...29,980,243
Ensembl chr 7:29,939,563...29,979,844
G
Wdr76
WD repeat domain 76
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 2:121,337,204...121,375,341
Ensembl chr 2:121,337,204...121,375,341
G
Wnt2
wingless-type MMTV integration site family, member 2
susceptibility
ISO
associated with hepatitis B;DNA:SNP: :rs4730775(human)
RGD
PMID:28328801
RGD:14402040
NCBI chr 6:17,988,939...18,032,771
Ensembl chr 6:17,988,939...18,030,584
G
Wrap53
WD repeat containing, antisense to Trp53
ISO
RNA:increased expression:liver:
RGD
PMID:26551349
RGD:11096781
NCBI chr11:69,452,580...69,471,076
Ensembl chr11:69,452,584...69,471,081
G
Xdh
xanthine dehydrogenase
ISO
protein:decreased activity:tumor (rat)
RGD
PMID:179860
RGD:5135059
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
Xpo1
exportin 1
ameliorates treatment exacerbates
ISO
human cell line in a mouse model mRNA:increased expression:liver (human)
RGD
PMID:25030088 PMID:27013579 PMID:31371628
RGD:151665796 , RGD:151667433 , RGD:151667441
NCBI chr11:23,205,768...23,248,250
Ensembl chr11:23,206,055...23,248,249
G
Xpo5
exportin 5
severity
ISO
DNA:snp, haplotype:3' utr:c.*659A>C (rs11077) (human)
RGD
PMID:24676133
RGD:11041737
NCBI chr17:46,513,737...46,554,524
Ensembl chr17:46,513,708...46,554,524
G
Xrcc1
X-ray repair complementing defective repair in Chinese hamster cells 1
susceptibility severity no_association disease_progression
ISO
DNA:missense mutation:cds:p.R399Q (rs25487) (human) DNA:missense mutations:cds:c.482C>T, c.1178G>A (p.P161L, p.R393H) (human) DNA:silent mutation, missense mutation:cds:c.1161G>A, c.1779C>G (p.L387L, p.S593R) (human) DNA:missense mutation:cds:p.R399Q (28152G>A) (rs25487) (human) DNA:missense mutation:cds:c.1804C>A (p.G506A) (human) DNA:missense mutation:cds:p.R399Q (human) DNA:SNPs:exons:c.1254C>T, c.1517G>C (human) associated with hepatitis B;DNA:missense mutation, haplotype:cds:p.R399Q (human) DNA:missense mutations:cds:p.R194W, p.R280H, p.R399Q (human) associated with Hepatitis C, Chronic;DNA:missense mutation:cds:p.R194W (human) associated with Hepatitis C, Chronic;DNA:missense mutation:cds:p.R399Q (human) DNA:SNPs:cds: 194C>T, 280A>G (human) DNA:SNP:exon 13: c.1471G>A, p.E491K (human) DNA:SNPs:exon 9, exon 15: c.910A>G, c.1686C>G (human) associated with Chronic Hepatitis C;DNA:SNP:exon 14: c.1517G>C, p.506G>A (human)
GAD RGD
PMID:15118671 PMID:28058700 PMID:24570146 PMID:23493666 PMID:29682247 PMID:26918371 PMID:24526467 PMID:22502666 PMID:23984316 PMID:14519756 PMID:23534753 PMID:19194663 PMID:23454624 PMID:29935355 PMID:29935355 PMID:28927037 PMID:24446299 PMID:24634229 PMID:32334466 More...
RGD:1331525 , RGD:14696702 , RGD:14696772 , RGD:14696773 , RGD:14985238 , RGD:14985240 , RGD:14985242 , RGD:14985243 , RGD:15014789 , RGD:15014790 , RGD:15014791 , RGD:15014792 , RGD:15036794 , RGD:15036797 , RGD:15036797 , RGD:150530503 , RGD:150530624 , RGD:150540332 , RGD:150540333
NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865
G
Yap1
yes-associated protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29698666
NCBI chr 9:7,932,000...8,004,890
Ensembl chr 9:7,932,000...8,004,597
G
Ythdf2
YTH N6-methyladenosine RNA binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28104805
NCBI chr 4:131,912,227...131,939,567
Ensembl chr 4:131,912,223...131,939,614
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
severity
ISO
RGD
PMID:27811373
RGD:14700875
NCBI chr15:36,770,505...36,803,228
Ensembl chr15:36,771,014...36,797,173
G
Zc3h12d
zinc finger CCCH type containing 12D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34545456
NCBI chr10:7,708,087...7,746,161
Ensembl chr10:7,708,234...7,746,160
G
Zfhx3
zinc finger homeobox 3
severity disease_progression
ISO
human cell line in a mouse model associated with Chronic Hepatitis B;protein:decreased expression:blood serum (human)
RGD
PMID:32277050 PMID:20534899
RGD:151361162 , RGD:151361169
NCBI chr 8:109,005,975...109,688,272
Ensembl chr 8:108,669,276...109,688,262
G
Zfp36
zinc finger protein 36
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 7:28,076,208...28,078,680
Ensembl chr 7:28,076,209...28,079,678
G
Zfp612
zinc finger protein 612
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21965783
NCBI chr 8:110,806,331...110,819,385
Ensembl chr 8:110,806,378...110,819,373
G
Zic2
zinc finger protein of the cerebellum 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:122,712,796...122,717,740
Ensembl chr14:122,712,847...122,717,264
G
Zic4
zinc finger protein of the cerebellum 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr 9:91,247,636...91,271,404
Ensembl chr 9:91,244,466...91,271,401
G
Zic5
zinc finger protein of the cerebellum 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr14:122,696,572...122,703,127
Ensembl chr14:122,694,207...122,703,089
G
Zwint
ZW10 interactor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28284560
NCBI chr10:72,490,678...72,510,796
Ensembl chr10:72,490,677...72,510,796
G
Ephx1
epoxide hydrolase 1, microsomal
ISO
associated with estrogen excess;protein:increased activity;liver (rat)
RGD
PMID:6133380
RGD:152998935
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Ggt1
gamma-glutamyltransferase 1
ISO
associated with estrogen excess;protein:increased activity;liver (rat)
RGD
PMID:6133380
RGD:152998935
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Met
met proto-oncogene
ISO
ClinVar Annotator: match by term: Pediatric hepatocellular carcinoma
ClinVar
PMID:9927037 PMID:17483355
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
G
Car12
carbonic anhydrase 12
ISO
mRNA:increased expression:liver
RGD
PMID:28304380
RGD:153352326
NCBI chr 9:66,619,026...66,674,127
Ensembl chr 9:66,620,968...66,674,127
G
Ctnnb1
catenin beta 1
ISO
protein:increased tyrosine phosphorylation:exon:
RGD
PMID:19101982
RGD:14402052
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Fgfr1
fibroblast growth factor receptor 1
ISO
protein:increased expression:liver:
RGD
PMID:24925055
RGD:11055933
NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734
G
Prkaca
protein kinase, cAMP dependent, catalytic, alpha
ISO
mRNA,protein:increased expression:liver (human)
RGD
PMID:27027723
RGD:151347845
NCBI chr 8:84,699,607...84,723,073
Ensembl chr 8:84,699,622...84,723,072
G
Idh1
isocitrate dehydrogenase 1 (NADP+), soluble
disease_progression
ISO
DNA:misssense mutation:cds:p.Arg132Cys(human) DNA:polymorphism: :rs12478635(human)
RGD
PMID:28403884 PMID:25355558
RGD:14974227 , RGD:14974228
NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
disease_progression
ISO
DNA:polymorphism: :rs11632348(human)
RGD
PMID:25355558
RGD:14974228
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
Lep
leptin
ISO
mRNA:increased expression:liver:
RGD
PMID:20723213
RGD:14696785
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lepr
leptin receptor
ISO
mRNA:increased expression:liver:
RGD
PMID:20723213
RGD:14696785
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
G
Tert
telomerase reverse transcriptase
disease_progression
ISO
mRNA:increased expression:liver:
RGD
PMID:28460432 PMID:20723213
RGD:14696783 , RGD:14696785
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
G
Prkaca
protein kinase, cAMP dependent, catalytic, alpha
susceptibility
IGI
RGD
PMID:28923495
RGD:151347843
NCBI chr 8:84,699,607...84,723,073
Ensembl chr 8:84,699,622...84,723,072
G
Sprtn
SprT-like N-terminal domain
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Progeroid features-hepatocellular carcinoma predisposition syndrome | ClinVar Annotator: match by term: Ruijs-Aalfs syndrome
OMIM CTD ClinVar
PMID:12503110 PMID:25261934 PMID:25741868
NCBI chr 8:125,624,612...125,632,903
Ensembl chr 8:125,624,625...125,632,900
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all